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1. Preface 
 
In the past 20 years, sustainability emerged as one of the keywords in the fields of society, politics 
and science. The key challenge nowadays is the need to produce high-quality products with 
minimum energy and waste. Especially in chemistry, one of the fundamental research goals is to 
develop sustainable, efficient and selective synthesis. In particular, the concept of sustainability is 
clearly defined by the use of low waste chemical transformations plus the use of catalysts in order 
to decrease the amount of energy required by a process; in fact catalysis leads to more efficient 
reactions in terms of energy consumption and waste production. The catalytically active species 
form reactive intermediates by coordination of the organic substrates, thus decreasing the 
activation energy required for the transformation. Formation of product should occur with 
regeneration of the catalyst and it can be described by its turnover-number (TON) providing a 
measure of how many catalytic cycles are executed by one molecule of catalyst.  
Catalysis is an important field in both academic and industrial research, approximately 80% of all 
chemical and pharmaceutical products on industrial scale are obtained using catalyst. During the 
last 50 years various catalysts based on transition metals were developed, in particular, catalytic 
systems based on noble metals like palladium, iridium, ruthenium and rhodium turned out to be 
very effective for a broad range of chemical transformations.  
Unfortunately, especially in the field of the asymmetric reactions, the number of the implemented 
processes is limited, and despite all advances in the technology, most of chiral pharmaceutical 
intermediates are still prepared via traditional resolution of diastereomeric salts.  
This lack of applied catalytic processes can be explained by various reasons:  
a) time-to-market pressure does not give enough time to optimize or to develop new catalytic 
methods;  
b) high cost of the catalysts (both the choice of the central metal and the design of the ligands) 
coupled with the relatively low turnover numbers that can be achieved in most cases makes this 
technology too expensive;  
c) limited availability of noble metals, as long-term supply for the chemical process could exceed 
their occurrence in nature;  
d) toxicity problems, since even trace amounts of toxic metals are often not allowed to occur in 
the final products, and they are usually difficult to recycle; 
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e) technology works fine on a limited number of benchmark substrates; however the catalyst is 
often too slow on real pharmaceutical intermediates (this is often caused by the presence of 
nitrogen-containing substituents that can bind to the catalyst). 
These limitations concern not only pharmaceutical companies but also other industrial sectors 
(like agro-chemistry, food industry or cosmetic sector) which require the use of enantiopure 
compounds.  
For these reasons, most catalytic reactions satisfy the criteria to reach a sustainable 
transformation only on a microscopic scale, in fact cheap catalysts, readily accessible and non-
toxic are needed for these purposes. Replacing precious metals with cheap first-row transition 
metals would be a major breakthrough, with an enormous scientific and industrial impact. In Table 
1 and Figure 1, a comparison of prices of noble metals (expressed in price per gram) with base 
metals (price per kilogram) is reported, showing that the latter are at least 1000 times cheaper.[1][2] 
For this reason, catalysis with inexpensive transition metals is an area undergoing rapid growth.[3]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Prices of noble and base metals 
Metal Price Abundance (ppm) 
Ru 1.22 €/g 1.0×10-3 
Rh 18.56 €/g 1.0×10-3 
Ir 16.24 €/g 1.0×10-3 
Pd 20.23 €/g 1.5×10-2 
Pt 32.86 €/g 5.0×10-3 
Au 38.68 €/g 4.0×10-3 
Fe 0.4996 €/Kg 5.63 ×104 
Co 23.65 €/Kg 2.5×101 
Ni 9.34 €/Kg 8.4×101 
Cu 4.4 €/Kg 6.0×101 
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Figure 1. Prices of noble and base metals (July 2016)[3] 
 
Global efforts in sustainability, coupled with high prices of noble metals, have recently attracted 
considerable attention in developing iron catalysis, because iron is an abundant, inexpensive, and 
environmentally non-toxic metal.[4] Iron is a fundamental element of our planet, the second most 
common metal after aluminium and it is accountable for one third of the Earth’s mass.  
People have known and used iron since nearly 3200 years and it always played a crucial role in 
humans’ world. Iron is essential in biology, we can find iron-based-proteins in all living organisms, 
from bacteria to human. The red color of our blood is caused by iron-containing proteins – 
hemoglobin and myoglobin – thanks to these complexes, blood is able to transport oxygen in our 
bodies. In many other processes, iron is the acting metal in the active site of many important redox 
enzymes: e.g. cellular respiration and oxidation and reduction in plants and animals. In addition 
to that over 80% of nitrogen is originated from the Haber-Bosch process of synthesizing ammonia 
using a heterogeneous iron catalyst. Iron can be considered as one of the least toxic transition 
metals,[5] and its use implicates less toxicity problems since limits for residual iron traces are 
hundreds times greater when compared to noble metals.[6] Iron is relatively cheap and tolerant to 
a number of functional groups, making it an interesting alternative to other transition metals 
typically applied in catalysis, especially for applications in pharmaceutical industry.  
These features are in line with the principles of Green Chemistry, which promoted the increasing 
research activity in the iron field starting about 15 years ago, as demonstrated by an increasing 
number of research articles published in the area (Figure 2 showed a Scopus® search from 1970 
till December 2015 for journal articles containing the phrase “iron catalysis”). 
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Figure 2. Number of iron catalysis-related publications over the last 50 years 
 
Rudyard Kipling, winner of the Nobel Prize in Literature in 1907, started his poem “Cold iron” with 
these lines: 
“Gold is for the mistress — silver for the maid —  
Copper for the craftsman cunning at his trade.  
“Good!” said the Baron, sitting in his hall,  
“But Iron — Cold Iron — is master of them all”.„ 
Nowadays, Beller reported in 2008[7] and Carsten Bolm in 2009[8] that a new iron age has begun, 
“from Rust to a Rising Star”. 
On the other hand, the Fe-based catalytic reductions reported so far suffer from serious 
limitations, such as difficult synthesis/lack of robustness of the catalyst, moderate 
activity/(enantio)selectivity, high cost/poor atom economy of the catalyzed process. These 
limitations need to be overcome, in order for Fe-catalysis to become of practical utility for the 
industrial production of fine chemicals. 
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2. Introduction: iron 
2.1. Electronic configuration, oxidation states, coordination geometries 
of iron 
 
Iron is the second most abundant element in the earth’s crust, it belongs to group VIII and period 
IV, with an electronic configuration of [Ar]3d64s2. It is difficult to find iron as a pure metal in nature 
due to its tendency to be oxidized in the presence of oxygen and moisture. The most common 
oxidation states of iron are +2 and +3, as is showcased by its halides: iron(II) chloride known as 
ferrous chloride and iron(III) chloride, ferric chloride. In air, most of iron(II) complexes are readily 
oxidized to the corresponding iron(III), which is the most stable and widespread iron species. 
Other observed oxidation states are +6, 0, -1, -2, but compared to other elements of the VIII group, 
iron never reaches its full oxidation state of +8.  
In its low oxidation states, it may act as an iron-centered nucleophile and catalyze reactions such 
as nucleophilic substitutions, additions to carboxylic substrates, cycloisomerization and others.[9] 
Iron(II) complexes (d6), show a coordination number of six with an octahedral ligand sphere, while 
iron(III) (d5), can coordinate from three to eight ligands but also often exhibits an octahedral 
coordination. In its most common oxidation states (+2 and +3), iron has a tendency to engage in 
single electron transfer reactions, and for this reason it has found widespread application as a 
catalyst for redox processes.[10] 
In 1963 Pearson introduced the hard and soft acids and bases (HSAB) principle, assigning Fe3+ as a 
hard acid and Fe2+ as borderline acid,[11] and for the quantification Parr and Pearson introduced 
the so called η values as an absolute measure for hardness. These values are determined relative 
to Al3+ (the metal with the highest η value of 45.8).[12] As expected, the hardness increases with 
the oxidation state: Fe0 (η = 3.9), Fe2+ (η = 7.2), Fe3+ (η = 13.1). Iron(0) is a soft Lewis acid, it 
coordinates five or six ligands in a trigonal bipyramidal and octahedral geometry. It should be 
noted that if the transition-metal atoms act as Lewis acid, it is in an excited valence state, so iron 
atoms are 3d8 and not 3d64s2. Despite these general studies, the observed Lewis acidity strongly 
depends on the type of the reaction that is promoted or catalyzed. 
Iron(0) and iron(II) complexes are the main oxidation states used in iron catalysis. Iron carbonyl 
complexes are of special interest due to their high stability, containing an iron(0) center capable 
of coordinating complex organic ligands. 
Introduction: iron 
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By contrast, many Fe-complexes have little propensity to participate in two-electron processes, 
which are typical of many reactions catalyzed by precious metals for example hydrogenations. 
Due to this reason, until recent years, iron has been scarcely exploited for classical transition metal 
reactions (oxidative addition/reductive elimination). 
 
2.2. General difficulties related to the development of new iron catalysts 
First-row transition metal catalysts possess unique features, which usually are not found with 
classical precious metal compounds. In particular, in order to mimic noble metals, iron must 
suppress one-electron redox reactions and facilitate the two-electron redox interplay (e.g. 
Fe(0)/Fe(II)). Other potential obstacles resulting from the propensity to undergo one-electron 
processes are related to radical chemistry and multiple oxidation states.[13] Furthermore, most of 
Fe(II)-complexes are paramagnetic due to the small energy gap (Δ0) between the t2g and the eg 
orbitals (Figure 3), and therefore NMR spectroscopy is scarcely useful for their characterization, 
which mostly relies on mass spectrometry and X-ray diffraction.  
 
Figure 3. MO diagrams for octahedral crystal field: distribution of six valence electrons in high-spin and 
low-spin Fe(II)-complexes 
 
2.3. Fundamental reactions that play a key role in iron catalysis 
Halogen-metal exchange, ligand exchange, insertion, haptotropic migration, transmetallation, 
oxidative addition, reductive elimination, β-hydride elimination and demetallation are 
fundamental reactions that play a key role in transition metal catalysis. 
Oxidative addition (Scheme 1) is generally observed in d8 systems such as Pd(II), Ni(II), Ir(I), Rh(I), 
Co(I), Os(0), and also for iron it is possible that the oxidation state increases from (0) to (II). The 
reactivity for this elemental reaction step increases from right to left in the periodic table and 
from top to bottom within the respective triad. It is furthermore influenced by the ligand sphere: 
strong σ-donor ligands and poor π-acceptor ligands favor the oxidative addition due to increased 
electron density at the metal. 
Introduction: iron 
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Scheme 1. Oxidative addition 
 
Another important reaction is the insertion; hydroformylation[14] and alkene polymerization are 
well-known industrial processes. Scheme 2 shows how carbon monoxide is used to obtain 
aldehydes and ketones from the carbonylation of alkyl groups. 
 
Scheme 2. Example of insertion of carbon monoxide 
 
The reductive elimination (last step in Scheme 2) releases the organic product in a concerted 
mechanism, in which the electron count of the metal is reduced by two. A potential limiting aspect 
for iron catalysis is the tendency for coordinative saturation; in diene-iron complexes, for example, 
the dissociation of a ligand or the reductive elimination is not favored, and the free ligand can be 
obtained after the removal of the iron by demetallation. This usually requires harsh oxidative 
conditions, which oftentimes led to the decomposition of the complex by giving inert iron oxides, 
while at the same time, such strong conditions might also destroy sensitive organic ligands. 
Consequentially, milder conditions are needed to obtain the desired product. For example, in iron-
mediated [2+2+1] cycloadditions, the demetallation of the (η4-cyclopentadienone)iron tricarbonyl 
complexes is achieved by using a different method [see paragraph 3.3.5, Scheme 48].[15] 
 
2.4. Importance of the ligands 
Homogeneous transition metal based catalysis has seen a rapid growth in recent years, mainly 
thanks to the selectivity (chemo, regio, stereo) requirements, which is highly desirable for new 
processes and products, but also because of an environmental advantage related to the 
minimization of side products according to “green chemistry”.[16] 
A ligand is the keystone of a catalytic system and allows to tune the reactivity and selectivity by 
modifying its steric and/or electronic properties, in order to improve the catalytic properties of 
Introduction: iron 
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the complex.[17] For these reasons, the properties of a complex are defined by the interaction 
between the ligands and the metal center. The metal complex can be stabilized by tri- and 
tetradentate ligands which can bear phosphorus and/or nitrogen donors such as porphyrins or 
diiminodiphospine.  
Ligands can be also modified for specific needs and stability,[18] and in many cases their structures 
are not affected during the reaction, acting as “spectators”.  
The main drawback for base metals is their electronic structure, which is prone to one-electron 
redox changes, different from noble metals, that, as already mentioned, easily undergo two-
electron redox changes, (e.g. Rh(I)/Rh(III), Ir(I)/Ir(III), Pd(0)/Pd(II)), which can be used to promote 
bond breaking or making. Overcoming this one-electron transfer tendency is a challenge, both for 
reactivity control as well as for stabilizing and maintaining the catalytic functions of the complexes.  
Recent advances in transition metal catalysis brought new types of “reactive” ligands, endowed 
with the characteristic property of synergistic cooperating with the metal to mimic the bond-
making and bond-breaking processes.[19] These ligands can be divided into two categories: redox 
non-innocent or cooperative ligands.  
In 1966 Jørgensen introduced the term “non-innocent”: “ligands are innocent when they allow 
oxidation states of the central atom to be defined”.[20] Since it is ambiguous to determine the 
oxidation state, usually set of spectroscopic studies have to be performed, like: Raman or electron 
paramagnetic resonance (EPR), X-ray absorption (XAS), UV-vis or Mössbauer spectroscopy. These 
ligands have the ability to delocalize part of the electronic density of the complexes. In this way 
they become a kind of “electronic reservoir” during the reaction and catalytic process, and allow 
multi-electron transformations for base metals. Radical-type transformation can also be initiated 
and controlled, and redox processes can also occur. As a result, new “redox isomers” can form, 
which should not be confused with resonance structures, and can exhibit a variety of different 
properties and reactivities.  
Cooperative (or chemically non-innocent) ligands are “participating directly in bond-activation and 
undergo reversible chemical transformations”.[21] 
The metal part of the complex acts as a binding site and brings reactants together, in that way, 
the metal and the ligand act cooperatively in a synergistic way and their interactions trigger a 
chemical transformation, but at the same time can show also an intrinsic reactivity. 
“Non-innocent” does not identify a particular group of ligands, it is rather a state, which can be 
attributed to any ligand under the right conditions. Observed “non-innocent” behavior of a ligand 
in a metal complex does not guarantee that it will act in the same way with a different metal or 
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under different conditions. Only detailed spectroscopic investigations can confirm the “non-
innocent” nature of the ligand in the specific transformation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Iron-catalyzed hydrogenation and asymmetric hydrogenation 
19 
 
3. Iron-catalyzed hydrogenation and asymmetric hydrogenation 
 
It has been often overlooked, that the first catalytic homogenous hydrogenation was not based 
on a noble metal but on copper.[22] In any case the most commonly accepted date for the birth of 
homogenous reduction is 1966, when Wilkinson found RhCl(PPh3)3 as an effective catalyst for the 
hydrogenation of alkenes.[23] Replacement of the triphenylphosphine ligands from this catalyst 
with a chiral phosphine led to the first examples of asymmetric hydrogenation (AH). Subsequently 
research on rhodium complexes bearing different ligands spread, and a huge variety of ligands 
were developed (e.g. monodentate phosphines,[24] chiral bidentate or monodentate phosphorus 
ligands,[25] BINAP[26]). It was clear, as already mentioned, that the choice of proper ligands for a 
given metal center is essential to obtain a high level of catalytic activity and selectivity for the 
desired transformation.  
It is well known that stereochemistry plays a crucial role in synthesis of new drugs or 
agrochemicals. Compounds have to precisely fit into the active sites of enzymes and it is also 
common that two enantiomers of the same molecule can show completely different properties. 
In the case of fragrances or flavor additives, they can just smell or taste differently. In the case of 
drugs, one enantiomer can have a therapeutic use, while second can be highly toxic or even 
possess strong teratogenic properties (e.g. Thalidomide). For these reasons, enantiopure chiral 
molecules, especially in the field of pharmaceutical intermediates, are regulated by the US's Food 
and Drug Administration (FDA).[27]  
Enantioselective catalysis is in principle the most efficient strategy for the synthesis of enantiopure 
molecules and in particular asymmetric hydrogenation is a suitable method for large-scale 
applications due to its operational simplicity, atom economy, high conversions (and enantiomeric 
excesses) which can be obtained without harsh, dangerous and energy-consuming conditions. 
Enantioselective transfer hydrogenation for the reduction of ketones, imines and conjugated C=C 
double bonds, using isopropanol and formic acid/trimethylamine instead of H2, also gained a 
prominent position in recent years, even if the most used sources of hydrogen remains molecular 
hydrogen.[28] 
As already mentioned in the last 15 years there was a development of iron catalysis, where some 
iron complexes demonstrated to have catalytic activity for the reduction of unsaturated 
substrates (alkenes, ketones, aldehydes, imines) by molecular hydrogen or different hydride 
sources, in which the Fe-H is involved as a key intermediate. 
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3.1. Fe-H complexes 
The synthesis of iron hydride complexes can be done via different routes: 
1) Protonation of an anionic iron complexes: 
 
2) Substitution of halides (one electron donor ligand) with a hydride, using NaBH4 or LiAlH4 
as hydrogen source: 
 
3) Oxidative addition of H2 or E-H to a low valent and unsaturated iron complex: 
 
4) β-elimination of an alkyl iron complex to obtain the hydride complex coordinated to the 
olefin: 
 
Fe-H plays an important role in homogenous catalysis; hydride complexes usually act as important 
intermediates in the catalytic cycle for hydrometalation such as e.g., hydrosilylation or 
hydrogenation reactions.[29] 
 
The first iron hydride complex, Fe(CO)4(H)2, was reported in 1931 by Hieber and Leutert,[30] the 
complex was synthesized and isolated at low temperature from Fe(CO)5 and OH-: 
 
but it decomposed at room temperature into Fe(CO)5, Fe(CO)3 and H2. 
In Figure 4 three iron hydride complexes are presented, which were prepared, isolated and 
characterized spectroscopically and in some cases also X-ray crystal structures were obtained. The 
first structurally characterized iron complex contained a μ-H ligand, [NEt3H][HFe3(CO)11] (Structure 
a, Figure 4),[31] was reported in 1965. In 1970, the first terminal hydride iron complex was 
characterized by X-ray analysis, CpFeH(CO)(SiCl3)2.[32] In 1972, the first X-ray structure of a 
dihydride iron complex, cis-[Fe(H)2{PPh(OEt)2}4], was reported.[33] 
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Figure 4. Lewis representations of the first X-ray crystal structures of three types of iron hydride 
complexes a, b and c 
 
The spectroscopic characterization of this class of compounds can be problematic, but still it is 
possible to find characteristic signals in different spectroscopic methods. 
The 1H-NMR spectra for diamagnetic iron hydride complexes show diagnostic signals in high field. 
IR spectra are also helpful because the Fe-H stretching frequencies are observed in the range of 
1500 – 2200 cm-1, even though sometimes the intensities are weak and thus the method is not 
reliable. Crystallography methods are helpful to prove the structure of the complex, but in many 
cases the hydrides themselves are not detected, due to poor scattering of X-rays of the hydride 
and the estimation of Fe-H bond should be carefully evaluated. 
 
3.2. Hydrogenation of alkenes and alkynes 
3.2.1. Homoleptic ironcarbonyl complexes 
In the presence of carbon monoxide iron can form three stable homoleptic complexes: 
ironpentacarbonyl Fe(CO)5,[34] diironnonacarbonyl Fe2(CO)9 and triirondodecacarbonyl Fe3(CO)12 
(Figure 5). These compounds represent the source of iron for most artificial complexes. 
The first iron complex, Fe(CO)5, was discovered in 1891 by Berthelot[35] and Mond,[36] it is a stable 
18-electron complex and show a trigonal-bipyramidal geometry, where the carbon monoxide 
ligands are strong ligands capable of stabilizing low spin electronic structures of iron(0).  
Fe(CO)5 was used in the early attempts for iron-catalyzed hydrogenations.[37] In 1964 Frankle et al. 
hydrogenated methyl linoleate and methyl linolenate to get monoenoic fatty esters.[38] 
Unfortunately, the reaction had to be performed at high hydrogen pressure (250 – 300 atm) and 
high temperature (200 °C). Due to these harsh conditions, there was very low chemoselectivity, 
making this method unacceptable also for industrial purposes. 
Also Noyori and co-workers used iron pentacarbonyl to obtain saturated ketones from α,β-
unsaturated ketones with very good yields.[39] Subsequently Wrighton discovered that the 
reactivity of Fe(CO)5 was improved under UV irradiation at room temperature, but unfortunately 
only poor yields and limited substrate scope were obtained.[40]  
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The mechanism of the hydrogenation was studied by Grant and co-workers,[41] where the active 
species in the hydrogenation was formed upon heating (>150 °C) or upon constant UV-irradiation 
of Fe(CO)5 to obtain Fe(CO)3, containing a vacant site for the coordination. 
Fe2(CO)9 is prepared via photolytic reaction from Fe(CO)5,[42] while Fe3(CO)12 can be obtained from 
Fe2(CO)9 by a thermal reaction. Due to slowly degradation, leading to pyrophoric iron, the last two 
complexes, which contain direct metal-metal bonds must be carefully handled under inert 
atmosphere. 
 
Figure 5. Homoleptic ironcarbonyl complexes 
 
3.2.2. Biomimetic complexes: iron porphyrins  
Porphyrins are a group of heterocyclic macrocycles, composed of four modified pyrrole subunits 
interconnected at their α-carbon atoms via methine bridges (=CH−). Several biomimetic catalysts 
took inspiration from natural iron-porphyrin complexes, in particular from the “heme”, a cofactor 
of the protein hemoglobin. Kano and co-workers used Fe-porphyrins together with NaBH4 as a 
hydride source to radically hydrogenate styrene, obtaining TOFs up to 81 h-1.[43] The key in this 
mechanism is the formation of the σ-alkyliron(III) complex 1a (Scheme 3), through the 
coordination of styrene to complex 1. Intermediate 1a, in the presence of a polar protic solvent, 
seems to be stabilized by extensive solvation, and rapidly transfers a proton from the solvent to 
styrene to afford the final product, ethylbenzene (EB).  
 
Scheme 3. Mechanism of the reduction of styrene using [Fe(TPP)Cl] 1 in the presence of NaBH4  
 
In fact, the role of the solvent is crucial to favor the equilibria between 1a and 1b, respect to 1b 
and 1c; in particular polar solvents are able to separate 1-phenylethyl radicals, which may couple 
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with each other to give the by-product, 2,3-diphenylbutane (DPB). In addition, isotope labeling 
experiments revealed that hydrogen atoms on the α- and β-position of the ethylbenzene come 
from the hydroxy proton of ethanol (C2H5OD) and the hydride of NaBD4. 
 
Sakaki et al. reported a similar approach with porphyrin [Fe(TPP)Cl] 1 to hydrogenate α,β-
unsaturated esters with high turnover frequencies (TOFs) up to 4850 h-1 (Scheme 4).[44] Again, 
deuterium labeling studies revealed that besides a hydride from NaBH4, a proton from methanol 
was transferred during the hydrogenation to the β- and α-carbons of the double bond. 
Unfortunately, in some cases isomerization was observed (e.g. from oct-1-ene to oct-2-ene). 
 
Scheme 4. Hydrogenation of α,β-unsaturated esters using [Fe(TPP)Cl] 1 
 
Several other complexes containing iron where found in the active site of natural proteins, e.g. a 
diiron complex in [Fe-Fe]-hydrogenases, a binuclear [Fe-Ni]-hydrogenase complex and a monoiron 
complex in [Fe]-hydrogenase (Figure 6). In [Fe-Fe]-hydrogenases (a), two Fe centers are bridged 
by a CO ligand and a small organic moiety, even though it is not clear if the moiety is a dithiolate.[45] 
On the other hand, [Ni-Fe]-hydrogenase (b) contains a large subunit with the Ni-Fe cluster[46] and 
a small one, an iron-sulfur cluster ([4Fe-4S]).  
 
Figure 6. Models for the active site of [Fe-Fe]-, [Ni-Fe]-, and [Fe]-hydrogenases 
 
Inoue et al., inspired by iron-sulfur clusters present in the active sites of hydrogenase enzymes, 
proposed a biomimetic approach.[47] The Fe4S4 cluster showed catalytic activity, in the presence of 
PhLi and hydrogen gas, in the hydrogenation of 1-octene and cis- and trans-stilbene with very 
good yields, although the iron cluster was more active with (Z)-alkenes (Scheme 5) and the 
selectivity favored terminal vs. internal double bonds when hexamethylphosphoric triamide 
(HMPT) was used as a cosolvent. 
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Scheme 5. Reduction of olefins using bio-inspired iron-sulfur clusters catalyst 
 
3.2.3. Multidentate P ligand iron complexes 
Bianchini and co-workers developed the first catalyst able to hydrogenate alkyne bond bearing a 
multidentate P ligand 3 in 1992.[48] This catalyst was able to promote the reduction of terminal 
alkynes to corresponding alkenes at room temperature, under atmospheric pressure of H2 
(Scheme 6).  
 
Scheme 6. Selective hydrogenation of 1-pentyne using multidentate P complex 
 
The proposed catalytic cycle shows a cooperative involvement of the ligand during the 
transformation, as it can leave a free coordination site for the incoming substrate by releasing one 
terminal phosphine arm (Scheme 7). 
 
Scheme 7. Catalytic cycle of the reduction of alkynes by a multidentate P-Fe complex 
 
Subsequently a substrate scope was performed, and it was observed that bulkier substituents on 
terminal alkynes RC≡CH (R = Ph, SiMe3, n-Pr, n-Pent, CH=CH(OMe)) gave lower conversions, and 
at the same time the rate of the conversion slowed down.[49] Luckily the reaction always 
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proceeded with a full selectivity of reducing alkynes to alkenes over alkanes, and it was postulated 
that the iron hydride disfavored the insertion of the olefins, in fact in the case of ethylene, a 
coordination to the metal center was observed, though it did not proceed further to insertion, 
even under different harsh conditions. 
 
In 2004 Peters and Daida reported the hydrogenation of olefins catalyzed by a polydentate 
phosphine complex 4 (Scheme 8).[50] The hydrogenation of alkenes required a high catalyst loading 
(10 mol%), but mild reaction conditions (rt, low pressure), while alkynes were undergoing 
undesired side reactions, such as reductive dimerization or polymerization.  
 
Scheme 8. Hydrogenation of olefins catalyzed by a polydentate phosphine complex 
 
Peters proposed a plausible mechanism (Scheme 9), involving an unusual Fe(II)/Fe(IV) catalytic 
cycle, with reversible dissociation of the ligand from the iron center in a similar way described by 
Bianchini.[51] In this mechanism, the iron(IV) trihydride phosphine complex 4 undergoes hydrogen 
loss to give the coordinatively unsaturated monohydride complex 4.1 (detected by NMR), 
followed by olefin coordination (4.2) and its insertion into the Fe-hydride complex to give the 
stable alkyl complex (4.3), which reacts with H2 to release the alkane and regenerate the active 
species (4.2). 
 
Scheme 9. Proposed mechanism for the reduction of alkenes by polydentate phosphine complex 
 
Furthermore, Peters developed a new ferraboratrane complex 5 (Scheme 10) for the 
hydrogenation of ethene and styrene, albeit with low TOFs (up 15 h-1).[51] Despite these 
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synthetically not promising results, mechanistic studies about the transformation were 
performed, which revealed a reversible iron-boron bond cleavage, where the boron atom can act 
as a shuttle for hydride transfer to substrate.  
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Scheme 10. Hydrogenation of olefins using a ferraboratrane complex 5 
 
In 2012 Beller and co-workers reported a selective hydrogenation of alkynes to alkenes; the active 
catalyst was formed in situ, starting from Fe(BF4)2∙6H2O and a tetraphos ligand 6, using formic acid 
as a hydrogen donor. In this way, quantitative yields for a broad range of aromatic and aliphatic 
terminal alkenes were observed. These were reduced under mild and base-free conditions, and 
several functional groups were tolerated (Scheme 11).[52] 
The catalytically active species is formed in situ by adding the tetraphos ligand (PP3) to the iron 
precursor, which splits the formic acid under concomitant carbon dioxide release to form 
[FeF(H2)(PP3)]+. Finally, phenylacetylene after coordination to the iron center, is reduced and the 
catalyst releases styrene to regenerate the active catalyst (Scheme 12).[52]  
 
Scheme 11. Selective semihydrogenation of (hetero)aromatic and aliphatic alkynes 
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Scheme 12. Proposed mechanism for the reduction of alkynes using Fe(BF4)2·6H2O in the presence of a 
tetraphos ligand (PP3) 
 
3.2.4. P,N,P- and tetradentate N-ligand complexes 
In 2013 Milstein and co-workers reported an acridine-based P,N,P-iron pincer complex 7 for the 
hydrogenation of alkynes to alkenes with high yields and excellent E-selectivity (Scheme 13).[53]  
This reaction was carried out under mild conditions (4-10 bar H2) and did not require the addition 
of an external base. Furthermore, the presence of many functional groups like carbonyl, nitrile or 
halogen substituents was tolerated by this catalytic system. 
 
Scheme 13. Hydrogenation of alkynes using an acridine-based P,N,P-iron pincer complex 
 
Thomas and co-workers formed an iron complex in situ from a tetradentate iminopyridine ligand 
8 and FeCl2 (Scheme 14), which was subsequently reduced with an organometallic coupling 
reagent (iPrMgCl) to form active, low valent catalyst, thus avoiding the isolation of the highly air- 
and moisture sensitive low valent iron species. In this way, a broad range of mono-substituted, 
1,1- and 1,2-substituted aryl- and alkyl-substituted alkenes were hydrogenated.[54] 
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Scheme 14. Reduction of olefins using an iron complex from a tetradentate iminopyridine ligand 
 
3.2.5. Bis(imino)pyridine complex 
Bis(imino)pyridine iron complexes are a very important group of iron catalysts as highly efficient 
catalysts for the hydrogenation of alkenes, presented by Chirik and co-workers in 2004.[56]  
The design of this catalyst took inspiration from the observation of previously reported active iron 
carbonyl compounds 10 in the hydrogenation of alkenes, in which it was proven that Fe(CO)3 with 
a vacant site was the active species,[41] plus a polymerization catalyst reported by Gibson and 
Brookhart 11 (Figure 7).[57]  
 
Figure 7. Bisiminopyridine iron complex 
 
Diiminopyridine (PDI) ligands are pyridine derivative with imine sidearms attached to the 2,6–
positions, where the three nitrogen centers can bind metals forming a so called pincer complex. 
These ligands are “non-innocent”, which means that they can change their oxidation state during 
the course of the catalytic cycle. 
 
Scheme 15. Synthesis of bis(imino)pyridine iron complexes 
 
Chirik chose DIP ligands because they are easily synthesized and easy-to-tune structurally in order 
to obtain a library of new catalysts.[58] The ligand, as shown in Scheme 15, can be synthesized by 
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Schiff base condensation of commercially available 2,6-diacetylpyridine with two equivalents of 
substituted anilines (e.g. 2,4,6-trimethylaniline and 2,6-diisopropylaniline). 
Unsymmetric variations have been developed subsequently by successive condensation of 
different anilines. The dicarbonyl portion of the backbone can be further modified (e.g 2,6-
dipyridecarboxaldehyde and 2,6-dibenzoylpyridine), even though the most commonly 
modification was achieved changing the anilines (Figure 8). 
 
Figure 8. Different types of bis(imino)pyridine iron complexes 
 
The highly conjugated ligand framework of bis(imino)pyridine stabilizes metals in an unusual 
oxidation state, in fact the ability of the neutral complex to accept up to three electrons leads to 
ambiguity about the oxidation states of the metal center. The complex Fe(PDI)(N2)2 9, obtained by 
reduction of the ferrous dihalide complex 11 with sodium amalgam, seemed to be an 18-electron 
complex, consisting of Fe(0) centre with five 2-electron ligands in a formal Fe(0)(PDI) complex 
(Figure 9). Despite this, a combination of spectroscopic techniques and density functional theory 
(DFT) calculations indicated, that this complex is better described as a high spin Fe(II) (d6) 
derivative of [PDI]2−, so the metal center transferred two electrons to the ligand.[59]  
 
Figure 9. Redox activity of bis(imino)pyridine ligands in iron coordination compounds 
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This non-innocent behavior allows iron-PDI complexes to participate in two-electrons redox 
reactions, in which the oxidation state at the metal remains unalterated throughout the catalytic 
cycle, and the two electrons stored in the ligand are shuttled from the ligand to the substrate. 
Complex 9 showed an excellent activity in the hydrogenation of olefins, particularly for a base 
metal, with TOF of 1814 h-1 for the reduction of 1-hexene at room temperature in 12 minutes and 
under 1 atm of H2 (Scheme 16). This result was comparable to the efficiency of many classical 
noble metal catalysts like Pd/C, Wilkinson's (Ph3P)3RhCl and Crabtree's [(COD)Ir(PCy3)Py]PF6, 
under identical conditions. Internal alkenes required longer reaction times in comparison to 
terminal olefins and the system was not affected by different functional groups like amines, 
ketones, esters or ethers.[59] In the case of α,β-unsaturated ketones, a decomposition of the 
catalyst was noted and only TOFs up to 240 h-1 were obtained in the hydrogenation of α,β-
unsaturated esters to the corresponding saturated esters. Another advantage of catalyst 9 was 
the possibility to conduct the reaction without solvent. 
 
Scheme 16. Hydrogenation of olefins using a bis(imino)pyridine iron complex 9 
 
The steric optimization of the ligand led to the development of complex 12 (Figure 8), which 
improved the activity of the catalyst, but a more remarkable effect was obtained upon 
introduction of electron-donating substituents, e.g. NMe2 at the 4-position of the pyridine ring 
(complex 13). Also, the dinuclear catalyst 14 revealed excellent catalytic activity. 
The proposed catalytic cycle, in Scheme 17, shows that loss of N2 forms the active species 9.1; and 
subsequent coordination of the olefin gives 9.2. This path is preferred over an oxidative addition 
of H2. Then oxidative addition occurs to provide the olefin dihydride intermediate 9.3, and finally, 
olefin insertion leads to 9.4. Reductive elimination yields the corresponding alkane and 
regenerates the active species.  
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Scheme 17. Proposed catalytic cycle of the hydrogenation catalyzed by a bis(imino)pyridine iron complex 
9 
 
Chirik and co-workers also evaluated the possibility to replace the imino functionalities with 
phosphino groups (Scheme 18).[61] Complex 15 had a different coordination model, where one 
nitrogen ligand was replaced by a hydride. Unfortunately, the efforts did not lead to an increased 
activity. During the hydrogenation of 1-hexane a lower TOF (325 h-1) was achieved respect to the 
one obtained with complex 9. 
 
Scheme 18. Hydrogenation of 1-hexane using a bis(diisopropylphosphino)pyridine iron complex 
 
Later on complexes with different imino functionalities were developed and new iron α-diimine 
complexes were developed (Scheme 19).[62] Since the dinitrogen-substituted complexes were 
comparably unstable, ligands like alkynes, alkenes (16) or dialkenes (17) were introduced to 
stabilize the structure. Despite these efforts relatively low TOFs of 90 h-1 were achieved in the 
hydrogenation of 1-hexene. 
Despite the significant achievements made by Chirik's group, their catalysts are highly air-
sensitive, so synthesis and manipulation must take place under rigorously dry conditions and 
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argon atmosphere, inside a glovebox. This makes an industrial application of this process nearly 
impossible.  
 
Scheme 19. Synthesis and hydrogenation activity of α-diimine iron alkyne complexes 16 and 17 
 
3.2.6. (Cyclopentadienyl)iron complex 
In 2014, Nakazawa and co-workers reported a very interesting example of transfer hydrogenation 
of alkynes with isopropanol, using a (hydrido)iron complex 18 with a Si-H functionalized 
cyclopentadienyl ligand. Unfortunately, the reaction is not very chemoselective, oftentimes 
leading to mixtures of the corresponding alkenes and alkanes (Scheme 20).[55]  
 
Scheme 20. Transfer hydrogenation of alkynes with isopropanol, using complex 18 
 
Even though the obtained results were not so impressive, it was the first reported example of iron 
complex involved in a transfer hydrogenation from isopropanol to be able to reduce an alkyne or 
an alkene. This complex did not hydrogenate polar unsaturated bonds like in ketones or 
aldehydes.  
Mechanistic studies revealed that hydrogen atoms were transferred first by hydrometalation 
(Scheme 21, 18.2), followed by reductive elimination (18.3 to 18.4).  
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Scheme 21. Proposed mechanism of the transfer hydrogenation of alkynes with isopropanol, using 
complex 18 
 
3.2.7. Iron nanoparticles 
De Vries and co-workers reported a non-ligand approach using iron nanoparticles (NPs) for the 
homogenous reduction of alkenes and alkynes.[63] Based on a methodology described by Bedford, 
Fe-NPs were prepared by reducing FeCl3 with EtMgCl in THF.[64] The hydrogenation was conducted 
using 5 mol% of Fe-NPs under mild reaction conditions (10-20 bar of H2, THF and 25 °C). Cis-1,2 
and 1,1-disubstituted alkenes gave a fast and quantitative conversion, while 1,2-trans-
disubstituted and cyclic cis-alkenes were reduced slower. 1-octyne was hydrogenated with a TOF 
of 118 h-1. Unfortunately the hydrogenation of tri- and tetrasubstituted alkenes with Fe-NPs was 
unsuccessful. In addition to this limitation, the presence of OH groups in the substrate slowed 
down the rate of the reaction. Fe-NPs obtained by the described method were found to be 
moderately stable, and were successfully applied in the continuous hydrogenation of norbornene, 
an important intermediate in the synthesis of pharmaceutical drugs.  
Another development in this field was the use of iron nanoparticles supported on graphene, which 
were found to be catalytically active in hydrogenation reactions with various cyclic and terminal 
olefins.[65] The main advantage was the efficient removal of the nanoparticles by simple magnetic 
decantation, and the so re-obtained NPs were shown to still be comparably catalytically active.  
The iron(0) particles obtained as products of the reaction of iron(III) chloride with ethylmagnesium 
chloride were found to contain about eight iron atoms as determined by X-ray absorption 
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spectroscopy. These small nanoclusters are most likely stabilized by the coordination of THF 
molecules.[66]  
Wangelin and co-workers induced a high Z-selectivity in alkene hydrogenation, using Fe-NPs in a 
biphasic heptane/ionic liquid system.[67] The presence of a nitrile function was essential for 
achieving high Z-selectivity, and the location of the nitrile group was not relevant: it could be 
introduced either as a substituent in the ionic liquid or as an acetonitrile additive (Scheme 22). 
The iron nanoparticles were easily removed thanks to the ionic liquid, which prevented 
aggregation and allowed to decant them. Furthermore, the layer could be reused six times without 
any loss in catalytic activity. Starting from different alkyl and aryl alkynes, the products were 
obtained in high yields and in most cases with almost complete Z-selectivity. 
 
Scheme 22. Fe-NPs in a biphasic heptane/ionic liquid system 
 
Beller’s group was able to obtain ultrasmall monodisperse Fe-NPs, about 2 nm in diameter, from 
the decomposition of {Fe[N(SiMe3)2]}2 under a hydrogen atmosphere.[68] These ultrasmall NPs are 
good models for the determination of the intrinsic reactivity of iron because they are well-defined 
and are not oxidized at their surface. The ultrasmall Fe-NPs were tested in hydrogenation under 
mild reaction conditions, 2.4 mol% of catalyst, 10 bar of H2, in mesitylene at room temperature. 
The iron nanoparticles were found to be active in the hydrogenation of terminal alkenes and 
alkynes, as well as cyclic alkenes, but were ineffective for non-cyclic internal alkenes and internal 
alkynes.  
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3.3. Hydrogenation of carbonyl compounds 
The hydrogenation of carbonyl compounds has long been dominated by rhodium, ruthenium, and 
iridium catalysts. Even though iron catalysts have also been studied for this purpose for decades, 
it was only recently that their efficiency was brought to levels that allow them to compete with 
noble metal catalysts for specific applications.[69] 
 
3.3.1. Iron carbonyl 
The only option for the catalytic hydrogenation of carbonyl compounds was the use of noble 
metals, until the 1980s. This changed when Markó and co-workers reported the use of Fe(CO)5 
together with triethylamine to hydrogenate various ketones (moderate conversion) and 
aldehydes (quantitative conversion) to the corresponding alcohols (Scheme 23). Markó and co-
workers were forced to use quite harsh conditions, 100 bar of total pressure (98.5% H2 + 1.5% CO) 
at 20 °C for aldehydes and 150 °C for ketones.[70]  
 
Scheme 23. Proposed mechanism for the hydrogenation of ketones using Fe(CO)5 
 
3.3.1.1. Diaminophosphine ligand and terpyridine ligand 
In 2004, Gao and co-workers took inspiration from Markó’s catalytic system by adding a chiral 
diaminophosphine ligand 21. The iron catalyst was formed in situ from the carbonyl(hydrido)iron 
cluster [Et3NH][HFe3(CO)11] and the corresponding ligand. This system was tested in the 
asymmetric transfer hydrogenation, using isopropanol as a hydrogen source, and revealed good 
to very high conversions with moderate to good enantiomeric excesses. The highest ee values (up 
to 98% ee) were obtained for sterically crowded ketones (Scheme 24).[71] 
Iron-catalyzed hydrogenation and asymmetric hydrogenation 
36 
 
 
Scheme 24. Transfer hydrogenation in the presence of a chiral diaminophosphine ligand 21 
 
Beller and co-workers introduced a three-component catalytic system consisting of: Fe3(CO)12 or 
FeCl2, a terpyridine ligand 22 and triphenylphosphine, in isopropanol as solvent and hydrogen 
donor in the presence of a base (Scheme 25). The system worked in the transfer hydrogenation 
for aliphatic and aromatic ketones.[72] The corresponding alcohols were obtained in good to 
excellent yields without a significant difference between the two iron catalysts, but the reaction 
outcome was strongly dependent on the choice of the base, but when iPrONa or tBuONa were 
used, the corresponding alcohols were obtained with high yields. 
 
Scheme 25. Three component catalytic system for transfer hydrogenation 
  
Beller’s group additionally developed a well-defined iron(II) tetradentate phosphine complex 23 
for the selective hydrogenation of α,β-unsaturated aldehydes.[73] Excellent yields of allylic alcohols 
were obtained from the corresponding allylic aldehydes, as well as alcohols from aromatic, 
heteroaromatic or alkyl aldehydes (Scheme 26).  
 
Scheme 26. Catalytic hydrogenation of aldehydes and α,β-unsaturated aldehydes by complex 23 
[FeF(L)][BF4] 
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This complex is believed to easily provide a free coordination site for the incoming substrate by 
temporarily releasing one terminal phosphine arm, as proposed by Bianchini and co-workers, for 
the related iron-catalyzed hydrogenation of alkynes.[48]  
Beller and co-workers also developed a dual iron-catalyzed process for the hydrogenation of α-
keto and α-imino esters (Scheme 27).[74] 
The hydrogen transferring agent is the NAD(P)H model dihydrophenanthridine (DHPD). A 
combination of Fe3(CO)12 and iron(II) triflate was employed as iron sources. The former is the 
catalyst of the hydrogenation of the DHPD and the transfer hydrogenation is catalyzed by Lewis 
acids, which can be the iron carbonyl, a derived species or the iron(II) salt. 
 
Scheme 27. Iron-catalyzed biomimetic reduction of ethyl phenylglyoxylate using DHPD 
 
3.3.1.2. Iron porphyrins and macrocyclic complexes 
Beller's group also followed a biomimetic approach, using in situ generated iron porphyrins 
instead of iron triphenylphosphine systems (Scheme 28).[75] This system was less base-dependent 
and allowed to obtain excellent conversions in the transfer hydrogenation of ketones with 
isopropanol, again independently from the applied iron source. Conversions up to 99% and TOFs 
up to 642 h-1 were reported for this biomimetic transformation. The method could also be applied 
to different 2-aryloxy- or 2-alkyloxy-substituted ketones with TOF up to 2500 h-1.[76]  
 
Scheme 28. Iron porphyrin applied in transfer hydrogenation 
 
Gao synthetized macrocyclic structures by a condensation of bis(o-formylphenyl)-
phenylphosphane 26 and (R,R)-cyclohexane-1,2-diamine 27 which led to the formation of a 22-
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membered diiminodiphosphine macrocycle 28 (Scheme 29).[77] Ligand 28 was then reduced with 
NaBH4, to obtain the corresponding diaminodiphosphine ligand 29. 
 
Scheme 29. Synthesis of the macrocyclic structures 28 and 29 
 
The new macrocycles 28 and 29, together with Fe3(CO)12, were compared in asymmetric transfer 
hydrogenation (ATH) of propiophenone (Scheme 30a). The diaminodiphosphine ligand 29 
appeared to be much more active than diiminodiphosphine macrocycle 28. By contrast with the 
previously reported catalyst 25/Fe3(CO)12 the use of different iron sources (like iron(0) Fe2(CO)9, 
iron(II) FeCl2 or iron(III) FeCl3) gave almost no activity in the reaction with both ligands. 
 
Scheme 30. Asymmetric transfer hydrogenation of ketones catalyzed by iron complexes formed from 
chiral macrocycle 28 or 29 
 
Gao and co-workers discovered that the use of ammonium salts as additives is promoting the 
reaction, even though their role remains unknown. The substrate screening revealed high activity 
of the catalytic system for a broad range of aromatic and heteroaromatic ketones (Scheme 30b).[77] 
To obtain more details about the interactions between the iron and the macrocycle, Gao and co-
workers synthesized iron complex 30, which was postulated to be a possible reactive 
intermediate. Gao and co-workers managed to isolate complex 30 from the corresponding ligand 
29 (Scheme 31). Since this complex was insoluble in iPrOH, the transfer hydrogenation reaction 
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was carried out in a mixture of toluene and iPrOH, but its catalytic activity was far inferior to the 
catalytic system formed in situ, shown in Scheme 30, this suggested that complex 30 is not the 
active species in the ATH of ketones.[78] 
 
Scheme 31. Synthesis of chiral P2N4−Fe(0) complex 30 and its catalytic activity 
 
Ligand 29 has also recently been applied in the asymmetric hydrogenation of aromatic and 
heteroaromatic ketones (Scheme 32), to the corresponding chiral alcohols in high yields and 
excellent ee values.[79] Further studies on the hydrogenation's mechanism revealed the formation 
of chiral macrocycle-modified iron nanoparticles, which is believed to be the active species. 
 
Scheme 32. Asymmetric hydrogenation using macrocyclic ligand 29  
 
3.3.2. P,N,N,P-complexes 
In 2008, taking inspiration by Gao, Morris and co-workers synthesized the well-defined iron 
diiminophosphine complexes 32a-b.[80] Complexes 32a-b were prepared by condensation of 
commercially available diamines and phosphinealdehyde (Figure 10) and it was expected that due 
to the hydrogenation reaction course, the imine donors in the synthesized complexes would be 
reduced to amines.[81] 
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Figure 10. Synthesis of P,N,N,P-complexes 
 
Complex 32a was tested in the asymmetric transfer hydrogenation of different ketones and imines 
using isopropanol and led to high conversions and TOFs up to 907 h-1 (comparable to the TOF’s 
reported for an analogue ruthenium catalyst), but only modest enantioselectivities were achieved 
(Scheme 33). The transfer hydrogenation of α,β-unsaturated ketones was complicated by some 
reduction of the C=C bond. 
Several modifications of the ligands have been studied in terms of their influence on the catalytic 
activity of the iron complex. Changing the starting diamine, complex 32b was obtained and 
compared to complex 32a showing higher activity and selectivity (Scheme 33).[82] 
 
Scheme 33. Transfer hydrogenation of ketones and imines using iron diiminophosphine complex 32a-b 
 
In subsequent studies Morris discovered that the active species in the reaction were actually iron 
nanoparticles formed from complexes 32a-b. In fact, electron microscopy imaging showed that 
iron nanoparticles were forming during the reaction.[83] Support to this proposition derived not 
only from scanning transmission electron microscopy (STEM), but also from superconducting 
quantum interference device (SQUID), and X-ray photoelectron spectroscopy (XPS) analysis. 
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According to Morris, the flexible six-membered chelate rings were responsible for the occurring 
of the formation of Fe-NPs, in fact under reducing conditions, they allowed ligand dissociation to 
form active Fe-NPs. This was the first reported example of use of Fe-NPs to promote 
enantioselective transformations. To avoid this phenomenon, Morris and co-workers developed 
a second generation diiminophosphine complexes 33a-e, containing five-membered rings, 
synthetized from the condensation of an enantiopure diamine and dialkyl- or 
diarylphosphinoacetaldehydes (Figure 11).[84][85] 
 
Figure 11. Second generation diiminophosphine complexes 
 
Using the second generation catalyst, the maximum TOF obtained was 30000 h-1 with high 
enantiomeric excesses (up to 90%) for complex 33e. The substituents on phosphorus were crucial 
for the activity; moderate size and moderate donor ability were required, otherwise complexes 
were catalytically inactive.[86] 
Complex 33d was an efficient catalyst for the reduction of functionalized acetophenones 
containing alkyl groups, cyclic alkanes, halogens and aromatic rings (Scheme 34). Furthermore, it 
was also active for the ATH of a variety of prochiral ketimines bearing diphenylphosphinoyl group 
at the nitrogen, which showed high conversions (up to 91%) with excellent ee (95-99%). 
 
Scheme 34. Transfer hydrogenation of ketones and ketoimines using a second generation iron 
diiminophosphine complex 33d 
 
Further mechanistic studies revealed that the ligand is modified twice (Scheme 35).[87] The first 
step to activate the catalyst is a deprotonation of 33d using a base in order to form bis-anionic 
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biseneamide 33d.1. In the second activation step, a slow addition of a proton and a hydride from 
the isopropanol to one of the eneamide groups occurs, in order to form the intermediate 33d.2. 
This hydrogenated side “monoanionic amido-eneamido complex” is the active iron complex. If 
both side were hydrogenated, the complex would be non-active.[88] During the catalytic cycle the 
P,N,N,P-ligand 33d.2 takes a proton and a hydride from isopropanol to form first 33d.3 and then 
33d.4, which then delivers them to the substrate to form 33d.5. The hydride transfer from iron to 
the carbonyl group of acetophenone proceeds according to an outer-sphere pathway, where the 
substrate is not coordinated to the metal, and the proton is transferred from the amino group of 
the ligand to the carbonyl oxygen (similar to the mechanism reported by Noyori for Ru(II)[89]). This 
is an example of redox non-innocent ligand, as the diiminodiphosphino ligand actively participates 
in the mechanism of C=O reduction by mediating the proton transfer.  
 
Scheme 35. Proposed mechanism of the second generation catalyst complex 33d 
 
The third generation catalysts presented by Morris are shown in Figure 12, complexes 34a-e 
contain unsymmetrical ligands, obtained by condensation of enantiopure P−NH−NH2 diamine and 
dialkyl- or diaryl-phosphinoacetaldehydes.[88]  
 
Figure 12. Third generation diiminophosphine complexes 
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Treatment of new complexes with base, allowed to directly convert them to catalytically active 
unsymmetrical amide-enamide catalysts, as already previously explained. These catalysts were 
tested in the asymmetric transfer hydrogenation and they were found to be very active for a huge 
variety of ketones and ketoimines, with TOF up to 200 s-1 (at 50% of conversion), TONs up to 6100 
and 99% ee (Scheme 36).[88]  
Recently a new unsymmetrical tetradentate P–NH–N–P' ligand has been synthesized, the new 
precatalyst 35 was tested in the ATH of ketones and gave a TONs up to 4300 and enantiomeric 
excesses up to 99%. The enantioselectivity of the system increased at the expense of the catalytic 
activity. The flexibility of the synthesis of these third generation catalysts offers the possibility of 
tuning their structure for the optimum reduction of a given substrate. 
 
Scheme 36. Catalytic activity of the new iron(II) Ph2P–NH–N–PCy2 complex 35 
 
Morris' group, besides transfer hydrogenation with isopropanol, expanded their research also 
towards new catalysts for the asymmetric hydrogenation using molecular hydrogen.[90] The new 
complex 36 was obtained by the condensation of enantiopure P−NH2 amine and 
dicyclohexylphosphinoacetaldehyde (Scheme 37). The activation of the catalyst was performed 
using LiAlH4 to obtain the active P-NH-P catalyst for reducing ketones and imines. Complex 36 
showed TOFs up to 1980 h-1 with ee up to 85%, but the structure of the active catalyst is still under 
investigation.  
 
Scheme 37. Fourth generation pre-catalyst 36 applied in transfer hydrogenation  
 
Recently Mezzetti and co-workers reported the first example of enantiomerically pure C2-
symmetric macrocyclic ligands and the corresponding isolated iron(II) isolated complexes.[91][92] 
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Chiral P2N2–Iron(II) complex 37 revealed very good activity in ATH, both in terms of conversion 
and enantioselectivity (Scheme 38).[93] 
 
Scheme 38. Catalytic activity of a diimino-macrocycle 37 
 
Replacing the diimino macrocycle, with a diamino analogue, led to even higher activity in ATH of 
ketones (Scheme 39). Using 0.1 mol% of the catalyst, excellent results in terms of yields (up to 
98%) and enantioselectivities (up to 91% ee) were obtained with ketones, enones and imines.[94] 
In both the presented classes of complexes, iron's isonitrile ligands, turned out to affect both the 
enantioselectivity and the activity of the catalyst. 
 
Scheme 39. Asymmetric transfer hydrogenation using catalyst 38 
 
3.3.3. P,N,P-pincer ligand 
In 2011 Milstein and co-workers synthetized a (hydrido)iron(II) pincer P,N,P-complex 39 for the 
ATH of ketones, achieving high turnover numbers up to 1880.[95] The reaction proceeded under 
mild condition, 4 atm of H2 using only 0.05 mol% catalyst loading, in ethanol at room temperature 
(Scheme 40). 
 
Scheme 40. Catalytic activity of the (hydrido)iron(II) pincer P,N,P-complex 39 
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The proposed mechanism is represented in Scheme 41, the active species is a reactive 
dearomatized complex 40.1, which is stabilized by reversible addition of ethanol to generate the 
aromatic complex 40. The coordination of the ketone to 40.1, followed by isomerization to 
intermediate 40.2, makes the insertion of the substrate into the Fe-H bond possible. The alkoxo- 
carbonyl complex 40.3 gives the aromatic hydrido-alkoxy complex 40.4, when it reacts with 
hydrogen. Finally, elimination of the corresponding alcohol regenerates the active species. 
Remarkably, in this mechanism the pyridine ring of the tridentate ligand plays a key role flipping 
between the aromatic (40.4) and the dearomatized form (40.1), thus acting as a redox non-
innocent ligand. 
 
Scheme 41. Possible reaction mechanism for ketones hydrogenation using complex 40 
 
Subsequently Milstein developed a second-generation iron pincer catalyst 41 containing a 
borohydride ligand. The reaction was performed under similar conditions used for catalyst 40, but 
no additional base was required and TONs up to 1980 were achieved (Scheme 42).[96] 
Different substrates could be converted to the corresponding alcohols in good to high yields (44-
99%). Unfortunately benzaldehyde gave only low yields of benzylic alcohol, and α,β-unsaturated 
ketones led to mixtures of hydrogenated products. 
 
Scheme 42. Catalytic activity of the second-generation iron pincer catalyst 
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In 2014 Milstein observed that the P,N,P-ligand complex 41 (from the first generation of iron 
pincer catalyst), was also active in the hydrogenation of esters, in combination with a base 
(Scheme 43).[97] This was the first example of iron catalyst being able to catalyze this 
transformation, even though only activated trifluoroacetic esters were hydrogenated to 
trifluoroethanol. For this reason, there is not a real practical application. 
 
Scheme 43. Hydrogenation of trifluoroacetic esters with cat 42 
 
The iron catalyzed hydrogenation of non-activated esters was described subsequently by Beller[98] 
and Guan/Fairweather.[99] Both groups, inspired by osmium-catalysts for hydrogenation of 
esters,[100] discovered independently the catalytic activity of the hydrido borohydride P,N,P-pincer 
iron complex towards esters. The reaction was performed by Beller’s group at 30 bar of H2, in THF 
at 100-120 °C under base-free conditions with excellent yield (Scheme 44), while 
Guan/Fairweather used toluene or THF at 115 °C and 10-16 bar of H2. Fully saturated alcohols 
were obtained from corresponding α,β-unsaturated esters. This catalyst was also active with fatty 
esters under neat conditions. 
 
Scheme 44. Hydrogenation of activated esters using catalyst 43 
 
Complexes 42 and 43 opened a new chapter in the ester hydrogenation, proving that it can be 
done using complexes with a cheap and abundant metal such as iron. But in order to be suitable 
for a real industrial application, their catalytic activity has to be improved, and the complex pincer 
ligands should be ideally replaced with less expensive and easy-to-handle ones. 
In addition, Beller using the hydrido borohydride P,N,P-pincer iron complex described the 
selective hydrogenation of aliphatic and aromatic nitriles under mild conditions, and in particular 
adiponitrile to 1,6-hexamethylenediamine, an important building block for the polymer 
industry.[101] 
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3.3.4. Isonitrile complex 
In 2010 Reiser and co-workers reported a chiral bis(isonitrile)iron(II) complex 44 for the ATH of 
aromatic and heteroaromatic ketones.[102] The asymmetric transfer hydrogenation was performed 
under mild conditions, at room temperature in isopropanol as solvent and hydrogen source in the 
presence of a base (Scheme 45). Very good conversions were obtained but only modest 
enantioselectivities could be achieved (up to 67% ee). 
 
Scheme 45. Catalytic activity of the iron(II)–bis(isonitrile) complex 44 
 
A Meerwein-Ponndorf-Verley-type mechanism was proposed for this transfer hydrogenation 
(Scheme 46). After activation of 45 with tBuOK, and coordination of the isopropanol to the iron 
(45.1), a reduction of the coordinated isonitrile ligand to an imine can be observed (45.2). In this 
way, acetone is formed and removed, so the reaction follows an inner-sphere pathway, with 
substrate coordination at the Fe(II) center (45.3). It can be also underlined that the formation of 
an iron hydride species does not take place in the catalytic cycle. Finally the imine with a hydride 
absorbed from isopropanol, transfers it to the substrate (45.4) with subsequent release of the 
product. In this case the ligand showed a clearly non-innocent behavior. 
 
Scheme 46. Proposed mechanism for a general iron(II)–bis(isonitrile) complex 45 
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3.3.5. (Cyclopentadienone)iron complexes 
(Cyclopentadienone)iron tricarbonyl complexes were firstly reported by Reppe and Vetter in 
1953,[103] with the particularity of being easily synthesized and purified, due to their stability to 
air, moisture and column chromatography on silica gel. Unfortunately, it took 40 years until they 
were studied with more attention by Knölker[104] and Pearson.[105] In 1999, Knölker and co-workers 
synthesized and isolated the first (hydroxycyclopentadienyl)iron dicarbonyl complex 47 from the 
active stable (cyclopentadienone)iron tricarbonyl complex 46 using a Hieber-base reaction 
(Scheme 47) when the main focus was to obtain the free ligand.[106] 
 
Scheme 47. (Hydroxycyclopentadienyl)iron dicarbonyl complex 47 obtained by Hieber-base reaction from 
(cyclopentadienone)iron tricarbonyl complex 46 
 
Demetallation could be achieved using UV irradiation (Scheme 48), which induced ligand exchange 
of carbon monoxide by acetonitrile, leading to a labile tri(acetonitrile)iron complex, and 
subsequent bubbling of air through the solution at low temperature to obtain the free ligands in 
high yields.[15]  
A different method for demetallation is the Hieber-type reaction (Scheme 48), using sodium 
hydroxide to obtain the corresponding hydride complex followed by ligand exchange with 
iodopentane to afford the iodoiron intermediate, which is easily demetallated in the presence of 
air and daylight at room temperature.[106] 
 
Scheme 48. Two different method of demetallation (a) UV irradiation and (b) Hieber-type reaction 
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The potential use of the active hydride 46 remained concealed until 2007, when Casey and Guan 
reported its highly efficient catalytic activity for the chemoselective hydrogenation of aldehydes, 
ketones and imines under mild conditions.[107]  
Complex 47 showed similar properties to the structurally related Shvo catalyst 48, which was 
known since 1985 (Figure 13), a dimeric structure of a dinuclear ruthenium hydride complex, in 
which the hydride ligand bridges the two ruthenium metal center.[108] 
 
Figure 13. Dinuclear ruthenium hydride complex, known as Shvo catalyst 
 
The dissociation of the dimeric species 48 in solution led to the formation of the monomeric 
ruthenium complex which is the catalytic active species. In particular the 16e- complex 48a 
provides 48b by activation of H2. Catalyst 48b was used in the hydrogenation of aldehydes, 
ketones,[108] imines[110] and alkenes, with the obstacle for the latter to be bound by the complex, 
forming a stable complex that gradually poisons the catalyst.[109] Catalyst 48b was also used in 
transfer hydrogenation by Bäckvall and co-workers.[110] 
 
Casey and Guan demonstrated that hydride 47 is a highly efficient catalyst for the chemoselective 
hydrogenation of aldehydes, ketones and imines under mild conditions (3 atm of hydrogen, at 
room temperature in toluene) (Scheme 49). A large number of functional groups were tolerated 
under these reaction conditions, such as isolated carbon-carbon double or triple bonds, halides, 
nitro groups or epoxides and esters. Hydride 47 has been successfully applied also in transfer 
hydrogenation conditions, using isopropanol.[7][107][111] Sun and coworkers performed 
computational studies to confirm that catalyst 47 is not able to hydrogenate olefins and alkynes 
under relatively low temperatures.[112]  
 
Scheme 49. Hydrogenation and transfer hydrogenation using (hydroxycyclopentadienyl)iron complex 47 
 
The main drawback of the active hydride 47, was its sensitivity to air, moisture and light. For this 
reason, it was necessary to prepare it and handle it in a glove-box. Later contributions 
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demonstrated that it is possible to use bench-stable (cyclopentadienone)iron pre-catalyst 46 and 
to activate it in situ (Figure 14).  
 
 
Figure 14. Activation of (cyclopentadienone)iron tricarbonyl pre-catalyst 46 to form the active hydride 
species 47 
 
The first method is based on the mono-decoordination of one of the CO ligands with oxidative 
cleavage using Me3NO.[113] The same effect can be also obtained by UV irradiation.[117] The active 
complex C can be considered as a frustrated Lewis pair, so in presence of hydrogen it can split H2 
to form the active hydride B. The hydride itself, as previously reported, can be also obtained by in 
situ Hieber reaction of (cyclopentadienone)iron A with aqueous bases (e.g.: K2CO3).[114][115] 
The mechanism of the transformation of this non-innocent ligand has been carefully 
investigated.[116] The ligand is able to interconvert between cyclopentadienone C and 
hydroxycyclopentadienyl B form, allowing an unusual catalytic cycle involving Fe(0) and Fe(II) 
(Scheme 50, Cycle I). The active species C splits hydrogen and then catalyzes the reduction of 
carbonyl compounds according to a concerted outer-sphere mechanism, in which the substrate is 
not directly connected to the iron, but there is an interaction between the OH group of the ligand, 
which allows transient substrate's activation by hydrogen-bonding and the hydride delivery by the 
iron. Additionally, hydride B (Scheme 50, Cycle II) is also able to catalyze the dehydrogenation of 
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alcohols to carbonyl compounds in an Oppenauer-type oxidation and "hydrogen-borrowing" 
reactions (like amination of alcohols). 
 
Scheme 50. Catalytic pathways: hydrogenation of C=O and C=N double bonds (Cycle I) and Oppenauer-
type alcohol oxidation (Cycle II) catalyzed by (cyclopentadienone)iron complexes. 
 
Beller optimized the reaction conditions for ketones hydrogenation, obtaining TON up to 3800 
using pre-catalyst 46 (Scheme 51).[114] 
 
Scheme 51. Hydrogenation of ketones using bench-stable 46 
 
3.3.5.1. Modification of the Knölker-Casey complex 
From the point of view of ligand design, two main strategies for the modification of the framework 
of the Knölker-type complexes have been followed, in order to improve the catalytic activities or 
achieve novel reactivity.  
The first strategy is the modification of the substitution pattern of the cyclopentadienone ring, by 
tuning the steric and electronic properties of the complexes: 
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- changing the nature of the cycle fused to the cyclopentadienone ring, replacing the 
original six-membered ring of the Knölker-Casey complex or the modification of the 
nature of the substituents at the 2- and 5-positions. 
A five-membered ring was obtained in two step synthesis, starting from the silylation of the 
commercially available 1,6-heptadiyne followed by a [2+2+1] cycloaddition. Other alkylation 
presented in Figure 15 allowed to obtain alkyl chains or heteroatoms (O, S,[104b] N[113a]) in the 
backbone. While the TMS groups were replaced with different silyl groups (TBDMS or TIPS), or 
phenyl groups.[113a][114]  
 
a) NaH (2.2 eq), propargylic bromide (2.2 eq), THF, 3 h, reflux; b) K2CO3, propargylic bromide (2.2 eq), 
acetone, rt, 24 h; c) NaOH, propargylic bromide (1 eq), triethylbenzyl ammonium chloride, H2O, 60 °C, 3 h; 
d) nBuLi, trialkylsilyl chloride, THF, -78 °C, 3 h; v) Fe2(CO)9, toluene, 110 °C, 18 h - 3 days. 
Figure 15. Modification of the substitution pattern of the cyclopentadienone 
 
The catalytic activity of these complexes was tested and it was observed that catalysts which bear 
phenyl substituent on the cyclopentadienone, led to the lowest yields. This behavior was 
explained either by the electronic properties of the aromatic substituent compared to a silyl group 
or the lack of steric hindrance around the iron center, which led to a possible dimerization of the 
complex, as shown in the X-ray analysis, and in a decreased stability, since the complex become 
thermally labile. The second hypothesis could also be confirmed evaluating the increase steric bulk 
of the silyl substituent, which resulted in an improvement of the catalytic activity (TBDMS = TIPS 
> TMS). 
Concerning the backbone, there is not clear explanation for the behavior of the complexes, even 
though DFT calculations, demonstrate that the presence of a heteroatom, stabilized the transient 
16-electron species and have less propensity to dimerize. 
- Finally, also the carbonyl moiety has been recently silylated (see paragraph 3.2.6).[55]  
- Chiral versions were also synthesized, but they will be discussed in the next paragraph.[118] 
[117] 
 
The second strategy to modulate the structure of these complexes relies on the substitution of 
one of the carbonyls with other ligands. The exchange of the ligand was performed in oxidative 
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conditions using Me3NO, in the presence of the new ligand such as nitriles (acetonitrile[15][119] or 
benzonitrile[135]), pyridines,[135] phosphines (triphenylphosphine),[105] and more recently N-
heterocyclic carbenes (NHC),[136] (Figure 16). 
A chiral version using a phosphoramidite ligand was presented by Berkessel[117] in order to induce 
enantioselectivity, but this will be discussed in the next paragraph.  
 
Figure 16. General modifications of Knölker-type complexes: replacement of one CO ligand 
 
On a different approach, in order to obtain a labile ligand easily to remove to form the active 
hydride complex, Funk and co-workers employed the air-stable nitrile-ligated 
(cyclopentadienone)iron complex 49, originally synthesized by Knölker[15] as catalysts for the 
transfer hydrogenation of aldehydes and ketones using isopropanol as hydrogen source (Scheme 
52).[119] Excellent yields for a large number of primary and secondary alcohols were obtained. 
 
Scheme 52. Example of air-stable nitrile-ligated (cyclopentadienone)iron complex 
 
In the case of the NHC carbenes, the complexes were prepared using a photolytic method, under 
UV irradiation for 20 h in toluene. These catalysts were then tested in the dehydration of primary 
benzamides into benzonitrile derivatives, under hydrosilylation conditions, using the inexpensive 
PMHS (polymethylhydrosiloxane) as dehydrating reagent. 
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Figure 17. NHC-carbenes derived iron complexes and their application to the dehydration of primary 
benzamides into benzonitrile 
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3.3.5.2. Asymmetric reductions 
The groups of Berkessel[117] in 2011 and Wills[118] in 2012 made the first attempts to perform 
enantioselective reductions using Knölker-type complexes. Berkessel replaced one of the CO 
ligands starting from 51 with a chiral phosphoramidite ligand L* by a photolytic method (under 
UV irradiation) or an oxidative one (Me3NO) (Scheme 53).   
 
Scheme 53. (Cyclopentadienone)iron complex containing a chiral phosphoramidite ligand 52 
 
Pre-catalyst 52 hydrogenated acetophenone with only 31% ee, in addition the reaction required 
constant UV irradiation to remove the second CO ligand and form the active hydride species. 
Berkessel performed NMR studies to investigate the reason for this low enantioselectivity, and 
found out that under hydrogen, two iron hydride diastereoisomers 52a and 52b were formed at 
the newly generated iron-stereocenter in a ratio 1:0.69 (Scheme 54), due to the non-selective 
dissociation of CO from pre-catalyst 52, this also explained why the enantioselectivity of the 
reaction is low. Moreover, upon hydrogenation, also a partial removal of the chiral ligand was 
observed, giving 2% of the achiral active hydride complex 52c. 
 
Scheme 54. Formation of diastereoisomers upon hydrogenation of 52 
 
Wills presented a different approach to solve the chirality problem. The new chiral 
cyclopentadienone pre-catalyst 53 was obtained by insertion of a remote chiral center in addition 
to the planar symmetry of a (cyclopentadienone)iron complex (Scheme 55).[118] Complex 53 was 
tested in the ATH of acetophenone in the presence of formic acid/triethylamine as a hydrogen 
source, but only ee up to 25% was achieved. This poor enantiocontrol was independent on the 
metal employed, as the corresponding ruthenium chiral catalyst was able to achieve only 21% ee.  
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Scheme 55. Asymmetric transfer hydrogenation using a chiral (cyclopentadienone)iron complex 
 
Beller and co-workers developed a procedure for the asymmetric hydrogenation of N-aryl 
ketoimines using an achiral pre-catalyst 47 in combination with a chiral phosphoric acid, (S)-
TRIP.[120] The proposed mechanism is displayed in Scheme 56, where the Brønsted acid acts as a 
“chiral template” forming hydrogen bonds simultaneously with the catalyst and with the 
substrate. A wide variety of different N-aryl ketoimines were hydrogenated with high yields and 
excellent ee.  
Employing the same system it was also possible to hydrogenate quinoxalines to 
tetrahydroquinoxalines and 2H-1,4-benzoxazines to dihydro-2H-benzoxazines, with high yields 
and excellent ee.[121] Furthermore, Beller and co-workers applied this methodology also for the 
asymmetric reductive amination of ketones with anilines, once more with high yields and excellent 
ee.[123] 
 
Scheme 56. “Chiral template system” using iron pre-catalyst 47 and (S)-TRIP 
 
The above-mentioned methodology was employed in a combinatorial multi step, one-pot 
hydroamination of alkynes followed by enantioselective hydrogenation (Scheme 57).[124]  The first 
step was catalyzed by  a gold(I) complex 54, followed by hydrogenation carried out using 46 with 
a chiral Brønsted acid, to afford high yields and high enantioselectivities.  
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Scheme 57. One-pot enantioselective reductive hydroamination using 52, 46 and (S)-TRIP 
 
3.3.5.3. Reductive amination of aldehydes, ketones and alcohols 
Cyclopentadienone complex 46 was also applied to reductive amination by Renaud and co-
workers.[125] The reaction was applied to primary or secondary amines and also ketones and 
aldehydes. Subsequently, Renaud discovered that more electron-rich (cyclopentadienone)iron 
complex 55 was more effective for the reductive amination of aromatic aldehydes (Scheme 
58).[126] 
 
Scheme 58. Reductive amination using complexes 46 and 55 
 
Further amine functionalization was exploited by Feringa and Barta using (cyclopentadienone)iron 
complex 46. Simple and direct N-alkylation of amines with alcohols using a hydrogen-borrowing 
process was performed.[127] Different primary alcohols and amines were coupled with good yields. 
 
Scheme 59. N-alkylation of amines with alcohols using complex 46 
 
In comparison to the reductive amination by Renaud (Scheme 58 and Scheme 60A), alcohol 
substrates were acting as a hydrogen source in the process in Scheme 60B, easier to perform. The 
only drawback of this hydrogen borrowing process, was its ineffectiveness with different substrate 
than primary alcohols. 
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Scheme 60. A) reductive amination and B) hydrogen borrowing methodologies to obtain alkylated amines 
 
Recently, Zhao and co-workers improved significantly the hydrogen borrowing strategy.[128] Using 
iron hydride 47 together with a Lewis acid, such as AgF, they managed to perform amination not 
only of primary alcohols, but also secondary (Scheme 61). The mechanism of this transformation 
proceeded via hydrogen borrowing from alcohol (as so, use of an enantiopure alcohol leads to 
racemate product). Unfortunately the role of the Lewis acid is not clear, but it can be assumed 
that AgF can assist the imine formation step and activate it towards reduction by iron hydride 47. 
 
Scheme 61. Amination of secondary alcohol supported by Lewis acid using catalyst 47 
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3.4. Hydrogenation of sodium carbonate and carbon dioxide 
The first hydrogenation of carbon dioxide and sodium bicarbonate was described by Beller in 
2010, using an iron catalyst (Scheme 62).[129] The catalyst was formed in situ from Fe(BF4)∙6H2O 
and the tetraphos ligand 6. The obtained results were very promising for the application of an iron 
catalyst in this new field. 
 
Scheme 62. Sodium bicarbonate and carbon dioxide hydrogenation using an iron catalyst and tetraphos 
ligand 6 
 
Subsequently Beller exploited an analogous in situ formed catalytic system with ligand 46. A huge 
improvement in the catalyst activity was observed (Scheme 63).[130] Sodium bicarbonate was 
hydrogenated reaching excellent TONs up to 7500. Carbon dioxide was reduced to methyl formate 
using methanol, as a solvent, and trimethylamine, as a base, with TONs up to 1700. When the 
hydrogenation was carried out in the presence of a secondary amine and DMF in THF, TONs up to 
5100 were obtained. 
 
Scheme 63. Hydrogenation of sodium bicarbonate and carbon dioxide using tetraphos ligand 46 
 
Iron-catalyzed hydrogenation and asymmetric hydrogenation 
59 
 
Milstein used a new iron pincer complex 42 for the hydrogenation of bicarbonate and CO2.[131] 
Reduction of CO2 was effective with TONs up to 788, but sodium bicarbonate led only to moderate 
yields (Scheme 64). The reaction was carried out at low hydrogen pressure and moderate 
temperatures. 
 
Scheme 64. Hydrogenation of sodium bicarbonate and carbon dioxide using pincer complex 42 
 
In the proposed catalytic cycle in Scheme 65, the key step of the mechanism is a direct hydride 
transfer from a trans-dihydridoiron complex 42 to carbon dioxide, after the insertion of CO2 to 
obtain intermediate 42.1. The catalyst is then regenerated by complexation of dihydrogen (42.2 -
42.3) and subsequent heterolytic cleavage upon attack of hydroxide or by dearomatization of the 
pyridine followed by proton migration.  
 
Scheme 65. Proposed catalytic cycle for the hydrogenation of carbon dioxide using pincer complex 42 
 
Gonsalvi proposed a tetraphos iron(II) catalyst 56 for the hydrogenation of sodium bicarbonate 
with TONs up to 1229 (Scheme 66).[132] 
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Scheme 66. Hydrogenation of sodium bicarbonate using catalyst 56 
 
Recently Zhou proved that the (cyclopentadienone)iron complex 46 can work also in the 
hydrogenation of sodium bicarbonate with a good TON up to 450 (Scheme 67a).[133] Unfortunately 
attempts to hydrogenate carbon dioxide were unsuccessful.  
Renaud described a diamino-cyclopentadienone iron complex 55 for hydrogenating sodium 
bicarbonate with TONs up to 1246 (Scheme 67b).[134] 
 
Scheme 67. Hydrogenation of sodium bicarbonate using iron complex 46(a) and 55(b) 
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3.5. Summary of iron catalyzed reduction 
 
 
In the last 20 years, iron catalyzed reductions progressed really fast. Definitely Chirik and co-
workers reported the biggest contribution to the olefin reduction (complex 13) and up to now no 
examples of more active catalysts for carbon-carbon double bond reduction were reported. In 
addition, no asymmetric hydrogenation was reported with any olefin. The best results in alkyne 
reduction were reported by Beller and co-workers (Fe(BF4)∙6H2O with ligand 6) and Milstein and 
co-workers (complex 7), both systems providing good activity and selectivity, but a good catalyst 
for reduction of alkynes to fully unsaturated alkanes is still missing.  
A lot of structurally different catalyst for the reductions of C=O bond were developed and proved 
to be efficient: P,N,N,P-ligands (35), macrocyclic P2N4- (29) or P2N2-ligands (37), pincer P,N,P-
ligands (41), P,P,P,P-ligands (23), isonitrile (44) or cyclopentadienyl (46). Approximately all of the 
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reported ligands act as chemically or redox non-innocent, demonstrating that this is the best 
option to stabilize low valent iron species.  
Most of the catalysts described, suffer at least one of these serious limitations: difficult synthesis, 
lack of robustness and moderate activity/enantioselectivity. These catalysts are often difficult to 
handle due to air- and moisture-sensitivity, therefore a glovebox is required for synthesis and 
manipulation, and in some cases even for the setup of hydrogenation tests.[121] These drawbacks 
need to be overcome in order for iron catalysis to become of practical utility for the industrial 
manufacturing of fine chemicals. 
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4. Results and Discussion 
 
(Cyclopentadienone)iron tricarbonyl complexes, as already described in paragraph 3.3.5, are 
robust pre-catalyst which are particularly attractive due to their versatile applications in redox 
catalysis: they have been successfully applied in hydrogenations, hydrogen transfer, including 
asymmetric versions, as well as oxidation, reductive amination and more recently in hydrogen-
borrowing reactions. 
One of the main advantages, compared to other iron complexes, is their stability to air and 
moisture. Additionally, they are easily synthesized and purified by simple silica gel 
chromatography. These characteristics prompted many groups to investigate structural 
modifications to optimize the reactivity of these complexes. 
A major challenge remaining so far unmet is the development of chiral complexes to be used as 
enantioselective pre-catalyst in the hydrogenation reactions. In fact, both the replacement of one 
CO ligand with a chiral phosphoramidite by Berkessel and co-workers[117] and the insertion of a 
stereocenter in the ring fused to the cyclopentadienone,[118] only led to marginal enantiomeric 
excesses. The only somewhat successfully approach was developed by Beller and co-workers, 
using a chiral phosphoric acid additive as a sort of “chiral template” between catalyst 47 and the 
substrate. In this way, ketimines could be hydrogenated with excellent conversions and 
enantiomeric excesses (up to 98%), but this methodology was not applied for ketones (Figure 
18).[120][121][122][124] 
 
Figure 18. Reported cyclopentadienone iron complexes for enantioselective transformations 
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4.1. Aim of the thesis 
The aim of the research carried out during my PhD was to develop new iron catalysts for the 
hydrogenation of carbonyl compounds.  
In particular, we investigated the field of (cyclopentadienone)iron tricarbonyl complexes looking 
for chiral complexes for the asymmetric hydrogenation of ketones and the development of more 
stable and reactive complexes. 
For this reasons we took into consideration three different approaches: 
- The first approach was the modification of the 3, 4-positions on the cyclopentadienone 
ring, where we decided to introduced a chiral backbone, in the form of a binaphthyl 
moiety, in order to prepare new chiral complexes.[137][138] 
- In a second approach we replaced one of the CO ligands in the new chiral 
(cyclopentadienone)iron tricarbonyl complex with a chiral phosphoramidite ligand, in 
order to improve the enantiomeric excess of the catalyzed process. 
 
Figure 19. Modifications on the classical (cyclopentadienone)iron tricarbonyl complex 
 
- The third approach involved the modification of the 2,3- and 4,5-positions in two different 
ways: 
a) in the first attempts an intermolecular cyclization was applied using two alkynes in 
the presence of Fe(CO)5; 
b) subsequently in order to obtain a complex showing planar chirality, we decided to 
synthesize the corresponding cyclopentadienone, followed by a complexation using 
an iron carbonyl source. 
 
Figure 20. Different approaches to obtain a 2,3- and 4,5-substituted (cyclopentadienone)iron tricarbonyl 
complexes, showing planar chirality 
 
The catalyst must be prepared in a simple way, including the preparation of the ligands/complexes 
from commercially available materials, good atom economy and affordable cost of reagents. In 
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addition, reasonable stability of the catalysts or pre-catalysts to air and moisture should be 
evaluated in order to avoid the use of a glovebox. Finally the catalytic process should present high 
efficiency in terms of conversion and enantioselectivity. 
 
4.2. Towards a (R)-BINOL derived complexes 
As mentioned in section 3.3.5, previous attempts to prepare chiral complexes by the introduction 
of a sterocenter in the backbone of the cyclopentadienone moiety[118]; met with relatively low 
success. 
For this reason, we decided to introduce a [(R)-1,1'-bi-2-naphthyl] backbone (Figure 21), reasoning 
that the binaphthyl group with its stable, rigid framework could more efficiently shape the space 
around the iron atom and induce higher enantiomeric excesses. In addition, (R)-BINOL is readily 
available and relatively cheap chiral starting material (price ~1 €/g).[140] 
A similar approach had recently been proposed by Cramer and co-workers with the synthesis of 
the chiral Cp rhodium(I) complex 57.[139]  
 
Figure 21. Idea for synthesizing a new chiral iron pre-catalyst 58 
 
Evaluating the structure of our proposed catalyst we could anticipate that the binaphthyl 
stereoaxis would be relatively far away from the reaction center. Accordingly, we planned some 
structural modifications that in principle could improve the transfer of the stereochemical 
information or act as a directing groups for substrates (Scheme 68), as already reported for others 
BINOL-derived complexes.[139][141] 
On the other hand, another possibility to introduce chirality is to substitute one CO ligand with a 
chiral ligand (e.g. chiral phosphoramidite). 
 
Scheme 68. General structure of new chiral iron pre-catalysts and possible modifications that could 
improve the enantioselectivity in the asymmetric hydrogenation 
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The first attempt was the synthesis of the 3,3'-unsubstituted pre-catalyst 58, bearing TMS groups 
in the 2,5-positions of the cyclopentadienone ring (Figure 21). Its synthesis is depicted in Scheme 
69, starting from commercially available (R)-BINOL 59. The early steps, up to 62, are simple 
chemical transformations, previously reported by Maruoka and co-workers.[142] (R)-BINOL was 
triflated to 60, which reacted in a Kumada cross-coupling performed with a methyl-Grignard 
reagent to obtain the bis-methyl derivative 61, without loss of enantiopurity (confirmed by optical 
rotation measurements). The bis-bromide 62 (also commercially available but expensive) was 
then prepared by radical bromination using NBS.[143] Unfortunately, using a known procedure for 
the addition of (TMS-ethynyl)magnesium bromide to benzyl bromide in the presence of CuI,[144] 
led to no conversion when the bis-bromide 62 was exposed to these conditions. However, the 
synthesis of the bis-alkyne 64 could be achieved under similar conditions when the bis-iodide 63 
was used, which could be easily obtained through a Finkelstein reaction starting from the bis-
bromide 62. Cyclization of 64 in the presence of Fe2(CO)9 under the conditions reported by Renaud 
and co-workers[113a] afforded a new pre-catalyst 58. Complex 58 is stable to air, moisture and can 
be purified by silica column chromatography. The cyclization step was also performed using the 
cheaper and more stable Fe(CO)5, but in this case overnight heating was necessary. The optical 
rotation of the complex obtained using Fe2(CO)9 [α]D (c=0.43 in CH2Cl2) = -32.11, was comparable 
with the catalyst obtained using Fe(CO)5 [α]D (c=0.09 in CH2Cl2) = -32.24. It is reasonable to assume 
that no racemization occurred, but nevertheless experiments to verify this assumptions were 
conducted. 
 
Scheme 69. Synthesis of new chiral iron complex 58 
 
To test the enantiomeric purity of 58, we also prepared the other enantiomer of the complex 
following the same synthetic path but starting from (S)-BINOL, [α]D (c=0.24 in CH2Cl2) = 32.18. 
Further investigations were performed to verify the enantiomeric purity using chiral HPLC. In this 
case several chiral columns were used (OD-H, OB-H, AD-H, CELLULOSE2, CELLULOSE3, 
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CELLULOSE4, AMYLOSE2) injecting the two enantiomers separately (Figure 22, Figure 23) and a 
racemic mixture prepared by adding equal amounts of the two enantiomers (Figure 24). 
Unfortunately, despite every attempt in changing the chiral column, flow rate and solvent mixture, 
it was impossible to obtain a perfect separation of the two peaks when we injected a mixture of 
the two enantiomers (Figure 24). Nevertheless the presence of the other enantiomer in the 
samples of either R or S, complex 58 was never observed. 
 
Figure 22. HPLC chromatogram of the (R)-enantiomer of complex 58 using CELLULOSE2 as a chiral column, 
in hexane:iPrOH 95:5, 0.5 mL/min 
 
 
 
Figure 23. HPLC chromatogram of the (S)-enantiomer of complex 58 using CELLULOSE2, as a chiral column, 
in hexane:iPrOH 95:5, 0.5 mL/min 
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Figure 24. HPLC chromatogram of a mixture of the (S)- and (R)-enantiomer of complex 58 using 
CELLULOSE2 as a chiral column, in hexane:iPrOH 95:5, 0.5 mL/min 
 
Complex 58 was tested in the hydrogenation of acetophenone giving 62% conversion and a 
disappointing 8% ee (Scheme 70), using previously reported reaction conditions:[115] employing 
K2CO3 as an activator, 30 bar of hydrogen pressure at 70 °C in a mixture of iPrOH/H2O. We 
expected moderate conversion, since the newly synthetized catalyst required optimization of the 
hydrogenation’s condition, while the low enantiomeric excess confirmed our hypothesis that the 
binaphthyl stereoaxis is relatively far from the reaction center, leading to an inefficient transfer of 
stereochemical information from the stereogenic element to the reaction center.  
 
Scheme 70. Asymmetric hydrogenation of acetophenone using chiral complex 58 
 
To obviate this problem we devise two solutions: the synthesis of new chiral complexes derivatives 
with substituents at the 3,3'-positions, and the replacements of a CO ligand with a bigger, maybe 
chiral ligand, such as the phosphoramidite described by Berkessel (see paragraph 3.3.5.2).[117]  
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4.2.1. Replacement of a CO ligand with a chiral phosphoramidite ligand 
(S)-Monophos 65 was prepared reacting (S)-BINOL, with P(NMe2)3 in toluene following the simple 
synthetic procedure reported by De-Vries and Feringa.[145]  
Complex 58 was subjected to oxidative removal of one CO using Me3NO in the presence of the (S)-
Monophos, yielding the air-stable complex 66 (Scheme 71), which was isolated in good yields and 
thoroughly characterized.  
The same reaction was also performed using (R)-Monophos, to synthesize complex 67, in order to 
evaluate possible match and mismatch combinations in the hydrogenation reaction. 
 
Scheme 71. Replacement of one CO ligand with a chiral phosphoramidite ligand in complex 58 
 
In order to evaluate the reactivity of complexes containing a phosphoramidite ligand, we decided 
to synthesize complexes 71, 72, 73 and 74 by decarbonylation with trimethylamine-N-oxide in the 
same way described in Scheme 71 starting from 46,[105b][104] 51[104] and 70 respectively. 
Complex 70 was synthetized (Scheme 72) in a similar way of 46 and 51, starting from the 
commercially available 1,7-octadiyne 68, which was treated with nBuLi and tBuCl to afford 69, and 
then cyclized using Fe(CO)5 to isolate 70 in 65% yield. 
 
Scheme 72. Tethered synthesis of complex 70 
 
The resulting complexes were then employed as pre-catalysts in the hydrogenation of 
acetophenone, screening different methods for their activation. The results are summarized in 
Table 2.  
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Table 2. Screening of different activators using iron tricarbonyl complexes (46, 51, 70) and the 
corresponding substituted phosphoramidite complexes (71, 72, 74) 
 
Entry Pre-cat. Activator P H2 (bar) Temperature (°C) Time (h) Yield (%)[c] ee (%)[c,d] 
  K2CO3[a] 30 80 16 93 - 
1 46 Me3NO[a] 30 70 16 > 99 - 
  hν[b] 10 40 6 78 - 
  K2CO3[a] 30 80 16 < 5 nd 
2 71 Me3NO[a] 30 70 16 < 5 nd 
  hν[b] 10 40 7 92 35, S 
  K2CO3[a] 30 80 16 66 - 
3 51 Me3NO[a] 30 70 16 66 - 
  hν[b] 10 40 6 58 - 
  K2CO3[a] 30 80 16 < 5 nd 
4 72 Me3NO[a] 30 70 16 < 5 nd 
  hν[b] 10 40 6 92 35, S 
  K2CO3[a] 30 80 16 93 - 
5 70 Me3NO[a] 30 70 16 98 - 
  hν[b] 10 40 6 97 - 
  K2CO3[a] 30 80 16 < 5 nd 
6 74 Me3NO[a] 30 70 16 < 5 nd 
  hν[b] 10 40 6 97 31, S 
[a] Reaction conditions: acetophenone/Fe/activator = 100:1:2, solvent: 5:2 iPrOH/H2O, c0,substrate = 1.43 M [b] 
Reaction vessel irradiated at λmax = 352 nm and 8 W; Reaction conditions: acetophenone/Fe= 20:1 solvent: 
toluene, c0,substrate = 0.047 M. [c] Determined by GC equipped with a chiral capillary column (MEGADEX 
DACTBSβ, diacetyl-t-butylsilyl-β-cyclodextrin) and dodecane as internal standard. [d] Absolute configuration 
is S (assigned by comparison of the optical rotation sign with literature data)[[147]  
  
Table 2 shows that tricarbonyl iron complexes (46, 51 and 70) can be activated to form the 
corresponding active hydride complexes in situ, employing K2CO3, Me3NO or UV irradiation as 
activator. Good conversions of 1-phenylethanol were obtained. In contrast, the use of 
phosphoramidite complexes 71, 72 and 74 led to very low conversions using either K2CO3 and 
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Me3NO. In fact, UV irradiation is required to remove a second CO ligand to activate the complex 
and obtain the active hydride catalyst. In all cases just moderate enantiomeric excesses were 
observed. 
Subsequently, a screening of solvents using pre-catalyst 72 was performed (Table 3).  
 
Table 3. Screening of different solvents using complexes 72 and 73[a] 
 
Entry Pre-catalyst Solvent Time - UV irradiation (h) Yield (%)[b] ee (%)[b,c] 
1 73 [(R)-Monophos] Toluene 6 92 31, R 
2 72 [(S)-Monophos]  Toluene 6 92 35, S 
3 72 Toluene 18[d] 92 13, S 
4 72 iPrOH 6 55 30, S 
5 72 iPrOH/H2O 5:2 16 11 55, S 
6 72 n-butylacetate 3 35 47, S 
7 72 EtOAc 6 28 60, S 
[a] Reaction vessel irradiated at λmax = 352 nm and 8 W; Reaction conditions: acetophenone/Fe= 20:1, 
c0,substrate = 0.047 M. [b] Determined by GC equipped with a chiral capillary column (MEGADEX DACTBSβ, 
diacetyl-t-butylsilyl-β-cyclodextrin) and dodecane as internal standard. [c] Absolute configuration is S 
(assigned by comparison of the optical rotation sign with literature data).[147] [d] Xenon lamp emitts white 
light over a wide range of wavelengths (from 380 to 950 nm) from 7.5 J/cm2 to 12.5 J/cm2. 
 
The iron phosphoramidite complex 72, catalyzed the asymmetric hydrogenation of acetophenone 
only when subjected to UV irradiation under hydrogen pressure, yielding up to 92% of (S)-1-
phenylethanol and 35% of ee (Table 3, Entry 2). As expected, the catalyst containing (R)-Monophos 
73, (Entry 1) gave the opposite selectivity (31% ee; major enantiomer: (R)-1-phenylethanol). The 
irradiation under white light (Entry 3) gave very low conversion and loss of ee comparing to the 
UV irradiation. Change of the solvent (Entry 4-7) gave similar or better ee but with low conversion. 
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Table 4. Test of pre-catalysts 66 and 67 in the asymmetric hydrogenation of acetophenone[a] 
 
Entry Pre-catalyst Solvent Time - UV irradiation (h) Yield (%)[b] ee (%)[b,c] 
1 58 Toluene 4 35 17, R 
2 67 [(R)-Monophos] Toluene  6 82 39, R 
3 66 [(S)-Monophos] Toluene 7 97 29, S 
4 66 iPrOH /H2O 5:2 6 <2 50, S 
5 66 iPrOH /H2O 5:2 16 8 52, S 
6 66 EtOAc 16 20 43, S 
[a] Reaction vessel irradiated at λmax = 352 nm and 8 W; Reaction conditions: acetophenone/Fe = 20:1, 
c0,substrate = 0.047 M. [b] Determined by GC equipped with a chiral capillary column (MEGADEX DACTBSβ, 
diacetyl-t-butylsilyl-β-cyclodextrin) and dodecane as internal standard. [c] Absolute configuration is S 
(assigned by comparison of the optical rotation sign with literature data)[147] 
 
The binaphthyl-derived complexes 58, 66 and 67 were then tested (Table 4) in the hydrogenation 
of acetophenone under UV irradiation, where 58 yielded up to 35% of 1-phenylethanol and 17% 
of ee (Table 4, Entry 1), while 66 and 67, containing Monophos, showed an increase of 
enantiomeric excesses and very good conversions (Entry 2-3). In addition, complex 67 represents 
the matched combination of 58 and (R)-Monophos giving 39% ee of (R)-1-Phenylethanol, whereas 
66 is the mismatched combination with (S)-Monophos, which affords (S)-1-Phenylethanol in 29% 
ee. Change of the solvent (Entry 4-6) increased the ee in the hydrogenation reaction, but with 
reduced conversion. 
 
Since the results were not so promising, we decided to avoid other trials using different 
phosphoramidite ligand, but we reasoned that an increased steric bulk next to the 
cyclopentadienone ring could enanche the transmission of stereochemical information. We 
planned the synthesis of pre-catalyst 76, installing four methyl groups directly next to the 
cyclopentadienone ring. Unfortunately, the methylation of compound 64, led to a decomposition 
of the starting material (Scheme 73).  
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Scheme 73. Attempt to increase the steric bulk next to the cyclopentadienone ring 
 
After this trial, we decided to focus our attention on the 3,3'-position of the binaphtyl moiety, and 
in particular to install bulky substituents. A simple inspection of molecular models suggested that 
bulky 3,3'-substituents on the binaphthyl moiety would enhance the enantiofacial discrimination 
(Figure 25). 
 
Figure 25. Suggested transition state for the ketone hydrogenation reaction, highlighting the assumed 
importance of bulky 3,3'-substituents 
 
4.3. Towards the synthesis of a library of 3,3'-substituted chiral 
(cyclopentadienone)iron tricarbonyl complex 
In a first instance, we speculated that the flat and rigid β-naphthyl groups might efficiently play 
the role of bulky 3-3’ substituents (Figure 26). 
 
Figure 26. Idea to insert β-naphthyl on the 3-3'-positions of the binaphthyl moiety. 
 
Scheme 74 presents the synthesis starting from the commercially available (R)-3,3'-dibromo-[1,1'-
binaphthalene]-2,2'-diol, 78, which was triflated to yield 79. The arylated product 80 was obtained 
by a Suzuki-Miyaura cross coupling employing β-naphthyl boronic acid. This reaction proceeded 
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very slowly, probably due to the bulkiness of the β-naphthyl substituents. A subsequent Kumada 
coupling with MeMgI afforded 81, which was brominated under radical conditions to yield the bis-
bromide 82, which was subsequently transformed into the bis-iodide by a Finkelstein reaction 
with NaI. To our surprise this reaction did not proceed as easily as in the case of the unsubstituted 
bis-bromide 62. A mixture of compounds was observed in the crude reaction mixture and it was 
impossible to separate them. In addition, compound 82 was revealed to be very unstable and 
underwent rapid degradation. Furthermore, the reaction with the (TMS-ethynyl)magnesium 
bromide on the crude reaction mixture of 83 did not give the corresponding compound 84.  
 
Scheme 74. Attempts to synthesize β-naphthyl complex 77 
 
After the unsuccessful synthesis represented in Scheme 74, we decided that it was necessary to 
introduce the bulky 3,3'-substituents in a late step of the synthetic pathway, since their presence 
hampered the functionalization of the 2,2'-positions of the binaphthyl system. Additionally, we 
evaluated the possibility to prepare a small library of 3,3'-substituted complexes to figure out the 
role of the 3,3'-substituents. In order to facilitate the synthesis, a common precursor easily 
synthesized on gram scale and easily modifiable in one or two synthetic steps, was necessary 
(Scheme 75). 
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Scheme 75. New approach to synthesize new family of chiral iron complexes 
 
It was necessary to evaluate that the cyclopentadienone(iron) trycarbonyl complex was stable to 
harsh conditions needed for subsequent modifications, including the use of BBr3 as a 
demethylating agent and the formation of HBr, as a side product during the transformation. In 
addition, the typical experimental conditions of the Suzuki-Miyaura coupling might have caused 
an in situ Hieber reaction, which would have formed the sensitive active hydride complex and 
eventually lead to decomposition of the complex.  
A series of test reactions are represented in Scheme 76, using two pre-catalysts 58 and 46, and 
luckily, a quantitative recovery of the iron complexes was accomplished in every case. This proved 
the stability of our chiral complex and made us confident to proceed with the new synthetic 
strategy. 
 
Scheme 76. Testing the stability of cyclopentadienone iron tricarbonyl complexes 
 
The new synthetic path to insert a 3,3'-dimethoxy-substituents takes inspiration from the 
synthesis made by Maruoka and co-workers (up to 94, Scheme 77)[143] for related binaphthyl-
derivatives. We expected that the relatively small methoxy group would result in less sterical 
hindrance than the bulky β-naphthyl group used in the previous synthetic attempts (Scheme 74).  
The synthesis starts from (R)-BINOL 59, which is protected using methyl chloromethyl ether 
(MOMCl), to obtain compound 87, which was subjected to an ortho-lithiation, followed by 
treatment with trimethyl borate to obtain 88, which was directly oxidized to 89. The methylation 
of the hydroxy group of 89 was performed using MeI in the presence of K2CO3 to yield 90. Acidic 
hydrolysis removed the MOM protecting group to give 3,3'-dimethoxy-2,2'-binaphtyl derivative 
91. Compound 91 was converted into the bis-triflate 92, methylated in the presence of MeMgI 
and [Ni(dppp)Cl2] by Kumada coupling to yield the known compound 93. Subsequent radical 
bromination was carried out to yield the bis-bromide 94,[139] which was converted into the bis-
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iodide 95. Surprisingly, the formation of the bis-diyne using the (TMS-ethynyl)magnesium bromide 
in the presence of CuI, did not work with compound 95. Different reaction conditions were 
screened in order to synthesize compound 96, but without success for the formation of the 
desired product: 1) additional use of Pd(PPh3)4 to CuI; reaction of 95 with Gilman's cuprate (TMS-
ethynyl)2CuLi; 2) Kumada cross coupling using 95 and (TMS-ethynyl)magnesium bromide.  
To our delight, substitution of 95 with (TMS-ethynyl)lithium allowed to produce the diyne 96 in 
high yields, which was cyclized in the presence of Fe2(CO)9 to obtain 85 in 67% yield. 
 
Scheme 77.  Synthesis of chiral (cyclopentadienone)iron tricarbonyl complex 85 
 
We suppose that the alkynylation of 95 in the presence of (TMS-ethynyl)lithium is assisted by the 
electron pairs of the methoxy groups in the adjacent 3,3'-position of the binaphthyl moiety 
(Scheme 78). Additional evidence corroborating this hypothesis was given by the fact that the 3,3'-
unsubstituted bis-iodide 63 did not react with (TMS-ethynyl)lithium.  
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Scheme 78. 3,3'-dimethoxy groups directed the nucleophilic substitution to form the diyne 
 
The synthetic protocol in Scheme 77 was optimized to allow us to simplify our work and proceed 
on a multi-gram step synthesis (starting from up to 20 g of (R)-BINOL) of complex 85. Eleven steps 
are required, but no purification had to be used until the synthesis of compound 90 which was 
purified by column chromatography with a total yield of 55% from (R)-BINOL. Only three other 
chromatographic purifications were used for 92, 93 and the final complex 85. Crystallization was 
used in the purification of the bis-bromide 94 with similar yield obtained with flash column 
chromatography (84% vs. 89%) and the bis-iodide 95 was purified by simple filtration. Purification 
of the diyne 96 can be also avoided, to afford the final complex 85 in the same yield (54% for two 
steps). 
 
4.3.1. Screening conditions and optimization 
(Cyclopentadienone)iron tricarbonyl complex 85 was tested in the asymmetric hydrogenation of 
acetophenone, and similar conversions previously observed in the presence of 58 were obtained, 
but the enantiomeric excess increased up to 48%, 6 times higher respective to that of the 58 (Table 
5, entry 1 and 2). This early result demonstrated the importance of 3,3'-substituents, and we 
decided to optimize the experimental conditions for this reaction, performing a screening of 
different activators in order to improve the catalytic results. In particular, several bases of 
different strength were employed, to optimize the Hieber conditions for the activation of the Fe(0) 
per-catalyst, as well as trimethylamine-N-oxide to evaluate the efficacy of an oxidative method 
for the pre-catalyst activation. The reactions were performed under otherwise identical 
conditions, apart from the nature of the activator. The reaction outcome was evaluated by 
analysis of the NMR spectra of reactions crudes and injection in GC. In this way it was possible to 
confirm that no other by products were formed during the reactions thus assuring the selectivity 
of the reactions. In addition, the isolated yield of 1-phenylethanol, as product of the 
hydrogenation of acetophenone using complex 85 was determined, thus proving that the 
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conversions obtained by GC and NMR evaluations are comparable to the isolated yields. This 
procedure was followed for the screening of activators (Table 5), solvent screening (Table 6) and 
different pre-catalysts (Table 8).  
 
Table 5. Screening of the activators for new (cyclopentadienone)iron tricarbonyl complex 85[a] 
 
 
Entry Pre-cat. Activator Conv. (%)[b] ee (%)[b,c] 
1 58 K2CO3 62 8 
2 85 K2CO3 54 49 
3 85 Li2CO3 9 52 
4 85 Na2CO3 25 53 
5 85 Cs2CO3 29 51 
6 85 LiOH 49 51 
7 85 NaOH 35 50 
8 85 KOH 30 52 
9 85 K3PO4 23 53 
10 85 Me3NO 84 50 
[a] Reaction conditions: Substrate/Pre-cat./Activator = 100:1:2, P(H2) = 30 bar, solvent = 5:2 iPrOH/H2O, 
c0,substrate = 1.43 M, T = 70 °C, time = 18 h. [b] Determined by GC equipped with a chiral capillary column 
(MEGADEX DACTBSβ, diacetyl-t-butylsilyl-β-cyclodextrin). [c] Absolute configuration is S (assigned by 
comparison of the optical rotation sign with literature data)[147] 
 
This screening showed that the enantiomeric excess is almost independent on the applied 
activator (entries 2-10). In terms of conversion, initially the most efficient inorganic activator 
appeared to be K2CO3 (entry 2), but the best results were obtained with trimethylamine-N-oxide 
(entry 10). Renaud and co-workers reported the use of Me3NO to remove one CO ligand from 85, 
in this way a vacant site is formed, and filled with H2 after splitting.[113] 
After finding the optimal activation pathway for the pre-catalyst 85, optimization studies 
continued to assess the effects of hydrogen pressure, temperature and solvent (Table 6). 
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Table 6. Optimization of the reaction parameters of the asymmetric hydrogenation of acetophenone 
promoted by pre-cat 85[a] 
 
 
Entry Solvent P H2 (bar) T (°C) Conv. (%) ee (%) 
1  iPrOH/H2O 5:2 30 70  84  50  
2  iPrOH/H2O 5:2 50 70  85  51  
3  iPrOH/H2O 5:2 30 80  59  50  
4  iPrOH/H2O 5:2 30 50  33  55  
5[d]  iPrOH/H2O 5:2 30 70  100[e]  50  
6[f]  iPrOH/H2O 5:2 30 70  58  51  
7[g]  iPrOH/H2O 5:2 -- 70  13  53  
8  iPrOH  30 70  15  54  
9  EtOH/H2O 5:2 30 70  21  49  
10  CF3CH2OH/H2O 5:2 30 70  74  42  
11  DME/H2O 5:2 30 70  56  52  
12  Dioxane/H2O 5:2 30 70  56  52  
13  CH3CN/H2O 5:2 30 70  3  53  
14  DMF/H2O 5:2 30 70  26  54  
15  DCE/H2O 5:2 30 70  34  54  
16  Toluene/H2O 5:2 30 70  8  53  
[a] Reaction conditions: Substrate/Pre-cat. 85/Me3NO = 100:1:2, P(H2) = 30 bar, c0,substrate = 1.43 M. [b] 
Determined by GC equipped with a chiral capillary column (MEGADEX DACTBSβ, diacetyl-t-butylsilyl-β-
cyclodextrin). [c] Absolute configuration is S (assigned by comparison of the optical rotation sign with 
literature data)[147] [d] 2 mol% 85 (4 mol% Me3NO) employed. [e] Yield of the isolated product 94%. [f] 
c0,substrate = 0.72 M. [g] no hydrogen was applied to perform only asymmetric transfer hydrogenation 
 
To obtain full conversion, 2 mol% of 85 had to be used (Table 5, entry 5), in fact, increasing the 
pressure (entry 2) or temperature (entry 3) did not lead to full conversion. A slight increased of 
enantiomeric excess was observed at lower temperature (entry 4), but with a concomitant 
decrease of conversion. Additional solvent mixtures were tested (entries 9-16), but none of them 
led to better results than the 5:2 isopropanol/H2O mixture. The presence of water appeared to be 
crucial for the conversion (entry 8), maybe due to the poor solubility of Me3NO in isopropanol.  
Substrate concentration was also very important, because when the reaction was diluted twice 
(entry 6 vs. 1), a remarkable decrease of conversion was observed. Pre-catalyst 85 was also tested 
in the asymmetric transfer hydrogenation (entry 7), but low conversions were obtained. This 
underlines that the main catalytic activity is coming from the hydrogenation pathway. Still, a 
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background consisting of transfer hydrogenation with isopropanol is also occurring (TOP, ATH, 
Scheme 79), luckily this had no negative effect on overall results, since the obtained enantiomeric 
excess was almost the same. 
 
Scheme 79. Comparison of asymmetric transfer hydrogenation and asymmetric hydrogenation with 
complex 85 
 
4.3.2. Synthesis of the library of new chiral pre-catalyst 
After the promising enantiomeric excess obtained with 85, we decided to chase the initial plan to 
synthesize complexes bearing different 3,3'-substitutents from the common precursor 85. The 
first attempt to demethylate complex 85, employing BBr3 and typical conditions for the 
demethylation of aryl methyl ethers (0 °C, CH2Cl2), gave no conversion, but the unreacted 
substrate gave no sign of decomposition and turned out to be very stable to BBr3 (as expected 
after initial experiments with similar complexes presented in Scheme 76). However, using tetra-
n-butylammonium iodide (TBAI) as an additive[148] and increasing the reaction temperature (in 
DCE), the bis-OH derivative 86 was obtained in 80% yield (Scheme 80). Employing these harsh 
conditions, we proved again the great stability of (cyclopentadienone)iron tricarbonyl complexes. 
 
Scheme 80. Demethylation of complex 86 
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Luckily, we were able to grow a crystal of 86 suitable for single-crystal X-ray diffraction analysis by 
slow diffusion of hexane into a CH2Cl2 solution of complex 86 (Figure 27). 
 
Figure 27. ORTEP diagram (CCDC 1037376) of the molecular structure of 86 (thermal ellipsoids set at the 
50% probability level) 
 
Starting from 86, we planned our strategy of using simple transformation in order to prepare 
complexes with bulkier 3,3'-substituents. We started with a simple esterification and we were able 
to obtain two new pre-catalysts in good yields: the bis-acetate 97 and bis-benzoate 98 (Scheme 
81). 
 
Scheme 81. Synthesis of ester-derived complexes 97 and 98 
 
The next goal was to form bis-ether derivatives. Unfortunately, the etherification did not proceed 
as easily as in the case of esterification. Even though we managed to obtain only the 
bis(benzyl)ether complex 99 with 70% yield (Scheme 82), attempts to synthesize the 
bis(isopropyl)ether, or the bis(tert-butyl)ether employing  isobutene or (tBuO)2CHNMe2 were not 
successful. 
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R = iPr: a) 2-iodopropane, K2CO3, acetone, reflux; b) 2-iodopropane, K2CO3, DMF, 100 °C; c) 2-iodopropane, 
NaH, neat, 75 °C; R = tBu: d) (tBuO)2CHNMe2, toluene, 100 °C 
Scheme 82. Synthesis of 3,3'-bis(benzylether) 99 and attempts of preparation of other ether-derived 
complexes 
 
Sulfonylation of 86 with methanesulfonyl chloride (MsCl) or p-toluenesulfonyl chloride (TsCl) 
occurred in high yields in the presence of triethylamine (TEA) and catalytic amounts of 4-
dimethylaminopyridine (DMAP), yielding complexes 100 and 101 (Scheme 83). The bis-triflate 
derivative 102 was obtained employing the Comins’ reagent [N-(5-chloro-2-pyridyl)bis-
(trifluoromethanesulfonimide)].[149] On the contrary, the reaction with trifluoromethanesulfonyl 
chloride (TfCl) or trifluoromethanesulfonic anhydride (Tf2O) under similar conditions did not 
afford complex 102. 
 
Scheme 83. Synthesis of sulfonyl esters-derived complexes 100, 101 and 102 
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Since the final aim was to insert aryl substituents on the 3,3'-positions of the binaphthyl moiety, 
we decided to use the bis-triflate 102 in the Suzuki-Miyaura cross-coupling. Unfortunately, under 
typical conditions for this cross-coupling,[150] using β-naphthyl boronic acid, only a mono-
substituted complex 103 was obtained in 17% yield (Scheme 84). Since the triflate group placed 
nearby the Fe(CO)3 group is sterically less accessible, we supposed that the structure of the 
obtained monosubstitution product 103 is the one represented in Scheme 84, where the bulky 
aryl group is located far from the Fe center. 
 
Scheme 84. Suzuki-Miyaura coupling with 102 
 
We attributed the low conversion to the steric bulkiness of the β-naphthyl group and we decided 
to carry out further attempts using the less demanding phenylboronic acid. We started employing 
the same reaction conditions used in Scheme 84, but again we were able to obtain just a mono-
substituted complex 104 (Table 7, entry 6), albeit in a nearly quantitative way. Slightly modified 
conditions (Entry 3: Pd(OAc)2/(S)-Phos or entry 4-5: Pd(OAc)2/PPh3 instead of [Pd(PPh3)4]) gave 
almost the same result. While using PCy3 (entry 1-2), instead of PPh3 or (S)-Phos, no reaction or 
degradation were observed.[151][152] Degradation of the iron complex was also observed, when 
relatively strong bases and/or water were used, probably caused by a side Hieber-base reaction, 
in which the unstable (hydroxycyclopentadienyl)iron complex was produced.  
 
Table 7. Screening of different methods for arylation of bis-triflate Fe18 by Suzuki-Miyaura cross-coupling 
[a] 
 
 
Entry Catalyst 
PhB(OH)2 
[eq] 
Base 
[eq] 
Additive 
[eq] 
T 
(°C) 
Solvent 
NMR ratio (%) 
102 104 105 
1[151] 
15% Pd(OAc)2 
18% PCy3 
2.5 KF [3.3]  60 THF 97 3 - 
2[151] 15% Pd(OAc)2 2.5 KF [3.3] KBr [2.2] 60 THF 97 3 - 
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18% PCy3 
3[153] 
25% Pd(OAc)2 
50% (S)-Phos 
3 K3PO4 [4]  85 toluene  100 - 
4 
20% Pd(OAc)2 
40% PPh3 
2.5 K3PO4 [3]  85 dioxane  80* - 
5 
20% Pd(OAc)2 
40% PPh3 
2.5 KBr [3] KBr [2.2] 85 dioxane 2 80* - 
6[150] 10% Pd(PPh3)4 2.5 K3PO4 [3] KBr [2.2] 85 dioxane 5 74* - 
7[154] 
[5%+5%] 
Pd(PPh3)4  
2.5 K3PO4 [3] KBr [2.2] 85 dioxane  74* - 
8 10% Pd(PPh3)4  2.5 K3PO4 [3] 
KBr [2.2] 
H2O [6] 
85 dioxane  100 - 
9 5% Pd(PPh3)4 2.5 K3PO4 [3] KBr [5.6] 110 dioxane  100 - 
10 5% Pd(PPh3)4 2.5 K3PO4 [5]  100 DMF degradation 
11 5% Pd(PPh3)4 2.5 K3PO4 [3] 
TBAB 
[2.2] 
85 dioxane 100  - 
12 10% Pd(PPh3)4 5 K3PO4 [6] KBr [2.2] 85 
dioxane/
H2O 
degradation 
13 10% Pd(PPh3)4 5 K3PO4 [6] KBr [2.2] 85 dioxane  100 - 
14 5% Pd(PPh3)4 2.5 
Ba(OH)2 · 
8 H2O [3] 
KBr [2.2] 85 dioxane  100 - 
15[152] 10% Pd(PPh3)4 5 
Ba(OH)2 · 
8 H2O [6] 
 85 
DME/ 
H2O 
degradation 
16[152] 10% Pd(PPh3)4 5 
Ba(OH)2 · 
8 H2O [3] 
 85 
DME/ 
H2O 
degradation 
17 10% Pd(PPh3)4 2.5 
Ba(OH)2 
[3] 
KBr [2.2] 85 dioxane 65 35 - 
18 5% Pd(PPh3)4 2.5 tBuOK [3] KBr [2.2] 85 dioxane degradation 
19[155] 4% PEPPSI-iPr 2.5 K2CO3 [6]  60 dioxane 100   
20 5% PEPPSI-iPr 2.5 K3PO4 [3]  85 dioxane 100   
21 5% PEPPSI-iPr 2.5 
tBuOK 
[2.6] 
 60 iPrOH degradation 
22[156] 
5% Pd(IPr*) 
(cinnamyl)Cl 
3 K2CO3 [4]  40 EtOH degradation 
23[157] 
5% 
NiCl2(dppp) 
4 K3PO4 [8]  100 dioxane degradation 
24 
10% 
PdCl2(dppp) 
2.5 K3PO4 [3] KBr [2.2] 85 dioxane 50 50 - 
25 
10% 
PdCl2(dppp) 
2.5 
Ba(OH)2 · 
8 H2O [3] 
KBr [2.2] 85 dioxane 50 50 - 
[a] Conversion determined by NMR  
*isolated yield 
 
In total, 25 different palladium and nickel catalyzed cross coupling conditions were tested. 
Different ligands, bases, solvents and temperatures were evaluated, but unfortunately we were 
not able to obtain the desired bis-coupled complex 105. 
NMR studies on complex 104 confirmed that mono cross-coupling was taking place only on one 
side of the molecule. In particular, we supposed that the cross-coupling occurs only on the triflate 
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group placed on the opposite side to Fe(CO)3, since it is sterically less hindered and thus allows an 
easier access for the cross-coupling. 
We decided to explore a different approach to obtain the bis-phenyl derivative 105. Assuming that 
Fe(CO)3 was interfering with the Suzuki-Miyaura cross-coupling, we planned to remove that 
obstacle by demetallation, perform the cross-coupling on a 3,3'-substituted cyclopentadienone 
ligand and again form the iron complex. We believed that a subsequent insertion of the iron on 
the 3,3'-bisphenyl ligand with Fe2(CO)9 would have been easier than the cross-coupling with the 
metal complex. To asses this plan, using the methodology developed by Knölker,[106] 58 was 
decomplexed to yield the free ligand 106 quantitatively, and could be successfully re-complexed 
into 58 (Scheme 85). 
 
Scheme 85. Reversible decomplexation of 58 
 
After these promising results, we performed the decomplexation directly on the bis-triflate 
derived complex 102, as it would give us direct access to the Suzuki-Miyaura coupling with the 
obtained ligand 107 (Scheme 86). The decomplexation worked, even though just in 28% yield, and 
as expected, the cross coupling of compound 107 with phenylboronic acid easily gave ligand 108, 
bearing two phenyl groups in 3,3'-positions. Meanwhile, this was another indirect proof that the 
mono-substitution products 103 and 104, the unreacted triflate group is the one near to the 
Fe(CO)3 residue. Unfortunately, despite using different iron sources, higher temperatures, 
solvents or prolonged reaction times, the re-complexation of ligand 107 failed and no sign of 
desired iron complex 105 was observed. 
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Scheme 86. Attempted synthesis of complex 105 from 102 by decomplexation, cross-coupling and re-
complexation 
 
In summary, our synthetic efforts allowed us to build a small library of chiral iron complexes, 
starting from complex 85. An unprecedented synthetic pathway based on the high chemical and 
thermal stability of (cyclopentadienone)iron complexes and their direct modifications, using 
relatively simple transformations (Scheme 87). The strategy involved (a) deprotection of 86 
followed by: (b) esterification, (c) etherification, (d) sulfonylation or (e) cross-coupling with the 
triflate derivative. In this way, we were able to synthesize nine new pre-catalysts in few synthetic 
steps, avoiding time-consuming for parallel synthesis of each new complex and possible synthetic 
problems during multi-step synthesis. 
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Scheme 87. Scheme of synthetic routes starting from 85 to obtain 9 new different pre-catalysts 
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4.3.3. Catalytic tests with new chiral (cyclopentadienone)iron complexes 
Finally, we decided to test our library of chiral (cyclopentadienone)iron complexes, depicted in 
Scheme 87, in the asymmetric hydrogenation of acetophenone (Table 8) using the optimized 
conditions. 
Table 8. Screening of pre-catalyst 85, 86, 97-104 in the asymmetric hydrogenation of acetophenone [a] 
 
Entry Pre-cat. Substituents Conv. (%)[b] ee (%)[b,c] 
1 85 OMe 100 50 
2 86 OH 63 46 
3 97 OAc 3 46 
4 98 OBz 16 38 
5 99 OBn 38 39 
6 100 OMs 14 39 
7 101 OTs 20 37 
8 102 OTf 7 35 
9 103 Mono 2-Np 12 47 
10 104 Mono Ph 22 52 
[a] Reaction conditions: substrate/Pre-cat./Me3NO = 100:2:4, P(H2)=30 bar, solvent=5:2 iPrOH/H2O, 
c0,substrate=1.43 M, T = 70 °C, reaction time = 18 h. [b] Determined by GC equipped with a chiral capillary 
column (MEGADEX DACTBSβ, diacetyl-t-butylsilyl-β-cyclodextrin). [c] Absolute configuration is S (assigned 
by comparison of the optical rotation sign with literature data)[147] 
 
All newly synthesized pre-catalysts showed significantly lower catalytic activities and lower 
strereoselectivity compared to pre-catalyst 85. Full conversion of the acetophenone was never 
reached, and the best result in terms of catalytic activity was achieved with the dihydroxy-
substituted pre-catalyst 86 (Table 8, entry 2), derived from 85. The lesser steric bulk of the 3,3'-
substituents can explain the slightly decreased enantiomeric excess of 86 compared to 85. The 
low stereoselectivity of the other complexes is not simple to explain, since they bear bigger 3,3'-
substituents. Perhaps, esters 97-98 presented low conversion due to the possible carbonyl oxygen 
coordination to the iron center and its subsequent deactivation.[113a] In the case of ethers and 
esters, the bulky substituents are possibly able to move away from the zone of approach of the 
substrate because of free rotation of the C-O bond. In terms of stereoselectivity, only 103 and 104 
pre-catalysts (Entry 9-10) showed a comparable enantiomeric excess to 85, whereas the other 
complexes showed significantly lower values (Entries 3-8).  
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4.3.4. Substrate screening with the best chiral (cyclopentadienone)iron complex 85 
Since the best catalyst for the AH of acetophenone remained the 3,3'-bis-methoxy pre-catalyst 85, 
a substrate screening was performed using this complex (Table 9). 
 
Table 9. Substrate screening for pre-catalyst 85[a] 
 
Entry Substrate Conv. 
(%)[b] 
ee (%)[c]  
abs. conf.[d] 
 Entry Substrate Conv. 
(%)[b] 
ee (%)[c]  
abs. conf.[d] 
1 
 
100 50, S  8 
 
97 57, S 
2 
 
100 46, S 
 9[e] 
 
25 77, S 
3 
 
64 50, S 
 10 
 100 13, R 
4 
 
100 51, S 
 11 
 
78 59, R 
5 
 
43 68, S 
 12 
 
89 61, S 
6 
 
99 51, S 
 13 
 76 0 
7 
 
35 50, S 
 14 
 
22 77, S 
[a] Reaction conditions: substrate/Pre-cat. 85/Me3NO = 100:2:4, P(H2) = 30 bar, solvent = 5:2 iPrOH/H2O, 
c0,substrate= 1.43 M, T = 70 °C, reaction time = 18 h. [b] Determined by GC equipped with a chiral capillary 
column (see the Experimental part), conversions obtained by GC were confirmed by 1H-NMR of the reaction 
crudes, confirming that no other by-products were formed. [c] Determined by GC or HPLC equipped with a 
chiral capillary column (see the Experimental part). [d] Assigned by comparison of the sign of optical rotation 
with literature data (see the Experimental part). [e] Substrate/Pre-cat. 85/Me3NO = 100:5:10. 
 
Pre-catalyst 85 was screened with a range of acetophenone derivatives (entries 1-6, 9, 11, 14), as 
well with heteroaromatic (entries 7, 8, 12) and aliphatic ketones (entries 10, 13). A general trend 
can be observed; if the substituents next to the carbonyl group were bulkier, higher enantiomeric 
excesses were observed (up to 77% entry 9 and 14), but along with a decreased conversion as 
well. With a low steric hindrance, low (13% ee for entry 10) or no enantioselectivity (0% ee for 
entry 13) was observed, along with good to full conversion (entries 8-10). 
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4.3.5. Variation of the 2,5-substituents of the cyclopentadienone ring 
In agreement with our initial plan, 2,5-substituents of the cyclopentadienone ring might also 
influence the transmission of stereochemical information and affect the catalytic performance of 
the iron complex. For this reason, the modification of pre-catalyst 85 was taken into consideration 
by replacing the TMS groups in the 2,5-positions with other groups, such as: 
- TIPS (triisopropylsilyl ether) groups: increased steric bulk compared to TMS; 
- flat phenyl groups, which in principle could allow to install bulky 3,3'’-substituents by 
cross-coupling reaction;  
- the removal of any substituents from the 2,5-positions. 
To realize these modifications the synthesis of the cyclative carbonylation precursors was realized 
starting from the previously synthesized bis-iodide 95, which was reacted with different ethynyl-
lithium compounds in an analogous way described before (Scheme 88). Upon treatment of 95 
with [(TIPS)ethynyl)]lithium and [(phenyl)ethynyl]lithium, the new diyne compounds 109 and 110 
were isolated in good yield. Unfortunately, the subsequent cyclization of the TIPS derivative 111 
using Fe2(CO)9 led to no conversion, probably due to the excessive steric bulk of the TIPS groups. 
In contrast, the 2,5-bis-phenyl-substituted derivative 110 was complexed in good yield to obtain 
112. The 2,5-unsubstituted complex, was obtained by removing the TMS groups from diyne 96, 
using sodium carbonate in methanol, obtaining quantitative conversion to diyne 113, which 
unfortunately underwent degradation during the cyclization conditions. 
 
Scheme 88. Synthesis of complex 85 analogs modified at the 2,5-positions of the cyclopentadienone ring 
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The new complex 112 was tested in the AH of acetophenone, applying our optimized conditions 
for 85 (Scheme 89). 
 
Scheme 89. Test of pre-catalyst 112 in the asymmetric hydrogenation of acetophenone 
 
To our surprise, the new pre-catalyst 112 showed very low catalytic activity. Only 6% of the 
substrate was converted to (R)-phenylethanol, with only 11% ee. A possible explanation might be 
that the phenyl groups are not bulky enough to prevent dimerization of the activated hydride of 
112, which could lead to a decomposition as reported by Guan and co-workers for a related iron 
complex.[159] Additionally, computational studies on a related achiral (cyclopentadienone)iron 
complex with 2,5-phenyl groups, confirmed that phenyl groups lead to an increase of the 
activation energy of the hydrogenation process.[117b][160] 
Even after these negative result, we still decided to try to install 3,3'-phenyl substituents and to 
verify if bulky 2,5-TMS groups were really interfering with the Suzuki-Miyaura cross-coupling or 
not. The deprotection of complex 112 at room temperature in the presence of BBr3 proceed slowly 
and after 3 days of reflux, only a small amount of the desired product was obtained (15% yield), 
thus suggesting that, the TMS groups exert also some stabilizing effect on the cyclopentadienone 
ring, contrary to the phenyl groups. Complex 115 was converted to the corresponding triflate 116 
using the Comin's reagent, and subjected to the cross-coupling with phenylboronic acid under the 
best conditions previously reported, reaching a mixture of mono and bis-substituted products 117 
and 118. This result proved that, together with the Fe(CO)3, also the bulky TMS substituents 
interfered with the Suzuki-Miyaura coupling because the cross-coupling occur in both side of the 
molecule in the presence of flat phenyl groups, even though the reaction was very sluggish. 
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Scheme 90. Synthesis of 3,3'-bis(phenyl)cyclopentadienone iron complex 118 
 
The catalytic activity of complexes 112, 117 and 118 in the AH of acetophenone was studied (Table 
10). 
 
Table 10. Screening of pre-catalyst 112, 117 and 118 in the asymmetric hydrogenation of acetophenone[a] 
 
Entry Pre-cat. Substituents Conv. (%)[b] ee (%)[c,d] 
1 112 OMe 6 11, R 
2 117 Mono-Ph 10 16, R 
3 118 Bis-Ph 20 24, R 
[a] Reaction conditions: substrate/Pre-cat./Me3NO = 100:2:4, P(H2) = 30 bar, solvent = 5:2 iPrOH/H2O, 
c0,substrate = 1.43 M, T = 70 °C, reaction time = 18 h. [b] Determined by GC equipped with a chiral capillary 
column (MEGADEX DACTBSβ, diacetyl-t-butylsilyl-β-cyclodextrin). [c] Absolute configuration is S (assigned 
by comparison of the optical rotation sign with literature data)[147] 
 
In comparison to the bis-methoxy pre-catalyst bearing two phenyl groups at the 2,5-positions of 
the cyclopentadienone (complex 112), both new catalysts 117 and 118 revealed increased 
catalytic activity. The best result was obtained with 118, with 20% conversion and 24% ee, while 
117, showed lower conversion (10%) and 16% ee. Interestingly, complexes with 2,5-TMS 
substituents (85, 86, 97-104) produce the (S)-phenylethanol, while 2,5-phenyl substituted pre-
catalyst (112, 117, 118) led to the (R)-enantiomer. The inversion in the stereochemical preference 
demonstrated that 2,5-substituents on the cyclopentadienone play an important role in the 
transmission of the stereochemical information to the substrate.  
 
Results and Discussion 
93 
 
4.4. Towards planar chirality 
As already mentioned, the family of (cyclopentadienone)iron tricarbonyl complexes has gained 
increasing interest in the last few years. It should be underlined that (cyclopentadienone)iron 
complexes are usually synthesized by one-pot tethered cyclative carbonylation of diynes with 
large excesses of iron pentacarbonyl, Fe(CO)5 or diiron nonacarbonyl Fe2(CO)9, which results in 
concomitant complexation of the iron tricarbonyl moiety (Figure 15, paragraph 17). This approach 
requires a significant synthetic effort to obtain the diyne precursor with the proper 
functionalization, thus somehow limiting the possibility to tune the substitution pattern at the 
cyclopentadienone ring that allowed only for the same substituents at the 2,5- and 3,4-positions 
respectively. 
In principle, an intermolecular cyclative carbonylation/complexation could also be envisioned, 
starting from two discrete alkynes in the presence of the iron carbonyl reagent [Fe(CO)5 or 
Fe2(CO)9]. However, this approach has a limited scope, as it has been reported to occur in good 
yields only when very specific types of substituents on the alkyne, such as silyl groups[104a] or some 
substituents (e.g., Cl, OtBu and CF3) were employed.[161] Additionally it is important to report that 
the reaction of trimethylsilylacetylene with an iron source at 140 °C provides just the 2,5-
bistrimethylsyilylsubstituted(cyclopentadienone)iron tricarbonyl complex (Scheme 91). Very low 
yields (< 15%) were reported for the cyclization of more common alkynes such as, phenylacetylene 
and diphenylacetylene.[162] 
 
Scheme 91. Intermolecular cyclative carbonylation/complexation 
 
Cyclooctyne, the smallest isolated cyclic alkyne, is known to be very reactive, undergoing 
degradation upon prolonged standing. The compound is not commercially available, but can be 
easily synthesized in very good yields starting from cyclooctene (Scheme 92):[163] first the alkene 
is brominated with Br2 to form the corresponding 1,2-dibromoalkane. This compound is not 
isolated but directly treated with KOtBu to yield 1-bromocyclooctene 121 by the elimination of 
HBr. This vinylbromide is isolated and purified by distillation. Then, a second elimination in the 
presence of LDA allows to obtain the desired alkyne 123. According to the literature, when 
cyclooctyne 123 was reacted with Ni, W, Co and Fe carbonyl complexes,[164][165][166] several 
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products were isolated, among which, in the case of iron, substantial amounts of 
tris(hexamethylene)benzene 124 (derived from the cyclotrimerization of the alkyne), and minor 
quantities of the [bis(hexamethylene)cyclopentadienone]iron complex 123 (Scheme 92). This 
peculiar behavior raised our attention, and induced us to investigate the reaction, in order to 
optimize the formation of complex 123. The cyclative carbonylation of cyclooctyne was then 
performed in toluene using Fe(CO)5 under careful control of the temperature. Much to our delight, 
the reaction at 90 °C afforded complex 123 in a respectable 56% yield. This temperature proved 
to be optimal and crucial in order to minimize the formation of the trimerization product 124, and 
90 °C seems to be the optimal value. Indeed, when the reaction was performed at r.t., 124 was 
the only product observed, but also increasing temperature to 110 °C led to an increased 
formation of trimer at the expense of the desired complex 123, which was obtained in only 45% 
yield. 
 
Scheme 92. Synthesis of the [bis(hexamethylene)cyclopentadienone]iron tricarbonyl complex 123 
 
The proposed mechanism for the formation of 123 (Scheme 93) consists of a stepwise iron 
mediated [2+2+1] cycloaddition,[104][105][167][168][169] which is initiated by the sequential replacement 
of two carbon monoxides ligands by the two alkyne molecules thus generating the (bis-η2-
alkyne)iron tricarbonyl complex A. At this stage, iron(0) promotes the oxidative coupling of the 
two bound alkynes to form the intermediate ferrocyclopentadiene structure B. Insertion of a 
molecule of carbon monoxide into the iron-carbon bond followed by a subsequent rearrangement 
of the ferrohexadienone structure C affords the tricarbonyliron-complexed cyclopentadienone 
123. 
On the other hand the iron cyclobutadiene complex 125, which is a known side-product as 
reported by Wittig during the use of NiBr2 [166] was never observed in our case. 
Results and Discussion 
95 
 
 
Scheme 93. Proposed mechanism for the formation of complex 123 in a [2+2+1]cycloaddition 
 
Release of the ring strain of cyclooctyne probably plays an important role in facilitating the 
intermolecular cyclative carbonylation/complexation process. To confirm this hypothesis, we 
subjected cyclododecyne 128, prepared starting from the cyclododecanone 120,[170] which mainly 
differs from cyclooctyne for lesser ring strain, to the same reaction conditions adopted for the 
synthesis of 123 (Scheme 94). As expected, the reaction of compound 128 in the presence of 
Fe(CO)5 afforded the desired complex 129 only in very poor yield (5%), and no improvement could 
be obtained by changing the solvent (toluene, xylene) or increasing the reaction temperature. In 
this case, no trimerization product was observed and it was possible to recover the 
cylclododecyne. 
 
Scheme 94. The low-yielding synthesis of [bis(decamethylene)cyclopentadienone]iron tricarbonyl 
complex 129 
 
Complex 123 was thoroughly characterized spectroscopically, and crystals suitable for X-ray 
diffraction analysis could be grown by cooling a saturated solution of the [bis(hexamethylene)-
cyclopentadienone]iron complex 123 in nhexane/CH2Cl2. The X-ray structure reveals the usual 
piano-stool geometry with a certain degree of flexibility (Figure 28). 
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Figure 28. ORTEP diagram (CCDC 1511079) of the molecular structure of the 
[bis(hexamethylene)cyclopentadienone]iron complex 123 
 
4.4.1. Catalytic test with the new [bis(hexamethylene)cyclopentadienone]iron 
tricarbonyl complex 
The [bis(hexamethylene)cyclopentadienone]iron tricarbonyl 123 was tested in the reduction of 
ketones by hydrogenation and transfer hydrogenation.  
Table 11. Test of pre-catalyst 123 in the hydrogenation of acetophenone and screening of different 
activators[a] 
Pre-cat. 123 (1 mol%)
Activator (2 mol%)
H2
iPrOH/H2O 5:2
16 h
O OH
 
Entry Activator P (H2) [bar] T [°C] Conv. [%][b] 
1 K2CO3 10 70 < 5 
2 hν[c] 10 40 > 99 
3 Me3NO 10 70 52 
4 K2CO3 30 70 51 
5 Me3NO 30 70 > 99 
[a] Reaction conditions: Substrate/Pre-cat. 123/activator = 100:1:2, solvent: 5:2 iPrOH/H2O, c0,substrate = 1.43 
M, reaction time = 16 h. [b] Determined by GC equipped with a chiral capillary column (MEGADEX DACTBSβ, 
diacetyl-t-butylsilyl-β-cyclodextrin). [c] Reaction vessel irradiated at λmax = 352 nm and 8 W; solvent = 
toluene, Substrate/Pre-cat. 123 = 20:1, c0,substrate = 0.047 M. 
 
We firstly screened the known methodologies for the in situ activation of the pre-catalyst (Table 
11). Use of K2CO3 (in situ Hieber reaction) only led to a moderate conversion (Table 11, entry 1), 
while the other activation strategies (entries 2-3) were more successful: photolysis of a CO ligand 
by UV irradiation yielded full conversion, and oxidative cleavage with Me3NO gave 52% conversion. 
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Increasing the hydrogen pressure to 30 bar, the conversion grew to 51% in the presence of K2CO3 
(entry 4) and to completeness in the presence of Me3NO (entry 5). 
A substrate scope screening of pre-catalyst 123 was then performed adopting the activation 
protocol with Me3NO, which is compatible with standard hydrogenation equipment as it does not 
require UV irradiation. 
 
Table 12. Substrate screening for the hydrogenation of ketones in the presence of pre-catalyst 123[a] 
 
Entry Substrate Conv. [%][b]  Entry Substrate Conv. [%][b] 
1 
 
> 99 (98) [c] 
 
10 
 
> 99 
2 
 
> 99 
 
11 
 
15 
3 
 
> 99 (98)[c] 
 
12 
 
> 99 
cis : trans = 
60:40 
4 
 
> 99 (98)[c] 
 
13 
 
> 99 (94)[c] 
5 
 
> 99 
 
14 
 
> 99 (86)[c] 
6 
 
> 99 
 
15  
> 99 
7 
 
> 99 
 
16 
 
> 99[d] 
8 
 
80 
 
17 
 
99 
9 
 
> 99 
 
18 
 
No reduction 
    19  No reduction 
[a] Reaction conditions: subtrate/Pre-cat. 123/Me3NO = 100:1:2, P(H2) = 30 bar, solvent: 5:2 iPrOH/H2O, 
c0,substrate = 1.43 M, T = 70 °C, reaction time = 16 h. [b] Determined by 1H-NMR of the crude reaction mixture. 
[c] isolated yield; the reactions were carried out on a 2 mmol scale following the General Procedure 
(paragraph 6.8.1). 
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Several 4-, 3- and 2-substituted acetophenones were fully hydrogenated (Table 2, entries 2-6), 
regardless of the electron withdrawing or electron donating nature of the substituent. Notably, 
reducible groups such as carbon-halogen bonds (entries 4 and 6) or nitro group (entry 2) were not 
affected under the reaction conditions. 2-Acetylpyridine (entry 7) was also hydrogenated with full 
conversion, despite the presence of a coordinating nitrogen atom that - in principle - could poison 
the catalyst. α-Tetralone (entry 8) was the only aryl ketone to be hydrogenated with less than 
quantitative yield. Aliphatic ketones (entries 9-12) showed quantitative conversion with the 
exception of isophorone (entry 11). An α,β-unsaturated ketone was hydrogenated with only 15% 
yield. Despite the low conversion, it should be remarked that there was full selectivity for the C=O 
bond. No competing reduction of the conjugated C=C double bond was observed. Quite 
expectedly, the aldehyde substrates (entries 13-16) were smoothly hydrogenated to the 
corresponding alcohols. In the case of cinnamaldehyde (entry 16), some 3-phenyl-1-propanol 
(from reduction of both C=O and C=C) was also obtained, together with the expected cinnamyl 
alcohol. An activated ester (entry 17) was also hydrogenated to the corresponding alcohol with 
full conversion. As a limitation, alkynes (entry 19) and amides (entry 18) appear not to be suitable 
substrates, consistent with what was reported for the other Knölker-Casey-type complexes.[116] 
In addition, we tried to reduce benzalacetone in a selective way. The use of UV irradiation led to 
a mixture of hydrogenated product and isomerization products, while the use of Me3NO produced 
a 1:1 mixture of 4-phenyl-3-buten-2-ol (from C=O reduction) and 4-phenylbutan-2-ol (from 
reduction of both C=O and C=C). Even though this reduction is not chemoselective, it can be 
considered a good result when compared to the data reported by Morris and co-workers[90] 
employing a iron-pincer complex (S,S)-130, where no conversion was observed after 24 h, or the 
one reported by Milstein,[171] 131 where a mixture of hydrogenated products were shown. For the 
(cyclopentadienone)iron tricarbonyl complexes, Beller reported just the hydrogenation of α,β-
unsaturated aldehydes with very high efficiency for the selective reduction of the carbonyl 
moiety.[114] As – in a control experiment – 4-phenyl-3-buten-2-ol itself did not react at all under 
the same experimental conditions, we assume that 4-phenylbutan-2-ol was formed by 1,4-
reduction of benzalacetone followed by hydrogenation of the C=O double bond.  
The amount of over-reduction product (5%) was much lower in the case of the corresponding α,β-
unsaturated aldehyde (entry 16) respective to the benzalacetone (Scheme 95). This difference is 
explained by the fact that – in the case of entry 16 – 1,2-reduction of C=O competes more 
efficiently with the 1,4-reduction pathway due to the higher reactivity of the aldehyde compared 
to the keto group. 
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Scheme 95. Reduction of benzalacetone using: (a) Morris catalyst (S,S)-130; b) Milstein catalyst 131 and 
c) pre-catalyst 123 under UV irradiation or Me3NO as activators. 
 
After these results we decided to compare the catalytic activity of the 
[bis(hexamethylene)cyclopentadienone]iron tricarbonyl complex 123 to the “classical” 
(cyclopentadienone)iron complex 46 in the hydrogenation of acetophenone at low catalyst 
loading (0.1 mol%). As can be seen in Table 13, higher turnover numbers (TON) and turnover 
frequencies (TOF) were observed for complex 123 compared to 46. 
 
Table 13. Comparison between complexes 46 and 123 in the hydrogenation of acetophenone[a] 
 
Entry Pre-cat. Conv. [%] TON TOF [h-1] 
1 46 13 130 7.5 
2 123 62 620 35.9 
[a] c0, substrate = 1.429 M, substrate/Pre-cat./Me3NO = 100:0.1:0.2, P(H2) = 30 bar, T = 70 °C, 17 h, solvent = 5:2 
iPrOH/H2O. 
 
Such a remarkable difference in terms of activity prompted us to evaluate the kinetics of the 
acetophenone hydrogenation in the presence of pre-catalysts 46 and 123 (activated with Me3NO). 
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The conversions were calculated from the hydrogen uptake, measured with a computer-
controlled Parr autoclave system, shown in Figure 29.  
As can be seen in Figure 29, in the initial part of the two experiments (t < 20 min) the in situ formed 
complexes 46 and 123 showed similar activity, with typical pseudo-first order kinetic profiles. 
However, after about 20 min the two catalysts started behaving very differently: while the 123-
derived catalyst went on following pseudo-first order kinetics (Figure 29, blue diamonds ♦), the 
46-catalyzed reaction slowed down (Figure 29, red squares ■) and then proceeded until 
completion at reduced rate. These findings seem to suggest that the “classical” 46-derived catalyst 
undergoes rather fast decomposition,[159] so that most of it is transformed into a less active or 
inactive species before the hydrogenation of the acetophenone is complete. On the contrary, the 
catalyst derived from the new [bis(hexamethylene)cyclopentadienone]iron complex 123 seems to 
be more robust and does not undergo substantial decomposition before the hydrogenation is 
finished. The lower stability of catalyst 46 would also explain the lower TON, TOF and conversion 
obtained with the former at 0.1 mol% catalytic loading (Table 13). 
 
Table 14. Kinetic parameters of the hydrogenation of acetophenone in the presence of pre-catalysts 46 
and 123 after short reaction time (t < 20 min)[a] 
 
Entry Pre-cat. kapp [min-1][b] t1/2 [min] k [L mol-1 min-1][b] 
1 46 0.040 17.5 7.9 
2 123 0.036 19.3 7.2 
[a] Substrate/pre-cat./Me3NO = 100:1:2; solvent: 5:2 iPrOH/H2O; c0, substrate = 0.501 M; P(H2) = 30 bar; ccat. = 
5 mM. [b] kapp = k . ccat. 
 
Figure 29. Kinetics of acetophenone hydrogenation promoted by pre-catalyst 46 (■) and 123 (♦) activated 
with Me3NO. Reaction conditions: Substrate/Pre-cat./Me3NO = 100:1:2; solvent: 5:2 iPrOH/H2O; c0, substrate 
= 0.501 M; PH2 = 30 bar; T = 70 °C; ccat. = 5 mM 
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The proposed mechanism for the hydrogenation of acetophenone, shown in Scheme 96 (Cycle A), 
is the one commonly accepted for Knölker-Casey catalysts:[107][135] after the activation of pre-
catalyst 123 by de-coordination of one CO ligand, the active species 123a splits H2 generating the 
(hydroxycyclopentadienyl)iron complex 123b. The latter reacts with the substrate through a 
concerted pericyclic transition state (II), forming complex 123a together with the reaction 
product. 
 
 
Scheme 96. Proposed mechanism for ketones hydrogenation (Cycle A) and transfer hydrogenation (Cycle 
B) promoted by complex 123 activated with Me3NO 
 
Casey and Guan reported that the isolated (hydroxycyclopentadienyl)iron complex 47 is also able 
to catalyze the transfer hydrogenation of acetophenone with iPrOH.[107] We thus tested the 
(cyclopentadienone)iron complex 46 and our new [bis(hexamethylene)cyclopentadienone]iron 
complex 123, activated in situ with Me3NO, in this reaction (Table 15).  
 
Table 15. Transfer hydrogenation of acetophenone with iPrOH of pre-catalysts 123 and 46[a] 
 
Entry Pre-cat. Conv. [%][b] 
1 46 34 
2 123 90 
[a] Substrate/Pre-cat./Me3NO = 100:2:4, c0, substrate = 0.7 M, 70 °C, 17 h, solvent: 5:2 iPrOH/H2O. [b] 
Determined by GC equipped with a chiral capillary column (MEGADEX DACTBSβ, diacetyl-t-butylsilyl-β-
cyclodextrin). 
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Just as observed in the classical hydrogenation, pre-catalyst 123 was found more active than the 
“Knölker complex” 46: while only moderate conversion was obtained in the presence of the latter 
complex (Table 15, entry 1), use of pre-catalyst 123 allowed to obtain almost full conversion (Table 
15, entry 2). 
This finding is in agreement with the hypothesis that mechanism and active catalytic species are 
similar to those of the hydrogenation: as shown in Scheme 96 (Cycle B), first the active complex 
123a dehydrogenates iPrOH (through the pericyclic transition state III) forming the hydride 123b, 
then the latter reduces the substrate (through transition state II). 
 
4.5. Synthesis of a planar chiral (cyclopentadienone)iron tricarbonyl 
complex 
Having shown that complexes bearing different substituents than silylated groups at positions 2,5 
can indeed yield active catalysts for the hydrogenation of ketones by choosing an appropriate 
substituent pattern, we decided to explore intermolecular cyclizations using combinations of 
different alkynes in the presence of Fe(CO)5 to obtain complexes devoid of planar symmetry, and 
therefore chiral, as a different approach to enantioselective Knölker-Casey catalysts (Scheme 97). 
Different combinations were investigated combining diphenylacetylene, bis-
trimethylsilylacetylene and cyclooctyne, but unfortunately none of them afforded the mixed 
complex (with two different substituens at positions 2 and 5): the combinations of cyclooctyne 
afforded mainly complex 123, the [bis(hexamethylene)cyclopentadienone]iron tricarbonyl 
previously described, and in the case of diphenylacetylene minute amounts of the 
(tetraphenyl)cyclopentadienone iron complex 132, already known in literature were also formed. 
 
Scheme 97. Attempts of intermolecular cyclative/carbonylation using different alkynes 
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An alternative way to obtain cyclopentadienone complexes is the complexation of a 
cyclopentadienone with an iron source. For this reason, we thought that using fluorenone as a 
starting point might be a reasonable idea: it is commercially available and it can be easily 
brominated in the 2,7-positions using Br2/H2O at 90 °C,[172] in this way various substituents could 
have been installed. Unfortunately, when we tried to complex fluorenone with Fe(CO)5, we just 
recovered the starting material (Scheme 98), probably due to the presence of two aromatic rings, 
which delocalize the charge. 
 
Scheme 98. Attempts directed towards the complexation of fluorenone 
 
After this trial, we decided to focus our attention on different ligands: 137 and 143. In the first 
case (Scheme 99a) the synthesis starts from the 2-iodobenzoic acid 135, which reacts in an acyl 
Heck-Heck reaction with allylbromide to give 3-bromo-cyclohex-1-ene (136). Unfortunately, we 
were not able to isolate the desired ligand in the following step, 3,4-dihydro-1H-fluoren-9(2H)-
one 137, even after changing the Pd source or working under anhydrous conditions.[173]  
 
 
Scheme 99. Attempts directed towards the synthesis of complexes 138 and 144 starting from ligands 137 
and 143 
 
In the second synthesis in Scheme 99b, 1-indanone (139) was brominated to 3-bromoindenone 
140, which was subjected to a thermal decomposition to give the desired product 141, 2,3-
dibromoindenone, and a side product 142, identified as 5-bromo-7-benzo-fluorenone.[175] 
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Compound 141, was subjected to a Suzuki-Miyaura cross-coupling to afford the 2,3-
diphenylindenone 143 in 97% yield.[176] Fatefully, when we tried to form the iron complex, we 
recovered just the starting material. After these attempts we concluded that even one aromatic 
ring on the cyclopentadienone was enough to avoid the complexation using Fe(CO)5. 
 
It should be noted that only few methods for the synthesis of cyclopentadienones are known in 
the literature. The most common synthetic route to tetraarylcyclopentadienones involves the 
reaction of diaryl-α-diketones 145 (obtained by benzoin condensation of benzaldehydes followed 
by oxidation), with diphenylacetone 146 in the presence of KOH or NaOH, in refluxing EtOH for 
variable reaction times depending on the substituents (2-16 h).[177] 
Recently, a microwave-assisted condensation was developed, with consequent reduction of 
solvent and reaction time which goes from 2-16 h to 25 min under microwave heating.[178] 
 
Scheme 100. Synthesis of tetraarylcyclopentadienones starting from diaryl-α-diketones and 
diphenylacetone 
 
Another approach (Scheme 101) is the 1,1-cycloaddition of oxalyl chloride (149) with 1,4-dilithio-
1,3-dienes (147) or zirconcyclopentadienes (148), which forms the cyclopentadienone derivatives 
in the presence of CuCl (2 eq.). During the nucleophilic addition step the C-C bond of 1,2-
dicarbonyl is cleaved. The mechanism of the reaction is shown in Scheme 102, which suggests the 
formation of a chelated intermediate.[179]  
 
 Scheme 101. 1,1-cycloaddition of oxalyl chloride with 1,4-dilithio-1,3-dienes or zirconcyclopentadienes 
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Scheme 102. Proposed mechanism for the 1,1-cycloaddition 
 
A palladium-catalyzed [2+2+1] cyclocarbonylation of alkynes, under atmospheric pressure of 
carbon monoxide is reported in Scheme 103. The transformation is carried out under mild 
conditions and ligand-free conditions.[180]  
 
Scheme 103. A palladium-catalyzed [2+2+1] cyclocarbonylation of alkynes 
 
A different approach, reported in literature and shown in Scheme 104, involves the use of 
cyclopropenones, as excellent 3-carbon components in Rh(I)-catalyzed [3 + 2] cycloadditions with 
a wide range of alkynes, providing cyclopentadienones in a selectively way and high yield.[181] This 
Rh(I)-catalyzed [3 + 2] cycloaddition tolerates a broad range of aryl alkyne substituents: methyl-, 
methoxymethyl-, methyl ketone-, chloride-, and amide-functionalized phenylacetylenes. All react 
efficiently and regioselectively. Free alcohol, nitrile, aldehyde, and even 1,3-diyne moieties also 
react to provide cyclopentadienones with high regioselectivity. 
 
Scheme 104. Rh(I)-catalyzed [3 + 2] cycloadditions between cyclopropenones and alkynes 
 
More recently a water-accelerated multicomponent synthesis has been used as a key method for 
the preparation of cyclopentadienone derivatives, the three component condensation reactions 
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of primary amines with alkyl propiolates in the presence of triphenylphosphine in water at 80 °C 
formed the 4-oxo-2,5-cyclopentadiene-1,2-dicarboxylate derivatives (Scheme 105).[182] 
 
Scheme 105. Water-accelerated multicomponent synthesis 
 
Following the synthesis reported by Wender and co-workers (Scheme 104),[181] we were able to 
synthesize two new different cyclopentadienone ligands using [RhCl(CO)2]2 in the presence of 
diphenylcyclopropenone 150 and an alkyne (Scheme 106). In particular, we decided to employ 4-
octyne 151 to yield 152 in 65% yield and a propargylic alcohol, 4-phenyl-3-butyn-2-ol, 153 to afford 
154 in similar yield (Scheme 106).  
 
Scheme 106. Synthesis of cyclopentadienone 152 and 154 
 
Complex 155 and 156 were synthesized in the presence of Fe(CO)5 in toluene at 90 °C (Scheme 
107). These are the first examples of cyclopentadienone iron complexes with planar chirality. The 
early results in the hydrogenation reactions showed full conversion under the standard 
conditions, using Me3NO as an activator. 
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Scheme 107. Synthesis and catalytic activity of two new planar chiral catalysts 155 and 156 (racemic 
mixtures) 
 
Since compound 156 was reactive in the hydrogenation of acetophenone, we decided to proceed 
with the resolution of the alkynol, using an enantioselective esterification of a propargylic alcohol 
employing a lipase from Pseudomonas sp. (AK),[183] in this way we obtained the final complex as a 
diastereoisomeric mixture (Scheme 108). 
 
Scheme 108. Synthesis of a new planar chiral catalysts 160 (mixture of diastereoisomers) 
 
Work is in progress to separate the racemates of 155 and 156, and to establish a procedure to 
obtain a single diastereoisomer of 160. 
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5. Conclusion and Outlook 
 
My thesis was focused on finding new catalysts based on the most abundant transition metal – 
iron. In the last 20 years, this cheap and non-toxic metal has become the object of increasing 
interest in the scientific community, and remarkable progresses have been made in the 
development of iron catalyzed reactions. Despite these efforts there is still a lot of work to do to 
improve iron catalysts in order to became competitive with respect to the noble metal complexes. 
In fact, many of these iron catalysts are highly air- and/or moisture-sensitive, and their synthesis 
can be very difficult. In order for the homogeneous iron catalysts to become industrially relevant, 
more easy-to-prepare and stable catalysts have to be developed.  
During my PhD work, I focused my attention on the synthesis and characterization of 
(cyclopentadienone)iron tricarbonyl complexes and their application to stereoselective catalytic 
transformations. We chose (cyclopentadienone)iron complexes, because these complexes have 
the advantage of being easily synthesized and stable to air, water and light, in contrast to other 
iron complexes used for homogenous asymmetric hydrogenation. These catalysts can be activated 
in situ by reaction with bases, Me3NO or UV irradiation and converted into the active catalysts 
used for hydrogenation reaction, and this allowed to avoid the use of a glovebox.  
My research started with the development of a new binaphthyl-derived chiral 
(cyclopentadienone)iron tricarbonyl complexes, which displayed high stability to air, moisture and 
chromatography. We started from the unsubstituted chiral complex, which was obtained in 6 
steps from the (R)-BINOL, with an overall yield of 23%. The new complex 58 was tested in the 
hydrogenation of acetophenone, under the standard conditions reported by Beller, employing 
K2CO3, but very low enantiomeric excess was observed. We attribute this low ee to the remote 
position of the stereoaxis respective to the active center, and simple molecular models suggest 
that the presence of bulky 3,3'-substituents on the binaphthyl moiety can improve the level of the 
stereocontrol. We proceeded with the synthesis of a 3,3'-substituted version of the complex, and 
in particular, we decided to introduce a methoxy substituents. The synthesis, starting from the 
(R)-BINOL, required 11 steps but only 4 flash chromatography columns were necessary to achieve 
the pure complex 85 with an overall yield of 15%. The new methoxy-substituted complex catalyzes 
the asymmetric hydrogenation of ketones with better enantioselectivity (up to 77% ee) compared 
to any other reported chiral (cyclopentadienone)iron tricarbonyl complexes reported in 
literature.[117][118] In fact this result was nearly three times higher than previously reported 
enantiomeric excess in the literature for chiral (cyclopentadienone)iron complexes. 
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As the obtained enantioselectivity increases with the steric bulk of the binaphthyl 3,3'-
substituents, we focused our attention on the synthesis of new complexes with various 3,3'-
substituents starting from the 3,3'-dihydroxy-substituted complex, which was prepared by 
demethylation of the methoxy substituted pre-cat. Using rather simple transformation, e.g. 
esterification, etherification, sulfonylation and triflation reactions, we prepared six complexes 
with different substituents at the 3,3'-positions on the binaphthyl moiety from the common 
hydroxy derived precursor. In this way, a library of chiral (cyclopentadienone)iron pre-catalysts 
was developed. In addition, a Suzuky-Miyaura cross-coupling on the bis-triflate derived complex 
to install bulky aryl group was performed, but unfortunately just the mono-coupling derived 
complexes were obtained. Substitution at the 3,3'-positions of the binaphthyl system affected 
both the activity and the enantioselectivity in an unclear manner, and the methoxy-substituted 
complex remained the best pre-catalyst.  
 
The synthesis of analogs of methoxy substituted compound featuring different substituents at the 
2,5-positions of the cyclopentadienone ring was then undertaken, and the 2,5-bis(phenyl)-
substituted compound was prepared. Compared to the methoxy substituted complex, the latter 
showed low catalytic activity and the opposite stereochemical preference in the asymmetric 
hydrogenation of acetophenone. This finding suggests that both the binaphthyl 3,3'-substituents 
and the cyclopentadienone 2,5-substituents of the new catalysts play a role in the transmission of 
the stereochemical information. 
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In addition we also synthesized and fully characterized a new 
[bis(hexamethylene)cyclopentadienone]iron tricarbonyl complex 123. This new compound has 
been obtained in a preparatively useful yield (56%) by reaction of cyclooctyne with Fe(CO)5. The 
obtained yield is remarkable for this kind of intermolecular cyclative carbonylation/complexation, 
which usually gives good results only with a few, properly substituted alkynes.[104][161][162] 
The observed reactivity of cyclooctyne, the smallest cyclic alkyne, is probably due to ring strain, as 
suggested by the lack of reactivity of its unstrained higher homolog cyclododecyne during the 
cyclative carbonylation. The cyclooctyne-derived complex has been tested as pre-catalyst in the 
hydrogenation of ketones, in which, after activation with Me3NO, it displayed a catalytic activity 
superior (in terms of TON and TOF) to that of the well-known Knölker-Casey complex. The same 
trend was also observed in the transfer hydrogenation of acetophenone, which allowed to obtain 
a higher conversion compared to the Knölker-Casey complex. Kinetic studies on the hydrogenation 
of acetophenone of the two catalysts were also performed. This suggests that the difference 
between the two (cyclopentadienone)iron pre-catalysts is due to the higher stability of 
cyclooctyne-derived complex. 
 
Finally, we also started to explore the field of (cyclopentadienone)iron tricarbonyl complexes 
which contain planar chirality, preforming the cyclopentadienone ligand and subsequently 
inserting iron to form the desired complex. We evaluated the catalytic activity of the obtained 
planar chiral pre-catalyst, the results are promising, but the research to separate the two 
enantiomers (155, 156) or the two diastereoisomers (160) is still under investigation. 
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6. Experimental Part 
6.1. General Conditions 
All reactions were carried out in anhydrous conditions in flame-dried glassware with magnetic 
stirring under nitrogen or argon atmosphere, unless otherwise stated.  
The solvents for reactions were distilled over the following drying agents and transferred under 
nitrogen: CH2Cl2 (CaH2), MeOH (CaH2), THF (Na), dioxane (Na), Et3N (CaH2). Dry Et2O, acetone, 
toluene and CHCl3 (over molecular sieves in bottles with crown cap) were purchased from Sigma 
Aldrich and stored under nitrogen.  
The reactions were monitored by analytical thin-layer chromatography (TLC) using silica gel 60 
F254 pre-coated glass plates (0.25 mm thickness). Visualization was accomplished by irradiation 
with a UV lamp and/or staining with a potassium permanganate alkaline solution. Flash column 
chromatography was performed using silica gel (60 Å, particle size 40-64 μm) as stationary phase, 
following the procedure by Still and co-workers.[184] 
Proton NMR spectra were recorded on a Bruker spectrometer operating at 400.13 MHz. Proton 
chemical shifts are reported in ppm (δ) with the solvent reference relative to tetramethylsilane 
(TMS) employed as the internal standard (CDCl3 δ = 7.26 ppm; CD2Cl2, δ = 5.32 ppm; [D]6acetone, 
δ = 2.05 ppm; [D]6DMSO, δ = 2.50 ppm; CD3OD, δ = 3.33 ppm). The following abbreviations are 
used to describe spin multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br 
= broad signal, dd = doublet-doublet, td = triplet-doublet. 13C-NMR spectra were recorded on a 
400 MHz spectrometer operating at 100.56 MHz, with complete proton decoupling. Carbon 
chemical shifts are reported in ppm (δ) relative to TMS with the respective solvent resonance as 
the internal standard (CDCl3, δ = 77.16 ppm; CD2Cl2, δ = 54.00 ppm; [D]6acetone, δ = 29.84 ppm, 
206.26 ppm; [D]6DMSO, δ = 39.51 ppm; CD3OD, δ = 49.05 ppm). The coupling constant values are 
given in Hz.  
Infrared spectra were recorded on a standard FT/IR spectrometer. Optical rotation values were 
measured on an automatic polarimeter Jasco P1010 with a 1 dm cell at the sodium D line (λ = 589 
nm).  
Gas chromatography was performed on a GC instrument equipped with a flame ionization 
detector, using a chiral capillary column.  
High resolution mass spectra (HRMS) were performed on a Fourier Transform Ion Cyclotron 
Resonance (FT-ICR) Mass Spectrometer APEX II & Xmass software (Bruker Daltonics) – 4.7 T 
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Magnet (Magnex) equipped with ESI source, available at CIGA (Centro Interdipartimentale Grandi 
Apparecchiature) c/o Università degli Studi di Milano.  
Low resolution mass spectra (MS) were acquired either on a Thermo-Finnigan LCQ Advantage 
mass spectrometer (ESI ion source) or on a VG Autospec M246 spectrometer (FAB ion source).  
Elemental analyses were performed on a Perkin Elmer Series II CHNS/O Analyzer 2000. X-ray 
intensity data were collected with a Bruker Apex II CCD area detector by using graphite 
monochromated Mo-Kα radiation.  
Melting point were determined on a Büchi B-540 instrument. 
Chiral HPLC analysis were performed on a Shimadzu instrument equipped with a Diode Array 
detector. 
 
6.1.1. Materials  
Commercially available reagents were used as received: trifluoromethanesulfonic anhydride, 
triethylamine, methylmagnesium bromide (3 M in Et2O), N-Bromosuccinimide, benzoyl peroxide, 
ethynyltrimethylsilane, ethylmagnesium bromide (1 M in THF), n-BuLi (1.6 M in hexanes), BBr3 (1 
M in CH2Cl2), Bu4NI, NaI, MeI, CuI, Fe2(CO)9, DMAP, acetyl chloride, benzoyl chloride, benzyl 
bromide, chloromethyl methyl ether, methanesulfonyl chloride, p-tolueneslufonyl chloride, N-(5-
chloro-2-pyridyl)bis(trifluoromethane-sulfonimide), Pd(OAc)2, K3PO4, PPh3, KBr, phenylboronic 
acid, PCy3, (S)-Phos, Pd(cinnamyl)(IPr)Cl, PdCl2(dppp), NiCl2(dppp), Ba(OH)2∙H2O, Ba(OH)2 
anhydrous, Bu4NBr, KF, K2CO3, tBuOK, Me3NO, 1-iodopentane, ethynyltriisopropylsilane, 
ethynylbenzene and also compounds (ketones, aldehydes and esters) used in the substrate 
screening were purchased from commercial suppliers (TCI Chemicals, ACROS, Sigma Aldrich) and 
used as received. 
(R)-(+)-1,1'-bi(2-naphthol), (S)-(-)-1,1'-Bi(2-naphthol) (BINOL) and (R)-3,3'-dibromo-[1,1'-
binaphthalene]-2,2'-diol 78 are commercially available. Also (R)-2,2′-bis(bromomethyl)-1,1′-
binaphthyl 62 is commercially available, but it can be easily synthesized from BINOL according to 
the procedure described by Ooi et al.[185], while (R)-2,2'-bis(bromomethyl)-3,3'-dimethoxy-1,1'-
binaphthyl 94 was synthesized according to the procedure described by Cramer and co-
workers.[139]  
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6.2. Synthesis of complex (R)-58 
 
 
6.2.1. (R)-2,2'-bis(trifluoromethanesulfonyloxy)-1,1'-binaphthyl [60] 
OTf
OTf
60  
Trifluoromethanesulfoic anhydride (8.51 mL, 50.6 mmol, 2.2 eq) was added dropwise at -78 °C to 
a stirred mixture of (R)-BINOL (6.58 g, 23.0 mmol, 1 eq) and triehtylamine (9.62 mL, 69.0 mmol, 3 
eq) in CH2Cl2 (60 mL), under nitrogen in a Schlenk tube fitted with a Teflon screw cap. After the 
addition, the cooling bath was removed and the reaction mixture was stirred for 2 h at room 
temperature. The mixture was then poured into ice-cold 1 M HCl (40 mL) and extracted with 
hexane. The organic extracts were washed with saturated NaHCO3, brine and dried over Na2SO4. 
Evaporation of solvent gave the crude 2,2'-bis(trifluoromethanesulfonyloxy)-1,1'-binaphthyl 60, 
which can be either purified by flash column chromatography (9:1 hexane/CH2Cl2) to give a white 
powder or used in the following step without further purification.[186]  
Yield 12.66 g (quantitative yield); m.p. 83-89 °C; []D24 = -147.7° (c = 1.01 in CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 8.16 (d, 3J = 9.1 Hz, 2H), 8.02 (d, 3J = 8.3 Hz, 2H), 7.64 (d, 3J = 9.1 Hz, 
2H), 7.60 (ddd, 3J = 8.3 Hz, 3J = 6.9 Hz, 4J = 1.1 Hz, 2H), 7.43 (ddd, 3J = 8.3 Hz, 3J = 6.9 Hz, 4J = 1.1 Hz, 
2H), 7.28 (d, 3J = 8.4 Hz, 2H). 
13C NMR (100 MHz, CDCl3): 119.3, 123.5, 126.8, 127.3, 128.0, 128.4, 132.0, 132.3, 133.1, 145.4. 
IR (KBr): ν = 3062, 1508, 1424, 1246, 1140, 1065, 963, 865 cm-1. 
HRMS (ESI+): m/z 549.9878 [M]+ (calcd. for C22H12F6O6S2 549.9979). 
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6.2.2. (R)-2,2'-dimethyl-1,1'-binaphthyl [61] 
 
2,2'-Bis(trifluoromethanesulfonyloxy)-1,1'-binaphthyl 60 (12.66 g, 23.0 mmol, 1 eq) and 
NiCl2(dppp) (0.374 g, 0.69 mmol, 3 mol%) were dissolved in Et2O (30 mL), in a Schlenk tube fitted 
with a Teflon screw cap, under nitrogen. A 3 M ethereal solution of methylmagnesium iodide (30.7 
mL, 92.0 mmol, 4 eq) was added dropwise at 0 °C. Then, the reaction mixture was heated to reflux 
and stirred overnight. The mixture was poured into ice-cold 1 M HCl and the obtained mixture was 
filtered over celite to remove the catalyst. The filtrate was extracted with Et2O and the organic 
extracts were washed with brine and dried over Na2SO4. Evaporation of the solvent and 
purification of the residue by column chromatography on silica gel (100:1 hexane/ether) gave (R)-
2,2'-dimethyl-1,1'-binaphthyl 61, as a white powder. [187] 
Yield 6.36 g (98%); m.p. = 74-78 °C; []D24 = -39° (c = 1.12 in CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.92 (d, 3J = 8.4 Hz, 4H), 7.54 (d, 3J = 8.4 Hz, 2H), 7.42 (ddd, 3J = 8.4, 3J 
= 6.9, 4J = 1.2 Hz, 2H), 7.24 (ddd, 3J = 8.4, 3J = 6.9, 4J = 1.2 Hz, 2H), 7.08 (d, 3J = 8.4 Hz, 2H), 2.07 (s, 
6H). 
13C (100MHz, CDCl3): δ 135.2, 134.3, 132.8, 132.2, 128.8, 127.8, 127.3, 126.1, 125.7, 124.9, 20.1. 
IR (KBr): ν = 3049, 2918, 1506, 1352, 1026, 814, 746 cm-1. 
HRMS (ESI+): m/z 282.1400 [M]+ (calcd. for C22H18 282.1409). 
 
6.2.3. (R)-2,2'-Bis(bromomethyl)-1,1'-binaphthyl [62] 
 
A mixture of (R)-2,2'-dimethyl-1,1'-binaphthyl 61 (6.36 g, 22.52 mmol, 1 eq), N-bromosuccinimide 
(NBS) (8.42 g, 47.3 mmol, 2.1 eq), and benzoyl peroxide (82 mg, 0.338 mmol, 1.5 mol%) in CCl4 (40 
mL) was heated and refluxed overnight. In addition, during the first 4 h the reaction mixture was 
irradiated using a 100 W lamp. The resulting mixture was cooled to room temperature and then 
poured into water and extracted with EtOAc. The organic extracts were dried over Na2SO4 and 
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concentrated. The residue was purified by crystallization from CH2Cl2/hexane to give (R)-2,2'-
bis(bromomethyl)-1,1'-binaphthyl 62. [188]  
Yield 7.55 g (77%); m.p. = 180-183 °C; []D24 = +148° (c = 1.70 in benzene). 
 
1H NMR (400 MHz, CDCl3): δ 8.03 (d, 3J = 8.7 Hz, 2H), 7.94 (d, 3J = 8.1 Hz, 2H), 7.77 (d, 3J = 8.4 Hz, 
2H), 7.51 (ddd, 3J = 8.1 Hz, 3J = 6.9, 4J = 1.2 Hz, 2H), 7.28 (ddd, 3J = 8.4, 3J = 6.9, 4J = 1.2 Hz, 2H), 7.09 
(d, 3J = 8.7 Hz, 2H), 4.28 (s, 4H).  
13C (100 MHz, CDCl3): δ 134.2, 134.1, 133.3, 132.5, 129.9, 128.2, 127.8, 127.1, 126.88, 126.87, 31.6.  
IR (KBr): ν = 3047, 1595, 1506, 1433, 1360, 1329, 1211, 1026, 968, 821, 756, 721, 687 cm-1. 
HRMS (ESI+): m/z 437.9612 [M]+ (calcd. for C22H16Br2 437.9619). 
 
6.2.4. (R)-2,2'-Bis(iodomethyl)-1,1'-binaphthyl [63] 
 
NaI (13.6 g. 91 mmol, 10 eq) was added to a stirred suspension of (R)-2,2'-bis(bromomethyl)-1,1'-
binaphthyl 62 (4.01 g, 9.1 mmol) in acetone (50 mL), in a Schlenk tube fitted with a Teflon screw 
cap under nitrogen. The Schlenk was sealed and the mixture was heated to 58 °C and stirred 
overnight. To prevent possible photodegradation of 63, the reaction vessel was covered tightly 
with aluminum foil and the reaction workup was done in the presence of the smallest possible 
amount of light. After cooling down to 40 °C, acetone was removed in vacuo, and the obtained 
solid was dried under high vacuum for 30 min. Water (100 mL) was added, and the obtained 
suspension was stirred for 30 min. The mixture was filtered on a ceramic frit, and the solid product 
63 was washed with water (100 mL), sat. aq. Na2S2O3 (100 mL), water (100 mL), and ice-cold 2:1 
MeOH/hexane mixture (100 mL). Product 63 – a pale yellow powder – was dried on a frit and then 
under high vacuum.  
Yield 3.89 g (80% yield); m.p. = 130-132 °C (dec.); []D24 = +112.81° (c = 0.345 in CH2Cl2). 
 
1H NMR (400 MHz, [D6]acetone): δ 7.34 (d, 3J = 8.6 Hz, 2H), 7.25 (d, 3J = 8.2 Hz, 2H), 7.06 (d, 3J = 
8.6 Hz, 2H), 6.77 (td, 3J = 8.2 Hz, 4J = 1.1 Hz, 2H), 6.55 (td, 3J = 8.2 Hz, 4J = 1.2 Hz, 2H), 6.25 (d, 3J = 
8.6 Hz, 2H), 3.62 (d, 2J = 9.5 Hz, 2H AB system), 3.51 (d, 2J = 9.5 Hz, 2H, AB system). 
13C NMR (100 MHz, [D6]acetone): δ 136.2, 134.1, 133.0, 130.3, 129.2, 129.1, 127.8, 127.5, 127.3, 
5.7.  
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IR (film): ν = 2292.2, 1461.9, 1377.3, 1156.6 cm-1.  
Elemental analysis (%): C 49.26, H 3.03 (calcd. for C24H20I2O2: C 49.47, H 3.02). 
 
6.2.5. (R)-2,2'-Bis(3-(trimethylsilyl)prop-2-ynyl)-1,1'-binaphthyl [64] 
 
A solution of ethynyltrimethylsilane (0.565 mL, 4.0 mmol, 4 eq) in THF (5 mL) was added dropwise 
to a 1 M solution of ethylmagnesium bromide in THF (4.0 ml, 4.0 mmol, 4 eq) kept at 0 °C. The 
reaction mixture was heated to reflux and stirred for 1 h. After cooling to room temperature, CuI 
(0.095 g, 0.500 mmol, 0.5 eq) and compound 63 (0.534 g, 1.0 mmol, 1 eq) were added. The mixture 
was heated to reflux and stirred overnight. The reaction was quenched with saturated aqueous 
NH4Cl (5 mL), and the obtained aqueous phase was extracted with EtOAc (3 × 25 mL). The organic 
layer was washed with H2O (20 mL) and brine (20 mL), dried over Na2SO4 and concentrated in 
vacuo. Purification by column chromatography (95:5 hexane/CH2Cl2) gave the product 64 as a light 
yellow oil. 
Yield 0.38 g (80%); m.p. = 56 °C; []D24 = +134.55° (c = 0.348 in CH2Cl2). 
 
1H NMR (400 MHz, CD2Cl2): δ 8.03 (d, 3J = 8.5 Hz, 2H), 7.95 (d, 3J = 8.2 Hz, 2H), 7.89 (d, 3J = 8.5 Hz, 
2H), 7.45 (td, 3J = 8.2 Hz, 4J = 1.1 Hz, 2H), 7.24 (td, 3J = 8.2 Hz, 4J = 1.3 Hz, 2H), 6.99 (d, 3J = 8.5 Hz, 
2H), 3.35 (d, 2J = 19 Hz, 2H, AB system), 3.22 (d, 2J = 19 Hz, 2H, AB system), 0.12 (s, 18H). 
13C NMR (100 MHz, CD2Cl2): δ 134.2, 133.7, 133.4, 133.0, 129.1, 128.7, 127.2, 127.2, 126.3, 126.0, 
104.5, 87.6, 25.1, 0.3. 
IR (film): ν = 3059.0, 2959.8, 2174.8, 1484.9, 1265.1, 1249.8 cm-1.  
HRMS (ESI+): m/z 497.20980 [M + Na]+ (calcd. for C32H34Si2Na: 497.20913). 
 
6.2.6. Complex (R)-58 
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Diyne 64 (0.510 g, 1.07 mmol, 1 eq) and Fe2(CO)9 (0.781 g, 2.14 mmol, 2 eq) were dissolved in dry 
toluene (9 mL) and heated to 90 °C for 4 h, under argon. After cooling down to room temperature, 
the reaction mixture was filtered through a pad of celite. The filtrate was concentrated in vacuo, 
and the residue was purified by flash column chromatography (8:2 hexane/CH2Cl2) to obtain (R)-
58 as a pale yellow solid.  
Yield 0.320 g (46%); m.p. = 209 °C (dec.); []D19 = -32.24° (c = 0.9 in CH2Cl2). 
 
1H NMR (400 MHz, CD2Cl2): δ 8.04 (d, 3J = 8.5 Hz, 2H), 7.99 (d, 3J = 8.8 Hz, 1H), 7.97 (d, 3J = 8.8 Hz, 
1H), 7.68 (d, 3J = 8.5 Hz, 1H), 7.55 (d, 3J = 8.5 Hz, 1H), 7.52-7.45 (m, 2H), 7.30 (td, 3J = 8.5 Hz, 4J = 
1.1 Hz, 1H), 7.25 (td, 3J = 8.5 Hz, 4J = 1.1 Hz, 1H), 7.20 (d, 3J = 8.5 Hz, 1H), 7.09 (d, 3J = 8.5 Hz, 1H), 
3.76 (d, 2J = 15.7 Hz, 1H), 3.67 (d, 2J = 14.1 Hz, 1H), 3.45 (d, 2J = 15.7 Hz, 1H), 3.38 (d, 2J = 14.1 Hz, 
1H), 0.41 (s, 9H), 0.26 (s, 9H). 
13C NMR (100 MHz, CD2Cl2): δ 209.8, 181.4, 137.0, 135.6, 135.0, 134.6, 133.4, 132.5, 130.0, 129.7, 
128.9, 128.7, 127.5, 127.3, 127.1, 127.0, 126.9, 126.5, 113.1, 111.5, 76.0, 74.0, 34.8, 32.8, 0.9, 0.5.  
IR (film): ν = 3054.69, 2953.93, 2060.1, 2005.1, 1985.4, 1626.2, 1507.6, 1429.5, 1264.1, 1248.7  
cm-1.  
HRMS (ESI+): m/z 643.14164 [M + H]+ (calcd. for C36H35O4Si2Fe: 643.14294). 
 
6.3. Replacement of one CO ligand with phosphoramidite ligand 
6.3.1. Synthesis of a phosphoramidite ligand: Monophos [65] 
 
A mixture of (R)-binaphthol (2.0 g, 6.98 mmol) and hexamethyl phosphorous triamide (1.60 g, 9.77 
mmol, 1.4 eq) in 10 mL of dry toluene was refluxed under argon atmosphere for 2 h. After cooling 
down to room temperature, the precipitate was filtered on a frit and washed with Et2O to obtain 
white crystals.  
Yield 2.02 g (80%); m.p. 190-192 °C. 
 
1H NMR (400 MHz, CDCl3): δ 7.99 (d, 3J = 8.8 Hz, 1H), 7.93-7.95 (m, 3H), 7.54 (d, 3J = 8.8 Hz, 1H), 
7.43-7.45 (m, 3H), 7.42 (d, 3J = 8.8 Hz, 1H), 7.38 (d, 3J = 8.5 Hz, 1H), 7.26-7.32 (m, 2H), 2.58 (d, 3J = 
9.1 Hz, 6H). 
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13C NMR (400 MHz; CDCl3): δ 150.01, 149.98, 149.07, 132.83, 132.61, 131.39, 130.74, 130.27, 
130.02, 128.35, 128.27, 127.01, 126.93, 126.10, 124.79, 124.59, 123.96, 123.93, 122.81, 122.11, 
121.98, 121.97, 36.05, 35.91. 
13P-NMR (161.9 MHz; CD2Cl3): δ 148.76. 
 
6.3.2. General procedure for replacing one CO ligand with a phosphoramidite 
 
Me3NO (1.0 eq) was added to a degassed solution of the Fe-complex (1.0 eq) and the 
corresponding phosphoramidite 65 (1.1 eq) in dry toluene (30 mL) and then the mixture was 
refluxed for 4 h, under argon. After cooling the mixture to room temperature, the solvent was 
removed under pressure, and the residue was purified by flash column chromatography (8:2 n-
hexane/EtOAc) to obtained the final complex.  
 
6.3.3. Complex 71 [(S)-Monophos] 
 
Pale yellow solid 
Yield 52 mg (42%); m.p. 215 °C (dec.). 
 
1H NMR (400 MHz, CD2Cl2): δ 8.04 (d, 3J = 9.0 Hz, 1H), 8.01 (d, 3J = 9.0 Hz, 1H), 7.97-7.92 (dd, 3J = 
8.2 Hz, 4J = 3.0 Hz, 2H), 7.75 (d, 3J = 9.0 Hz, 1H), 7.42-7.46 (m, 2H), 7.21-7.33 (m, 5H), 2.59 (d, 2J = 
10.5 Hz, 6H), 2.30-2.80 (br. m, 4H), 1.20-1.80 (br. m, 4H), 0.22 (s, 9H), -0.09 (s, 9H). 
13C NMR (400 MHz, CD2Cl2): δ 214.2, 213.8, 179.9, 147.4, 148.3, 133.1, 132.9, 131.5, 131.3, 130.8, 
130.6, 128.4, 128.2, 126.9, 126.6, 126.4, 125.5, 125.3, 123.4, 122.4, 122.1, 120.6, 38.1, 31.0, 24.4, 
22.4, 22.0, 0.1, -0.2. 
31P NMR (161.9 MHz, CD2Cl2): δ 193.7. 
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IR (ATR): ν = 2943, 2002, 1944, 1591, 1508, 1464, 1433, 1398, 1370, 1325, 1287, 1242, 1227, 1204, 
1175, 1072, 978, 947, 841, 822, 770, 748, 712, 683, 650, 619 cm-1. 
HRMS (ESI+): m/z 750,00 [M + Na]+ (calcd. for C39H44FeNNaO5PSi2: 749,1845). 
 
6.3.4. Complex 72 [(S)-Monophos] and 73 [(R)-Monophos] 
 
Pale yellow solid 
72: Yield 181 mg (66%); m.p. 215 °C (dec.)  
73: Yield 176 mg (94%); m.p. 215 °C (dec.) 
 
1H NMR (300 MHz, CD2Cl2): δ 8.06 (d, 3J = 9.0 Hz, 1H), 8.02 (d, 3J = 9.0 Hz, 1H), 7.94-7.98 (dd, 3J = 
8.2 Hz, 4J = 3.0 Hz, 2H), 7.84 (d, 3J = 9.0 Hz, 1H), 7.44-7.49 (m, 2H), 7.19-7.33 (m, 5H), 5.08 (d, 2J = 
12.0 Hz, 1H), 4.73-4.85 (m, 3H), 2.47 (d, 2J = 10.5 Hz, 6H), 0.23(s, 9H), -0.36 (s, 9H). 
13C NMR (300 MHz, CD2Cl2): δ 213.1, 213.0, 182.0, 148.9, 148.1, 133.1, 133.0, 131.7, 135.5, 131.1, 
131.0, 128.6, 128.4, 127.1, 126.9, 126.8, 126.5, 125.8, 125.4, 123.6, 122.7, 121.9, 120.4, 112.7, 
108.5, 71.5, 68.7, 68.1, 62.3, 37.4, 0.6, -1.1. 
31P NMR (161.9 MHz, CD2Cl2): δ 194.6. 
IR (ATR): ν = 2015, 1958, 1603, 1503, 1460, 1410,1323, 1245, 1225, 1070, 1026, 976, 947, 840, 
750, 713, 693 cm-1. 
HRMS (ESI+): m/z 738.157 [M + H]+ (calcd. for C37H40FeNO6PSi2: 738,1559). 
Elemental analysis (%): C 57.49, H 5.38, N 1.76 (calcd. for C37H40FeNO6PSi2: C 57.73, H 5.30, N 1.80). 
 
6.3.5. Complex 70 
 
Yield 76 mg (72%); m.p. 152 °C. 
1H NMR (400 MHz; CDCl3): δ 2.77-2.82 (m, 2H), 2.57-2.62 (m, 2H), 1.77 (br s, 4H), 1.33 (s, 18H). 
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13C NMR (161.9 MHz, CDCl3): δ 210.2, 173.4, 100.4, 92.3, 33.3, 29.9, 24.9, 22.1. 
IR (ATR): ν = 2949.16, 2862.36, 2048.4, 1980.89, 1950.03, 1620.21, 1454.33, 1435.04, 1388.75, 
1361.74, 1355.96, 1300.02, 1205.51, 1089.78, 1074.35, 1016.49, 974.05, 966.34, 852.54, 748.38, 
736.38, 736.81, 626.87 cm-1. 
 
6.3.6. Complex 74 [(S)-Monophos] 
 
Pale yellow solid  
Yield 126 mg, (45%); m.p. = 135.5 °C. 
 
1H NMR (400 MHz; CD2Cl2): δ 8.06 (d, 3J = 8.9 Hz, 1H), 8.03 (d, 3J = 8.9 Hz, 1H), 7.97 (d, 3J = 8.2 Hz, 
2H), 7.84 (d, 3J = 8.9 Hz, 1H), 7.43-7.49 (m, 2H), 7.32 (d, 3J = 8.7, 2H), 7.22-7.29 (m, 3H), 2.71-2.82 
(m, 4H), 2.64 (d, 2J = 10.3 Hz, 6H), 2.38-2.59 (m, 4H), 1.34 (s, 9H), 1.16 (s, 9H). 
13C NMR (400 MHz, CD2Cl2): δ 215.96, 131.97, 131.26, 129.01, 128.72, 127.24, 127.05, 126.79, 
125.89, 125.73, 122.85, 121.12, 38.42, 38.36, 30.22, 30.12, 25.47, 24.81, 22.43, 21.90. 
31P NMR (161.9 MHz, CD2Cl2): δ 193.7. 
IR (ATR): ν = 2926.01, 2850.79, 1996.32, 1940.39, 1612.49, 1591.27, 1506.41, 1483.26, 1463.97, 
1433.11, 1390.68, 1361.74, 1325.1, 1284.59, 1226.73, 1203.58, 1172.72, 1072.42, 975.98, 945.12, 
852.54, 823.6, 808.17, 790.81, 771.53, 748.38, 711.73, 680.87, 650.01 cm-1. 
 
6.3.7. Complex 66 [(S)-Monophos] and 67 [(R)-Monophos] 
 
Complex 66: pale yellow solid  
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Yield 90 mg, (55%); m.p. = 225 °C; 
 
1H NMR (400 MHz, CD2Cl2): δ 8.06 (d, 3J = 8.4 Hz, 1H), 8.02 (d, 3J = 8.2 Hz, 1H), 7.97 (d, 3J = 8.2 Hz, 
1H), 7.94 (d, 3J = 8.5 Hz, 1H), 7.93 (d, 3J = 8.5 Hz, 1H), 7.86 (d, 3J = 8.4 Hz, 1H), 7.69 (d, 3J = 8.1 Hz, 
1H), 7.57-7.59 (m, 1H), 7.52 (d, 3J = 8.5 Hz, 1H), 7.44-7.49 (m, 2H), 7.38-7.41 (m, 1H), 7.34-7.36 (m, 
1H), 7.25-7.28 (m, 1H), 7.21-7.24 (m, 3H), 7.16-7.19 (m, 4H), 7.11 (d, 3J = 8.5 Hz, 1H), 7.09 (d, 3J = 
8.5 Hz, 1H), 7.06 (d, 3J = 8.5 Hz, 1H), 3.89 (d, 2J = 15.8 Hz, 1H), 3.48 (d, 2J = 15.8 Hz, 1H), 3.23-3.33 
(m, 2H), 2.22 (d, 2J = 10.0 Hz, 6H), 0.49 (s, 9H), 0.24 (s, 9H). 
13C NMR 400 MHz, CD2Cl2): δ 214.17, 214.02, 213.96, 179.53, 149.39, 149.31, 148.23, 148.18, 
136.80, 136.03, 134.66, 134.25, 132.90, 132.81, 132.73, 132.64, 132.45, 132.05, 131.27, 131.08, 
130.56, 130.23, 129.91, 129.07, 128.55, 128.31, 128.15, 126.89, 126.83, 126.69, 126.53, 126.37, 
126.28, 126.21, 126.19, 125.73, 125.44, 125.34, 125.04, 122.71, 121.74, 121.03, 120.67, 37.45, 
34.94, 31.33, 26.91, -1.11, -0.24. 
31P NMR (161.9 MHz, CD2Cl2): δ 195.22. 
IR (ATR): ν = 2924.09, 2906.73, 2848.86, 2011.76, 1950.03, 1606.7, 1593.2, 1508.33, 1463.97, 
1402.25, 1325.1, 1286.52, 1244.09, 1224.8, 1178.51, 1143.79, 1072.42, 1028.06, 979.84, 947.05, 
850.61, 821.68, 765.74, 750.31, 732.95, 713.66, 696.3, 682.3, 682.3, 682.8, 650.01 cm-1. 
 
Complex 67: pale yellow solid  
Yield 56 mg, (55%); m.p. = 223 °C. 
 
1H NMR (400 MHz, CD2Cl2): δ 8.11-7.95 (m, 6H), 7.84 (ddd, 3J = 13.0, 8.4, 4J = 3.5 Hz, 4H), 7.61-7.15 
(m, 12H), 7.09 (d, 3J = 8.4 Hz, 1H), 6.92 (d, 3J = 8.4 Hz, 1H), 4.05 (d, 2J = 14.7 Hz, 2H), 4.02 (dd, J = 
14.8, 5.1 Hz, 4H), 4.00 (d, J = 4.0 Hz, 2H), 3.72 (dd, 2J = 13.7, 4J = 3.1 Hz, 1H), 3.61 (d, 2J = 18.5 Hz, 
2H), 1.81 (d, 2J = 15.8 Hz, 6H), 0.29 (s, 9H), 0.22 (s, 9H). 
13C NMR (400 MHz, CD2Cl2): δ 214.17, 214.02, 213.96, 179.53, 149.39, 149.31, 148.23, 148.18, 
136.80, 136.03, 134.66, 134.25, 132.90, 132.81, 132.73, 132.64, 132.45, 132.05, 131.27, 131.08, 
130.56, 130.23, 129.91, 129.07, 128.55, 128.31, 128.15, 126.89, 126.83, 126.69, 126.53, 126.37, 
126.28, 126.21, 126.19, 125.73, 125.44, 125.34, 125.04, 122.71, 121.74, 121.03, 120.67, 37.45, 
34.94, 31.33, 26.91, -1.11, -0.24. 
31P NMR (161.9 MHz, CD2Cl2): δ 195.52 
IR (ATR): ν = 2924.09, 2906.73, 2848.86, 2011.76, 1950.03, 1606.7, 1593.2, 1508.33, 1463.97, 
1402.25, 1325.1, 1286.52, 1244.09, 1224.8, 1178.51, 1143.79, 1072.42, 1028.06, 979.84, 947.05, 
850.61, 821.68, 765.74, 750.31, 732.95, 713.66, 696.3, 682.3, 682.3, 682.8, 650.01 cm-1. 
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6.4. Synthesis of complex (R)-85 
 
 
6.4.1. (R)-2,2'-bis(methoxymethoxy)-1,1'-binaphthyl [87] 
 
A solution of (R)-BINOL (20.2 g, 70.5 mmol, 1 eq) in THF (100 mL) was added dropwise from a 
dropping funnel to a suspension of NaH (6.50 g, 60% in mineral oil, 162.5 mmol, 2.3 eq) in dry THF 
(300 ml) at 0 °C under argon atmosphere. After stirring for 1 h at room temperature, chloromethyl 
methyl ether (MOMCl) (12.5 mL, 162.5 mmol, 2.3 eq) was slowly added at 0 °C. Then the reaction 
mixture was allowed to warm to room temperature and stirred overnight. The reaction was 
quenched with saturated aqueous NH4Cl (100 mL) and extracted with EtOAc. The combined 
organic layers were washed with brine, dried over Na2SO4, and concentrated in vacuo. The 
resultant residue was crystallized from methanol to give the aimed product as a white crystal.  
Yield 21.65 g (82%); m.p. = 103–104 °C; []D20 = +94.3° (c = 1.1 in CHCl3)  
 
1H NMR (400 MHz, CDCl3) δ: 8.01 (d, 3J = 9.2 Hz, 2H), 7.93 (d, 3J = 8.4 Hz, 2H), 7.64 (d, 3J = 8.4 Hz, 
2H), 7.39 (t, 3J = 8.0 Hz, 2H), 7.28-7.24 (m, 2H), 7.14 (d, 3J = 8.3 Hz, 2H), 5.12 (d, 2J = 6.2 Hz, 2H), 
5.06 (d, 2J = 6.2 Hz, 2H), 3.21 (s, 6H). 
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13C NMR (100 MHz, CDCl3): δ 152.6, 134.0, 129.8, 129.4, 127.8, 126.3, 125.5, 124.0, 121.2, 117.2, 
95.1, 55.8. 
IR (solid): ν = 2904, 1590, 1505, 1236, 1146, 1010, 808 cm-1. 
HRMS: m/z 374.1527 [M]+ (calcd. for C24H22O4: 374.1518). 
 
6.4.2. (R)-3,3'-dihydroxy-2,2'-bis(methoxymethoxy)-1,1'-binaphthyl [89] 
 
Under argon atmosphere, to a solution of 87 (18.92 g, 50.5 mmol, 1 eq) in THF (150 mL) was added 
dropwise a 1.6 M hexane solution of n-BuLi (76 mL, 122 mmol, 2.4 eq) at -78 °C. The colour of the 
mixture changed from light yellow into brown. This mixture was allowed to warm to 0 °C and 
stirred for 1 h, then cooled back to -78 °C. Trimethoxyborane (17 mL, 152 mmol, 3 eq) was added 
dropwise and the resulting mixture was allowed to warm to room temperature and stirred 
overnight. Removal of THF under vacuum afforded the crude borate 88, which was suspended in 
benzene (175 mL), and hydrogen peroxide (30% aqueous solution, 15.5 mL) was added dropwise 
at 0 °C. This mixture was heated and refluxed for 2 h. After cooling to 10 °C, the resulting mixture 
was poured into ice-cooled saturated Na2SO3 and extracted with EtOAc. The organic extracts were 
washed with brine and dried over Na2SO4. Evaporation of the solvent and purification of the 
residue by column chromatography on silica gel (2:1 hexane/EtOAc) gave (R)-3,3'-dihydroxy-2,2'-
bis(methoxymethoxy)-1,1'-binaphthyl 89. 
Yield 18.06 g (88% yield); m.p. 120 °C; []D20 = -70.2° (c = 0.28 in CHCl3).  
 
1H NMR (400 MHz, CDCl3): δ 7.82 (d, 3J = 8.4 Hz, 2H), 7.58 (s, 2H), 7.52 (s, 2H), 7.39 (ddd, 3J = 8.1, 
3J = 6.9, 4J = 1.2 Hz, 2H), 7.14 (ddd, 3J = 8.1, 3J = 6.9, 4J = 1.2 Hz, 2H), 7.04 (d, 3J = 8.4 Hz, 2H), 4.77 
(d, 2J = 6.3 Hz, 2H), 4.71 (d, 2J = 6.3 Hz, 2H), 3.40 (s, 6H).  
13C NMR (100 MHz, CDCl3): δ 147.9, 144.8, 132.0, 128.2, 126.6, 125.7, 125.5, 125.3, 124.0, 111.8, 
99.6, 57.5. 
IR (KBr): ν = 3410, 2900, 1597, 1510, 1445, 1344, 1248, 1211, 1159, 1063, 984, 912, 876, 752, 680 
cm-1.  
HRMS (ESI+): m/z 405.1333 [M - H]- (calcd. for C24H21O6: 405.1351). 
Elemental analysis (%): C 70.71, H 5.44, O 23.55 (calcd. for C24H22O6: C 70.92, H 5.46, O 23.62). 
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6.4.3. (R)-3,3'-Dimethoxy-1,1'-bi-2-naphthol [90] 
 
A mixture of compound 89 (18.06 g, 44.4 mmol), K2CO3 (27.61 g, 199.8 mmol, 4.5 eq) and methyl 
iodide (13.8 mL, 222 mmol, 5 eq) in acetone (200 mL) was heated and refluxed overnight. The 
resulting mixture was poured into water and extracted with EtOAc. The organic extracts were 
washed with brine and dried over Na2SO4. Evaporation of the solvent gave the crude (R)-3,3'-
dimethoxy-2,2'-bis(methoxymethoxy)-1,1'-binaphthyl 90, which can be either purified by flash 
column chromatography (3:1 hexane/EtOAc) or used in the following step without further 
purification.  
Yield 16.9 g (88% yield); m.p. 129 °C; []D20 = +45.6° (c = 0.59 in CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.83 (d, 3J = 8.1 Hz, 2H), 7.38 (ddd, 3J = 8.1, 3J = 6.0, 4J = 2.1 Hz, 2H), 
7.32 (s, 2H), 7.09-7.17 (m, 4H), 4.93 (d, 2J = 5.7 Hz, 2H), 4.85 (d, 2J = 5.7 Hz, 2H), 4.05 (s, 6H), 2.59 
(s, 6H).  
13C NMR (100 MHz, CDCl3): δ 151.9, 144.3, 131.2, 128.9, 126.7, 126.2, 125.2, 123.9, 107.2, 98.0, 
56.0, 55.7.  
IR (KBr): ν = 3003, 2959, 2895, 1594, 1462, 1429, 1342, 1248, 1201, 1159, 1115, 1074, 1020, 980, 
922, 752 cm-1.  
HRMS (ESI+): m/z 457.1612 [M + Na]+ (calcd. for C26H26NaO6: 457.1622). 
Elemental analysis (%): C 71.81, H 6.05, O 21.97 (calcd. for C26H26O6: C 71.87, H 6.03, O 22.09). 
 
6.4.4. (R)-3,3'-dimethoxy-1,1'-bi-2-naphthol [91] 
 
Compound (R)-90 was dissolved in dioxane (110 mL) and 37% concentrated aqueous HCl (3 mL) 
was added and the mixture was heated to 45 °C for 3.5 h. After aqueous workup, the organic 
extracts were washed with brine, dried over Na2SO4, and concentrated to afford (R)-3,3'-
dimethoxy-1,1'-bi-2-naphthol [91], which can be directly used for the following reaction.  
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An analytical sample of 91 was purified by column chromatography on silica gel (1:1 
EtOAc/hexane). M.p. 242 °C; []D20 = +27.6° (c = 0.26 in CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.83 (d, 3J = 8.1 Hz, 2H), 7.37-7.34 (m, 4H), 7.20-7.10 (m, 4H), 6.05  (s, 
2H), 4.12 (s, 6H).  
13C NMR (100 MHz, CDCl3): δ 147.1, 143.6, 129.0, 128.8, 126.8, 124.6, 124.5, 124.0, 114.4, 106.2, 
56.0  
IR (KBr): ν = 3479, 1622, 1464, 1425, 1337, 1313, 1257, 1167, 1117, 1018, 883, 831, 748 cm-1.  
HRMS (ESI+): m/z 345.1126 [M - H]- (calcd. for C22H17O4: 345.1121). 
Elemental analysis (%): C 76.14, H 5.23, O 18.21 (calcd. for C22H18O4: C 76.29, H 5.24, O 18.48). 
 
6.4.5. (R)-3,3'-Dimethoxy-2,2'-bis(trifluoromethanesulfonyloxy)-1,1'-binaphthyl [92] 
 
Compound 91 was dissolved in dry CH2Cl2 (120 mL) and dry TEA (20mL, 150 mmol, 3 eq) was added 
to the mixture. After cooling at –78 °C, Tf2O (18,5 mL, 110 mmol, 2.2 eq) was added dropwise and 
the resulting mixture was allowed to warm to room temperature and stirred for 2 h. The mixture 
was then poured into ice-cooled 1 M HCl (180 mL) and extracted with CH2Cl2. The organic extracts 
were washed with saturated NaHCO3, brine and dried over Na2SO4. The residual crude product 
was then purified by column chromatography on silica gel (95:5 hexane/Et2O) to give (R)-3,3'-
dimethoxy-2,2'-bis-(trifluoromethanesulfonyloxy)-1,1'-binaphthyl 92. 
Yield 23.6 g (87% over 2 steps); m.p. 139 °C; []D20 = -118.3° (c = 0.24 in CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.88 (d, 3J = 8.4 Hz, 2H), 7.54 (ddd, 3J = 8.4, 3J = 6.9, 4J = 1.2 Hz, 2H), 
7.50 (s, 2H), 7.24 (ddd, 3J = 7.8, 3J = 6.9, 4J = 1.2 Hz, 2H), 7.15 (d, 3J = 7.8 Hz, 2H), 4.12 (s, 6H).  
13C NMR (100 MHz, CDCl3): δ 149.1, 137.6, 132.9, 127.7, 127.6, 126.8, 126.6, 125.4, 124.6, 118.0 
(q, JC-F = 321 Hz), 109.4, 56.4.  
IR (KBr): ν = 3466, 1603, 1468, 1425, 1331, 1209, 1132, 1105, 1011, 947, 895, 813, 745 cm-1. 
HRMS (ESI+): m/z 633.0067 [M + Na]+ (calcd. for C24H16F6NaO8S2: 633.0083). 
Elemental analysis (%): C 47.06, H 2.81, O 18.43 (calcd. for C24H16F6O8S2: C 47.22, H 2.64, O 18.67). 
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6.4.6. (R)-3,3'-Dimethoxy-2,2'-dimethyl-1,1'-binaphthyl [93] 
 
Compound 92 (8.56 g, 14.0 mmol, 1 eq) and NiCl2(dppp) (0.51 g, 0.94 mmol, 6.7 mol%) were 
dissolved in 55 mL of dry Et2O, under argon. A 3 M ethereal solution of MeMgI (23.5 ml, 70 mmol, 
5 eq) was added dropwise at 0 °C and the reaction mixture was stirred for 3 days at room 
temperature. The mixture was cooled with an ice bath, and poured slowly into ice-cold 1 M HCl 
(80 mL). The obtained mixture was filtered on celite to remove the catalyst and then the filtrate 
was extracted. The combined organic phases were washed with brine and then dried over Na2SO4. 
The residual crude product was then purified by column chromatography on silica gel (86:14 
hexane/CH2Cl2) to give (R)-3,3'-Dimethoxy-2,2'-dimethyl-1,1'-binaphthyl 93.  
Yield 3.88 g (81%); m.p. 197 °C; []D20 = +16.5° (c = 0.50 in CHCl3).  
 
1H NMR (400 MHz, CDCl3): δ 7.81 (d, 3J = 8.1 Hz, 2H), 7.37 (ddd, 3J = 8.1, 3J = 6.9, 4J = 1.2 Hz, 2H), 
7.24 (s, 2H), 7.07 (ddd, 3J = 8.1, 3J = 6.9, 4J = 1.2 Hz, 2H), 6.97 (d, 3J = 8.1 Hz, 2H), 4.05 (s, 6H), 1.94 
(s, 6H).  
13C NMR (100 MHz, CDCl3): δ 156.3, 136.5, 133.1, 128.1, 127.4, 126.5, 125.7, 125.3, 123.5, 104.2, 
55.4, 13.5.  
IR (KBr): ν = 2953, 1599, 1456, 1421, 1323, 1232, 1194, 1165, 1115, 1022, 748 cm-1.  
HRMS (FAB): m/z 342.1620 [M+] (calcd. for C24H22O2: 342.1608). 
Elemental analysis (%): C 83.92, H 6.42, O 9.31 (calcd. for C24H22O2: C 84.18, H 6.48, O 9.34). 
 
6.4.7. (R)-3,3'-Dimethoxy-2,2'-bis(bromomethyl)-1,1'-binaphthyl [94]  
 
A mixture of 3,3'-dimethoxy-2,2'-dimethyl-1,1'-binaphthalene 93 (3.77 g, 10.9 mmol, 1 eq), NBS 
(4.26 g, 23.9 mmol, 2.2 eq) and benzoyl peroxide (0.085 g, 3.2 mol %) in CCl4 (60 mL) was refluxed 
for 3 h, while irradiating with a 100 W lamp. After 22 h the reaction was cooled down and filtered 
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on a frit to remove succinimide and the solvent was removed under reduced pressure to obtain a 
foamy solid. The residue was purified by recrystallization from Et2O/hexane to obtained (R)-3,3'-
Dimethoxy-2,2'-bis(bromomethyl)-1,1'-binaphthyl 94 as white crystals. 
Yield 4.85 g (89%); m.p. 215–217 °C; []D20 = -158.9° (c = 0.30 in CH2Cl2). [139] 
 
1H NMR (400 MHz, CDCl3): δ 7.83 (d, 3J = 8.3 Hz, 2H), 7.45 (ddd, 3J = 8.1, 3J = 6.8, 4J = 1.3 Hz, 2H), 
7.34 (s, 2H), 7.12 (ddd, 3J = 8.2, 3J = 6.8, 4J = 1.3 Hz, 2H), 7.01 (d, 3J = 8.3 Hz, 2H), 4.28 - 4.37 (m, 
4H), 4.13 (s, 6H). 
13CNMR (100 MHz, CDCl3): δ 155.5, 136.4, 134.6, 127.7, 127.3, 127.2, 126.7, 126.6, 124.2, 106.4, 
55.8, 27.8.  
IR (ATR): ν = 3061, 3004, 2960, 2936, 2830, 1619, 1597, 1568, 1502, 1449, 1422, 1407, 1387, 1361, 
1327, 1294, 1265, 1238, 1215, 1195, 1169, 1151, 1131, 1106, 1019, 908, 865, 834, 788, 747, 731, 
690 cm-1.  
HRMS (ESI): m/z 419.0645 [M - Br]+ (calcd. for C24H20BrO2: 419.0641). 
 
6.4.8. (R)-2,2'-Bis(iodomethyl)-3,3'-dimethoxy-1,1'-binaphthyl [95] 
 
NaI (16.5 g, 110 mmol, 10 eq) was added to a stirred suspension of 94 (5.50 g, 11.0 mmol) in 
acetone (55 mL), in a Schlenk tube fitted with a Teflon screw cap, under nitrogen. The mixture was 
heated to reflux and stirred overnight. To prevent possible photodegradation of 95, the reaction 
vessel was covered tightly with aluminium foil and the reaction workup was done in the presence 
of the smallest possible amount of light. After cooling down to 40 °C, acetone was removed in 
vacuo, and the obtained solid was dried under high vacuum for 30 min. Water (100 mL) was added, 
and the obtained suspension was stirred for 30 min. The mixture was filtered on a ceramic frit, 
and the solid product 95 was washed with water (100 mL), saturated aqueous Na2S2O3 (120 mL), 
water (150 mL), and ice-cold 2:1 MeOH/hexane mixture (100 mL). Product 95, a pale-yellow 
powder, was dried on a frit and then under high vacuum.  
Yield 5.94 g (91%); m.p. = 169-173 °C (dec.); []D24 = +133.48 (c = 0.52 in acetone). 
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1H NMR (400 MHz, [D6]acetone): δ 7.93 (d, 3J = 8.2 Hz, 2H), 7.57 (s, 2H), 7.47 (td, 3J = 8.1 Hz, 4J = 
1.1 Hz, 2H), 7.13 (td, 3J = 8.1 Hz, 4J = 1.2 Hz, 2H), 6.9 (d, 3J = 8.1 Hz, 2H), 4.28 (d, 2J = 8.9 Hz, 2H, AB 
system), 4.20 (d, 2J = 8.9 Hz, 2H, AB system), 4.16 (s, 6H). 
13C NMR (100 MHz, [D6]acetone): δ 156.5, 136.1, 135.7, 128.1, 128.1, 128.0, 127.9, 127.6, 125.1, 
107.6, 56.3, 0.1.  
IR (film): ν = 3060.5, 2959.7, 2935.6, 1618.0, 1597.7, 1570.7, 1445.9, 1422.7, 1327.3, 1158.0  
cm-1. 
HRMS (ESI+): m/z 616.94566 [M + Na]+ (calcd. for C24H20I2O2Na: 616.94449). 
 
6.4.9. (R)-(3,3'-dimethoxy-1,1'-binaphthyl-2,2'-diyl)bis(prop-1-yne-3,1-diyl)) 
bis(trimethylsilane) [96] 
 
n-BuLi (1.6 M hexane solution, 11.6 mL, 18.5 mmol, 3 eq) was added dropwise to a solution of 
ethynyltrimethylsilane (1.82 g, 2.62 mL, 18.5 mmol, 3 eq) in THF (12 mL) kept at -60 °C. The 
obtained mixture was allowed to warm to 0 °C and stirred for 30 min at this temperature, then it 
was cooled down again to -60 °C. A solution of bis-iodide 95 (3.63 g, 6.11 mmol, 1 eq) in THF (45 
mL) was added and then the mixture was allowed to warm to room temperature and stirred 
overnight. The reaction was quenched with saturated aqueous NH4Cl and extracted three times 
with Et2O. The combined organic extracts were dried over Na2SO4 and concentrated in vacuo. 
Diyne 96 can be either purified by flash column chromatography (8:2 hexane/CH2Cl2) or used in 
the following step without further purification.  
Yield 2.61 g (80%); m.p. = 75-83 °C; []D24 = +55.56 (c = 0.555 in CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.81 (d, 3J = 8.2 Hz, 2H), 7.40 (t, 3J = 8.2 Hz, 2H), 7.32 (s, 2H), 7.09-7.02 
(m, 4H), 4.08 (s, 6H), 3.40 (d, 2J = 16.6 Hz, 2H, AB system), 3.29 (d, 2J = 16.6 Hz, 2H, AB system), 
0.00 (s, 18H).  
13C NMR (100 MHz, CDCl3): δ 155.9, 136.1, 134.0, 128.3, 126.9, 126.6, 126.6, 126.3, 124.0, 106.0, 
104.5, 83.6, 55.8, 19.6, 0.16.  
IR (film): ν = 3062.9, 2958.3, 2898.0, 2173.9, 1620.4, 1597.7, 1446.8, 1327.3, 1248.7, 1109.8  
cm-1.  
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HRMS (ESI+): m/z 557.23139 [M + Na]+ (calcd. for C34H38O2Si2Na: 557.23025).  
 
6.4.10. Complex (R)-85 
 
Diyne 96 (3.27 g, 6.11 mmol, 1 eq) and Fe2(CO)9 (4.55 g, 12.5 mmol, 2 eq) were dissolved in dry 
toluene (45 ml) and heated to 90 °C for 4.5 h, under argon. After cooling down to room 
temperature, the reaction mixture was filtered through a pad of celite (rinsing with CH2Cl2). The 
filtrate was concentrated in vacuo, and the residue was purified by flash column chromatography 
(93:7 hexane/EtOAc) to obtain (R)-85 as a pale yellow solid.  
Yield: 2.88 g (67% yield); m.p. = 233-237 °C (dec.); []D23 = -129.38 (c = 0.41 in CH2Cl2).  
 
1H NMR (400 MHz, CDCl3): δ 7.84 (m, 2H), 7.42 (t, 3J = 7.2 Hz, 2H), 7.33 (s, 1H), 7.30 (s, 1H), 7.11-
7.03 (m, 2H), 6.92 (d, 3J = 8.4 Hz, 2H), 4.37 (d, 2J = 15.5 Hz, 1H), 4.15 (d, 2J = 13.7 Hz, 1H), 4.04 (s, 
3H), 3.94 (s, 3H), 3.26 (d, 2J = 13.7 Hz, 1H), 3.12 (d, 2J = 15.5 Hz, 1H), 0.43 (s, 9H), 0.32 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 208.7, 181.1, 155.1, 154.8, 138.6, 137.2, 133.9, 133.8, 127.4, 127.2, 
127.1, 127.0, 126.9, 126.8, 126.6, 126.5, 126.4, 124.3, 124.1, 115.4, 107.8, 106.3, 105.7, 75.2, 74.9, 
55.6, 54.8, 26.3, 26.2, 0.7, 0.2.  
IR (film): ν = 3059.5, 2960.2, 2169.0, 2059.6, 2004.2, 1987.3, 1620.4, 1598.7, 1454.1, 1246.3, 
1111.3 cm-1.  
HRMS (ESI+): m/z 703.16264 [M + H]+ (calcd. for C38H39O6Si2Fe: 703.16410). 
 
6.5. Modification of the chiral Knölker complex 
6.5.1. Complex (R)-86 
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In a Schlenk tube fitted with a Teflon screw cap, BBr3 (1M CH2Cl2 solution, 14.0 mL, 14.0 mmol, 10 
eq) was added dropwise to a stirred solution of (R)-85 (0.99 g, 1.41 mmol, 1 eq) and Bu4NI (1.30 
g, 3.52 mmol, 2.5 eq) in DCE (40 mL) kept at 0 °C. The Schlenk was sealed and the mixture was 
heated to 84 °C and stirred for 3 days. After this time, the reaction was cooled down to 0 °C and 
ice-cold H2O (50 mL) was added. The mixture was extracted with CH2Cl2 (3  20 mL), washed with 
brine (30 mL) and then dried over Na2SO4. Filtration of the CH2Cl2 solution through a short pad of 
silica allowed to remove the ammonium salts (which eluted before the product), then complex 
(R)-86 – a pale yellow solid – was purified by flash column chromatography (83:17 to 77:23 
hexane/AcOEt).  
Yield 0.762 g (80%); m.p. = 187-195 °C (dec.); []D23 =  -115.07 (c = 0.515 in CH2Cl2). 
 
1H NMR (400 MHz, CDCl3): δ = 7.71 (d, 3J = 8.2 Hz, 2H), 7.39-7.35 (m, 3H), 7.31 (s, 1H), 7.06 (t, 3J = 
7.5 Hz, 2H), 6.98 (dd, 3J = 8.3 Hz, 4J = 2.3 Hz, 2H), 6.32 (br s, 2H), 4.34 (d, 2J = 15.6 Hz, 1H), 4.14 (d, 
2J = 13.8 Hz, 1H), 3.24 (d, 2J = 13.8 Hz, 1H), 3.11 (d, 2J = 15.5 Hz, 1H), 0.41 (s, 9H), 0.31 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ = 208.4, 180.3, 152.3, 152.2, 138.9, 137.7, 134.0, 133.9, 127.3, 127.3, 
127.1, 126.4, 126.1, 125.5, 123.8, 123.6, 114.7, 110.4, 109.5, 76.3, 75.4, 29.8, 26.4, 0.9, 0.5.  
IR (film): ν = 3236.0, 2953.4, 2852.7, 2065.9, 2010.4, 1996.9, 1575.1, 1342.2, 1248.2 cm-1.  
HRMS (ESI+): m/z 675.13152 [M + H]+ (calcd. for C36H35O6Si2Fe: 675.13277). 
 
 
 
X-Ray Crystal structure analysis of complex (R)-86  
Crystals suitable for X-ray diffraction analysis have been obtained by slow diffusion of hexane into 
a CH2Cl2 solution of complex (R)-86. Crystal data and details of data collection and refinement are 
given in Table 16. Intensity data were collected with a Bruker Apex II CCD area detector by using 
graphite monochromated Mo-Kα radiation. Data reduction was performed with SAINT, and 
absorption corrections based on multiscan were obtained with SADABS.[189] The structure was 
solved by direct methods using SHELXS-97 and refined by SHELXL-2013.[190] The program ORTEPIII 
was used for graphics.[191] Anisotropic thermal parameters were used for all non-hydrogen atoms. 
The isotropic thermal parameters of H atoms were fixed at 1.2 (1.5 for methyl groups) times those 
of the atom to which they were attached. All H atoms were placed in calculated positions and 
refined using a riding model with freely rotating methyl groups. 
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Table 16. Details of the crystal data and structure refinement for compound (R)-86 
 
Crystal Data   
Empirical formula  C40H44FeO8Si2 
Moiety formula  C36H34FeO6Si2∙C4H10O∙H2O 
Formula weight 764.78 
Crystal system  Orthorhombic 
Space group  P212121 
a/Å 11.1452(5) 
b/Å 16.4340(7) 
c/Å 22.8671(10) 
V/Å3  4188.3(3)Å3 
Z 4 
Temperature/K  130(2) 
Density (calculated) Dx/Mg m-3  1.213 
Absorption coefficient μ/mm-1 0.464  
Color, habit orange, prism 
Dimensions /mm 0.300.300.20 
Data Collection   
radiation,  /Å Mo K, 0.71073 
2 max/º   49.34 
h range  -1313 
k range  -1919 
l range  -2626 
Measured reflections  55474 
Independent reflections 7102 
Reflections with I>2(I)  6162 
Rint  0.0577 
Refinement on F2  
Data, restraints, parameters 7102, 1, 488 
S 1.049 
Final R, wR [F2>2(F2)] 0.0377, 0.0920 
Final R, wR (all data) 0.0478, 0.0985 
Flack parameter 0.000(7) 
(/)max 0.001 
max, min /eÅ3 0.359, -0.270 
 
An ORTEP view of the complex is presented in Figure 30 and selected geometrical parameters are 
collected in Table 17. The structure includes one water molecule, disordered over three positions 
labelled Ow1, Ow2 and Ow3 with occupancies 0.4, 0.4 and 0.2, respectively (only Ow1 is shown in 
Figure 30 for clarity) and one Et2O molecule. The latter, which is strongly hydrogen-bonded to one 
hydroxyl group (O1–H1) of the complex through its oxygen atom O7 (O1∙∙∙O7, 2.752 Å; O1–
H1∙∙∙O7, 164.4°), was probably bonded to the complex during solubilization attempts made before 
the crystallization. 
The crystal structure of (R)-86 shows typical geometrical parameters observed in related 
structures. In particular, the cyclopentadienone ring strongly deviates from planarity, with atom 
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C24 significantly bent away from the iron atom (see Table 17). The dihedral angle between the l.s. 
plane through the coordinated butadiene and the plane defined by C23, C24 and C25, 13.9(2)°, is 
typical for cyclopentadienone-iron complexes. The dihedral angle between the l.s. planes through 
the carbon atoms of the naphthyl moieties, 67.9(1)°, is quite similar to that found in other 
binaphthyl derivatives where the ortho positions are connected through a 
(diyldimethylene)cyclopentadienyl group. In Table 17 are also reported the relevant distances 
concerning atom O2, which remarkably affects the level of enantioselectivity in ketone 
hydrogenation.  
 
Figure 30. ORTEP view of the asymmetric unit of (R)-86.Et2O.H2O. Thermal ellipsoids are drawn at the 50% 
probability level (CCDC 1037376) 
 
Table 17. Selected interatomic distances (Å) for (R)-86 
 
Fe–C22  2.095(4) O2∙∙∙C29  5.356(3) 
Fe–C26  2.115(4) O2∙∙∙O5  6.296(3) 
Fe–C23 2.139(4) O2∙∙∙Fe 4.016(2) 
Fe–C25 2.145(4) O2∙∙∙O3 6.429(2) 
Fe–C24 2.310(4) O2∙∙∙Si2 4.408(2) 
  O2∙∙∙C36 3.641(4) 
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6.5.2. Complex (R)-97 
 
Acetyl chloride (32 µL, 0.44 mmol, 3 eq) was slowly added to a stirred solution of (R)-96 (100 mg, 
0.15 mmol, 1 eq), Et3N (83 µL, 0.59 mmol, 4 eq) and DMAP (1.6 mg, 0.015 mmol, 0.1 eq) in THF (2 
mL), then the mixture was refluxed for 3 h. After this time, the mixture was diluted CH2Cl2 and 
washed with 0.5 M HCl (2  5 mL), sat. aq. NaHCO3 (5 mL) and brine (5 mL). The organic phase was 
then dried over Na2SO4. Complex (R)-97 – a pale yellow solid – was purified by flash column 
chromatography (90:10 to 85:15 hexane/AcOEt).  
Yield 103.3 g (92%); m.p. = 162-166 °C; [α]D22 = +19.37 (c = 0.51 in CH2Cl2). 
 
1H NMR (400 MHz, CDCl3): δ 7.90 (d, 3J = 8.2 Hz, 1H), 7.87 (d, 3J = 8.2 Hz, 1H), 7.80 (s, 1H), 7.73 (s, 
1H), 7.52-7.43 (m, 2H), 7.25-7.17 (m, 2H), 6.99 (d, 3J = 8.4 Hz, 1H), 6.85 (d, 3J = 8.4 Hz, 1H), 4.00 (d, 
2J = 16.0 Hz, 1H), 3.89 (d, 2J = 14.3 Hz, 1H), 3.36 (d, 2J = 14.3 Hz, 1H), 3.34 (d, 2J = 16.0 Hz, 1H), 2.45 
(s, 3H), 2.39 (s, 3H), 0.45 (s, 9H), 0.32 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 208.2, 181.0, 170.1, 169.8, 146.1, 138.8, 137.5, 133.0, 132.9, 130.2, 
130.1, 128.7, 127.9, 127.8, 127.5, 127.0, 126.8, 126.7, 126.6, 121.6, 121.1, 112.0, 110.2, 74.9, 74.6, 
27.5, 26.6, 22.3, 21.9, 0.9, 0.5.  
IR (film): ν = 3062.4, 2953.9, 2923.6, 2903.3, 2852.7, 2062.5, 2007.5, 1989.7, 1768.4, 1624.25, 
1189.4, 1155.6, 1087.7, 849.0 cm-1. 
HRMS (ESI+): m/z 759.15207 [M + H]+ (calcd. for C50H43O8Si2Fe: 759.15395). 
 
6.5.3. Complex (R)-98 
 
Benzoyl chloride (26 µL, 0.22 mmol, 3 eq) was slowly added to a stirred solution of (R)-86 (50 mg, 
0.07 mmol, 1 eq), Et3N (41 µL, 0.3 mmol, 4 eq) and DMAP (0.8 mg, 0.007 mmol, 0.1 eq) in THF (1 
mL), then the mixture was refluxed for 4 h. After this time, the mixture was diluted with CH2Cl2 
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and washed with 0.5 M HCl (2  5 mL), sat. aq. NaHCO3 (5 mL) and brine (5 mL). The organic phase 
was then dried over Na2SO4. After concentration, the pure complex (R)-98 - a pale yellow solid - 
was purified by flash column chromatography (95:5 to 9:1 hexane/EtOAc).  
Yield 53 mg (81%); m.p. = 176 °C (dec.); [α]43627 =  -108.6 (c = 0.25 in CH2Cl2).  
 
1H NMR (400 MHz, CDCl3): δ 8.26 (m, 1H), 8.24 (m, 1H), 8.21 (m, 1H), 8.19 (m, 1H), 7.92 (d, 3J = 4.7 
Hz, 1H), 7.90 (d, 3J = 4.6 Hz, 1H), 7.83 (s, 1H), 7.82 (s, 1H), 7.72-7.64 (m, 2H), 7.59-7.46 (m, 6H), 
7.31-7.26 (m, 2H), 7.01 (dd, 3J = 8.4, 4J = 0.6 Hz, 1H), 6.97 (dd, 3J = 8.5, 4J = 0.6 Hz, 1H), 4.01 (d, 2J = 
14.5 Hz, 1H), 3.98 (d, 2J = 16.1 Hz, 1H), 3.58 (d, 2J = 14.6 Hz, 1H), 3.49 (d, 2J = 16.1 Hz, 1H), 0.10 (s, 
9H), 0.03 (s, 9H).  
13C NMR (100 MHz, CDCl3): δ 208.1, 181.0, 167.0, 166.6, 147.3, 147.1, 139.0, 137.8, 134.2, 134.1, 
133.3, 131.1, 130.7, 129.7, 129.7, 129.5, 129.2, 128.7, 127.8, 127.1, 126.9, 126.7, 121.1, 120.7, 
113.2, 109.1, 75.7, 74.8, 27.7, 27.2, 0.7, 0.3.  
IR (film): ν = 3062.9, 2953.9, 2897.5, 2062.0, 2007.5, 1990.2, 1740.4, 1624.7, 1266.0, 1246.3, 
1090.1, 1022.1, 847.1, 711.1 cm-1.  
HRMS (ESI+): m/z 883.187411 [M + H]+ (calcd. for C50H43O8Si2Fe: 883.18537). 
 
6.5.4. Complex (R)-99 
 
Benzyl bromide (53 µL, 0.45 mmol, 6 eq) was slowly added to a stirred solution of (R)-86 (50 mg, 
0.07 mmol, 1 eq) and K2CO3 (41 mg, 0.30 mmol, 4 eq) in DMF (0.37 mL) and stirred at 70 °C 
overnight. After this time, the reaction was cooled down to room temperature and diluted with 
Et2O (8 mL). The mixture was washed with H2O (3  5 mL) and the organic phase dried over Na2SO4. 
Complex (R)-99 – a pale yellow solid – was purified by flash column chromatography (9:1 
CH2Cl2/hexane).  
Yield 42 mg (70%); m.p. = 155 °C (dec.); [α]D32 = -20.6 (c = 0.92 in CH2Cl2).  
 
1H NMR (400 MHz, CDCl3): δ 7.80 (d, 3J = 8.1 Hz, 1H), 7.71 (d, 3J = 8.1 Hz, 1H), 7.46-7.23 (m, 14H), 
7.11-7.03 (m, 2H), 6.91-6.84 (m, 2H), 5.51 (d, 2J = 13.5 Hz, 1H), 5.46 (d, 2J = 13.5 Hz, 1H), 5.26 (d, 2J 
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= 11.3 Hz, 1H), 5.17 (d, 2J = 11.3 Hz, 1H), 4.38 (d, 2J = 15.6 Hz, 1H), 4.29 (d, 2J = 13.8 Hz, 1H), 3.35 
(d, 2J = 13.8 Hz, 1H), 3.15 (d, 2J = 15.6 Hz, 1H), 0.32 (s, 9H), 0.08 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 208.6, 181.1, 154.1, 153.6, 139.0, 137.6, 136.7, 136.1, 133.8, 133.6, 
129.1, 128.9, 128.7, 128.5, 128.1, 127.4, 127.4, 127.2, 127.1, 127.1, 127.0, 126.9, 126.9, 126.6, 
126.4, 124.3, 124.3, 114.8, 108.7, 108.6, 107.3, 75.8, 75.1, 70.5, 70.1, 26.4, 26.2, 0.8, 0.2. 
IR (film): ν = 3063.4, 3034.4, 2953.0, 2899.0, 2060.1, 2004.2, 1987.3, 1757.3, 1620.9, 1596.8, 
1246.3, 1105.5, 850.5, 738.1 cm-1.  
HRMS (ESI+): m/z 855.22583 [M + H]+ (calcd. for C50H47O6Si2Fe: 855.22685). 
 
6.5.5. Complex (R)-100 
 
Methanesulfonyl chloride (17 µL, 0.22 mmol, 3 eq) was slowly added to a stirred solution of (R)-
86 (50 mg, 0.07 mmol, 1 eq), Et3N (41 µL, 0.30 mmol, 4 eq) and DMAP (0.8 mg, 0.007 mmol, 0.1 
eq) in THF (1 mL), then the mixture was refluxed for 5 h. After this time, the reaction was cooled 
down to room temperature, diluted with EtOAc (5 mL) and washed with 0.5 M HCl (2  5 mL), sat. 
aq. NaHCO3 (5 mL) and brine (5 mL). The organic phase was dried over Na2SO4. After 
concentration, the pure complex (R)-100 was obtained as a pale yellow solid.  
Yield 40 mg (65%); m.p. = 172 °C (dec.); [α]D27 = -6.8 (c = 1.4 in CH2Cl2).  
 
1H NMR (400 MHz, CDCl3): δ 8.12 (s, 1H), 8.09 (s, 1H), 7.99 (d, 3J = 8.3 Hz, 1H), 7.96 (d, 3J = 8.3 Hz, 
1H), 7.56 (dd, 3J = 8.3 Hz, 3J = 7.0 Hz, 1H), 7.53 (dd, 3J = 8.3 Hz, 3J = 6.9 Hz, 1H), 7.33 (dd, 3J = 8.4 Hz, 
3J = 7.0 Hz, 1H), 7.28 (dd, 3J = 8.5 Hz, 3J = 6.9 Hz, 1H), 6.99 (d, 3J = 8.4 Hz, 1H), 6.85 (d, 3J = 8.5 Hz, 
1H), 4.25 (d, 2J = 16.2 Hz, 1H), 4.15 (d, 2J = 14.4 Hz, 1H), 3.35 (d, 2J = 14.4 Hz, 1H), 3.33 (d, 2J = 16.2 
Hz, 1H), 3.31 (s, 3H), 3.29 (s, 3H), 0.45 (s, 9H), 0.33 (m, 9H).  
13C NMR (100 MHz, CDCl3): δ 208.2, 181.4, 144.4, 143.5, 139.3, 138.0, 132.8, 132.7, 130.5, 130.5, 
128.8, 128.5, 128.4, 128.2, 128.0, 127.8, 127.8, 127.7, 126.6, 126.3, 121.9, 121.4, 111.1, 110.1, 
75.5, 75.1, 38.8, 38.6, 27.7, 26.7, 0.7, 0.5.  
IR (film): ν = 3054.2, 2986.7, 2066.4, 2010.4, 1994.5, 1617.5, 1265.6, 739.1, 705.3 cm-1.  
HRMS (ESI+): m/z 853.06820 [M + Na]+ (calcd. for C38H38O10S2Si2FeNa: 853.06985). 
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6.5.6. Complex (R)-101 
 
p-Toluenesulfonyl chloride (43 mg, 0.22 mmol, 3 eq) was slowly added to a stirred solution of (R)-
86 (50 mg, 0.07 mmol, 1 eq), Et3N (41 µL, 0.03 mmol, 4 eq) and DMAP (0.8 mg, 0.007 mmol, 0.1 
eq) in THF (1 mL), then the mixture was refluxed overnight. The reaction was cooled down to room 
temperature, diluted with EtOAc (5 mL) and washed with 0.5 M HCl (2  5 mL), sat. aq. NaHCO3 (5 
mL) and brine (5 mL). The organic phase was dried over Na2SO4 and then concentrated. Complex 
(R)-101 – a pale yellow solid – was purified by flash column chromatography (8:2 hexane/EtOAc).  
Yield 63 mg (96%); m.p. = 166-168 °C (dec.); [α]D23 = +168.6 (c = 1.2 in CH2Cl2). 
  
1H NMR (400 MHz, CDCl3): δ 7.92 (s, 1H), 7.85 (d, 3J = 8.3 Hz, 1H), 7.82 (d, 3J = 8.3 Hz, 1H), 7.79 (s, 
1H), 7.70 (d, 3J = 8.0 Hz, 2H), 7.65 (d, 3J = 8.0 Hz, 2H), 7.51 (t, 3J = 7.5 Hz, 2H), 7.29-7.19 (m, 6H), 
6.65 (d, 3J = 8.4 Hz, 1H), 6.54 (d, 3J = 8.5 Hz, 1H), 3.93 (d, 2J = 16.1 Hz, 1H), 3.92 (d, 2J = 14.3 Hz, 1H), 
3.01 (d, 2J = 14.3 Hz, 1H), 2.86 (d, 2J = 16.1 Hz, 1H), 2.40 (s, 3H), 2.37 (s, 3H), 0.43 (s, 9H), 0.27 (s, 
9H). 
13C NMR (100 MHz, CDCl3): δ 208.0, 181.3, 145.9, 145.9, 145.0, 145.0, 138.8, 137.3, 132.7, 132.5, 
132.4, 130.2, 130.1, 130.0, 129.9, 129.3, 128.9, 128.8, 128.5, 128.4, 128.3, 127.4, 127.3, 127.3, 
126.2, 126.1, 121.2, 121.2, 111.5, 108.6, 75.3, 74.9, 27.3, 26.4, 21.9, 21.9, 0.6, 0.6.  
IR (film): ν = 3054.2, 2986.7, 2916.8, 2066.4, 2010.9, 1422.2, 1265.6, 895.8, 740.5, 705.3 cm-1. 
HRMS (ESI+): m/z 983.14923 [M + H]+ (calcd. for C50H47O10S2Si2Fe: 983.15069). 
 
6.5.7. Complex (R)-102 
 
N-(5-Chloro-2-pyridyl)bis(trifluoromethanesulfonimide) (1.2 g, 3.0 mmol, 3 eq) was added to a 
stirred solution of (R)-86 (670 mg, 1.0 mmol, 1 eq), Et3N (550 µL, 4.0 mmol, 4 eq) and DMAP (12 
mg, 0.1 mmol, 0.1 eq) in CH2Cl2 (30 mL) and stirred at room temperature overnight. The reaction 
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was diluted with CH2Cl2 (30 mL) and washed with 0.5 M HCl (2  50 mL), 0.5 M NaOH (2  50 mL) 
and brine (50 mL). The organic phase was then dried over Na2SO4. Complex (R)-102 – a pale yellow 
solid – was purified by flash column chromatography (10:1 hexane/EtOAc).  
Yield 882 mg (94%); m.p. = 142-143 °C (dec.); [α]D24 = +43.9 (c = 1.9 in CH2Cl2).  
 
1H NMR (400 MHz, CDCl3): δ 8.14 (s, 1H), 8.12 (s, 1H), 8.03 (d, 3J = 8.5 Hz, 1H), 8.01 (d, 3J = 8.3 Hz, 
1H), 7.62 (t, 3J = 7.5 Hz, 1H), 7.61 (t, 3J = 7.5 Hz, 1H), 7.40 (t, 3J = 8.2 Hz, 1H), 7.38 (t, 3J = 8.1 Hz, 
1H), 6.90 (d, 3J = 8.5 Hz, 1H), 6.84 (d, 3J = 8.5 Hz, 1H), 4.18 (d, 2J = 16.2 Hz, 1H), 4.13 (d, 2J = 14.6 
Hz, 1H), 3.40 (d, 2J = 14.7 Hz, 1H), 3.35 (d, 2J = 16.2 Hz, 1H), 0.41 (s, 9H), 0.31 (s, 9H).  
13C NMR (100 MHz, CDCl3): δ 207.9, 181.3, 145.2, 144.9, 139.4, 137.9, 132.7, 132.6, 130.8, 130.7, 
128.9, 128.8, 128.8, 128.7, 128.4, 128.3, 127.8, 127.1, 126.2, 126.0, 120.9, 120.8, 119.0 (q, 1J(C,F) = 
324.5 Hz), 118.9 (q, 1J(C,F) = 324.5 Hz), 110.7, 108.7, 75.5, 75.5, 27.6, 26.8, 0.5, 0.4.  
19F NMR (282 MHz, CDCl3): δ -71.7, -72.7.  
IR (film): ν = 3066.7, 2954.9, 2925.5, 2903.3, 2852.7, 2065.4, 2011.9, 1993.6, 1629.1, 1427.6, 
1245.8, 1212.5, 1138.3, 915.5, 883.2, 844.7, 822.0 cm-1.  
HRMS (ESI+): m/z 961.01272 [M + Na]+ (calcd. for C38H32O10F6S2Si2FeNa: 961.01332). 
 
6.5.8. Complex (R)-103 
 
Complex (R)-86 (100 mg, 0.1 mmol, 1 eq), Pd(OAc)2 (4.5 mg, 0.02 mmol, 0.2 eq), PPh3 (10.5 mg, 
0.04 mmol, 0.4 eq), K3PO4 (63 mg, 0.3 mmol, 3 eq), KBr (26 mg, 0.22 mmol, 2.2 eq) and 
phenylboronic acid (30.5 mg, 0.25 mmol, 2.5 eq) were dissolved in dioxane (2.5 mL). The reaction 
was heated to 85 °C and stirred overnight. The mixture was diluted with CH2Cl2 (5 mL) and washed 
with 1 M NaOH (5 mL), H2O (5 mL) and brine (5 mL), then dried over Na2SO4. Complex 103 – a 
yellow solid – was purified by flash column chromatography (7:3 CH2Cl2/hexane).  
Yield 15 mg (17%). 
 
1H NMR (400 MHz, CDCl3): δ 8.12 (s, 1H), 7.89-8.02 (m 6H), 7.81 (m, 2H), 7.62 (t, 3J(H,H) = 8.0, 1H), 
7.54 (m, 3H), 7.41 (m 2H), 7.29 (t, 3J(H,H) = 8.0 Hz,1 H), 7.09 (m, 1H), 6.74 (d, 3J(H,H) = 8.0 Hz, 1H), 
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4.24 (d, 2J(H,H) = 14.8 Hz, 1H), 4.13 (d, 2J(H,H) = 15.8 Hz, 1H), 3.64 (d, 2J(H,H) = 14.8 Hz, 1H), 3.52 
(d, 2J(H,H) = 15.8 Hz, 1H), 0.34 (s, 9H), - 0.40 (s, 9H).  
ESI-MS in CH3CN: [M+H]2+ m/z 917.2 
 
6.5.9. Complex (R)-104 
 
Complex (R)-102 (100 mg, 0.1 mmol, 1 eq), Pd(OAc)2 (4.5 mg, 0.02 mmol, 0.2 eq), PPh3 (10.5 mg, 
0.04 mmol, 0.4 eq), K3PO4 (63 mg, 0.3 mmol, 3 eq), KBr (26 mg, 0.22 mmol, 2.2 eq) and 
phenylboronic acid (30.5 mg, 0.25 mmol, 2.5 eq) were dissolved in dioxane (2.5 mL). The reaction 
was heated to 85 °C and stirred overnight. The mixture was diluted with CH2Cl2 (5 mL) and washed 
with 1 M NaOH (5 mL), H2O (5 mL) and brine (5 mL), then dried over Na2SO4. Complex (R)-103 – a 
yellow solid – was purified by flash column chromatography (6:4 to 8:2 CH2Cl2/hexane).  
Yield 69 mg (80%); m.p. = 157-158 °C (dec.); [α]D21 = +88.3 (c = 0.6 in CH2Cl2).  
 
1H NMR (400 MHz, CDCl3): δ 8.10 (s, 1H), 8.01 (d, 3J = 8.2 Hz, 1H), 7.93 (d, 3J = 8.2 Hz, 1H), 7.90 (s, 
1H), 7.63-7.31 (m, 8H), 7.26 (dd, 3J = 8.5 Hz, 3J = 7.3 Hz, 1H), 7.02 (d, 3J = 8.5 Hz, 1H), 6.70 (d, 3J = 
8.5 Hz, 1H), 4.27 (d, 2J = 14.8 Hz, 1H), 4.11 (d, 2J = 15.8 Hz, 1H), 3.58 (d, 2J = 14.8 Hz, 1H), 3.50 (d, 
2J = 15.8 Hz, 1H), 0.33 (s, 9H), -0.15 (s, 9H).  
13C NMR (100 MHz, CDCl3): δ 208.1, 180.8, 144.9, 141.6, 141.3, 139.4, 136.1, 132.7, 132.5, 132.5, 
132.1, 131.1, 130.9, 128.6, 128.3, 128.1, 127.9, 127.6, 127.4, 127.0, 126.4, 125.7, 120.0, 118.9 (q, 
1J(C,F) = 321.3 Hz), 111.8, 111.2, 75.9, 75.5, 29.5, 27.5, 0.5, 0.4.  
19F NMR (282 MHz, CDCl3): δ -72.1.  
IR (film): ν = 3054.7, 2987.2, 2065.4, 2009.5, 1639.7, 1421.8, 1265.6, 744.4, 705.3 cm-1.  
HRMS (ESI+): m/z 889.10212 [M + Na]+ (calcd. for C43H37O7F3S1Si2FeNa: 889.10049). 
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6.5.10. Conditions adopted for the attempted synthesis of complex 105 
 
Entry Catalyst 
PhB(OH)2 
[eq] 
Base 
[eq] 
Additive 
[eq] 
T 
(°C) 
Solvent 
NMR ratio (%) 
102 104 105 
1[151] 
15% Pd(OAc)2 
18% PCy3 
2.5 KF [3.3]  60 THF 97 3 - 
2[151] 
15% Pd(OAc)2 
18% PCy3 
2.5 KF [3.3] KBr [2.2] 60 THF 97 3 - 
3[153] 
25% Pd(OAc)2 
50% (S)-Phos 
3 K3PO4 [4]  85 toluene  100 - 
4 
20% Pd(OAc)2 
40% PPh3 
2.5 K3PO4 [3]  85 dioxane  80* - 
5 
20% Pd(OAc)2 
40% PPh3 
2.5 KBr [3] KBr [2.2] 85 dioxane 2 80* - 
6[150] 10% Pd(PPh3)4 2.5 K3PO4 [3] KBr [2.2] 85 dioxane 5 74* - 
7[154] 
[5%+5%] 
Pd(PPh3)4  
2.5 K3PO4 [3] KBr [2.2] 85 dioxane  74* - 
8 10% Pd(PPh3)4  2.5 K3PO4 [3] 
KBr [2.2] 
H2O [6] 
85 dioxane  100 - 
9 5% Pd(PPh3)4 2.5 K3PO4 [3] KBr [5.6] 110 dioxane  100 - 
10 5% Pd(PPh3)4 2.5 K3PO4 [5]  100 DMF degradation 
11 5% Pd(PPh3)4 2.5 K3PO4 [3] 
TBAB 
[2.2] 
85 dioxane 100  - 
12 10% Pd(PPh3)4 5 K3PO4 [6] KBr [2.2] 85 
dioxane/
H2O 
degradation 
13 10% Pd(PPh3)4 5 K3PO4 [6] KBr [2.2] 85 dioxane  100 - 
14 5% Pd(PPh3)4 2.5 
Ba(OH)2 · 
8 H2O [3] 
KBr [2.2] 85 dioxane  100 - 
15[152] 10% Pd(PPh3)4 5 
Ba(OH)2 · 
8 H2O [6] 
 85 
DME/ 
H2O 
degradation 
16[152] 10% Pd(PPh3)4 5 
Ba(OH)2 · 
8 H2O [3] 
 85 
DME/ 
H2O 
degradation 
17 10% Pd(PPh3)4 2.5 
Ba(OH)2 
[3] 
KBr [2.2] 85 dioxane 65 35 - 
18 5% Pd(PPh3)4 2.5 tBuOK [3] KBr [2.2] 85 dioxane degradation 
19[155] 4% PEPPSI-iPr 2.5 K2CO3 [6]  60 dioxane 100   
20 5% PEPPSI-iPr 2.5 K3PO4 [3]  85 dioxane 100   
21 5% PEPPSI-iPr 2.5 
tBuOK 
[2.6] 
 60 iPrOH degradation 
22[156] 
5% Pd(IPr*) 
(cinnamyl)Cl 
3 K2CO3 [4]  40 EtOH degradation 
23[157] 
5% 
NiCl2(dppp) 
4 K3PO4 [8]  100 dioxane degradation 
24 
10% 
PdCl2(dppp) 
2.5 K3PO4 [3] KBr [2.2] 85 dioxane 50 50 - 
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25 
10% 
PdCl2(dppp) 
2.5 
Ba(OH)2 · 
8 H2O [3] 
KBr [2.2] 85 dioxane 50 50 - 
* Isolated yield 
 
6.5.11. Free ligand 106 
 
A solution of complex 58 (104 mg, 0.16 mmol, 1 eq), in THF (2.7 mL) and aqueous 1 M NaOH (1.3 
mL) was stirred for 2.5 h under an argon atmosphere. Then 1-iodopentane was added (50 μL, 0.38 
mmol, 2.4 eq) and the yellow solution turned brown. After stirring the mixture for an additional 
15 min under argon, H3PO4 (85%, 50 μL) was added, the reaction stirred for 5 min and the organic 
layer separated. The aqueous layer was extracted with Et2O (2 x 7 mL). The combined organic 
layers were dried over Na2SO4 and filtered through a short path of silica gel. After addition of 
Na2S2O3∙5 H2O (105 mg) and Celite (65 mg) the filtrate was stirred slowly in the air for 16 h in the 
presence of daylight. Filtration through a short path of Celite, evaporation of the solvent, and flash 
chromatography (9:1 hexane/ CH2Cl2) of the residue on silica gel provided the free ligand 106. 
Yield 79 mg (99%). 
 
1H NMR (400 MHz, CDCl3): δ 7.95 (d, J = 8.4 Hz, 4H), 7.53 (d, J = 8.4 Hz, 2H), 7.51 – 7.46 (m, 2H), 
7.30 (d, J = 3.6 Hz, 4H), 4.02 (d, J = 14.8 Hz, 2H), 3.22 (d, J = 14.8 Hz, 2H), 0.27 (s, 18H). 
 
6.5.12. Free ligand 107 
 
A solution of complex (R)-102 (150 mg, 0.16 mmol, 1 eq), in THF (2.7 mL) and aqueous 1 M NaOH 
(1.3 mL) was stirred for 2.5 h under an argon atmosphere. Then 1-iodopentane was added (50 µL, 
0.38 mmol, 2.4 eq) and the yellow solution turned brown. After stirring the mixture for an 
additional 15 min under argon, H3PO4 (85%, 50 µL) was added, the reaction stirred for 5 min and 
the organic layer separated. The aqueous layer was extracted with Et2O (2  7 mL). The combined 
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organic layers were dried over Na2SO4 and filtered through a short path of silica gel. After addition 
of Na2S2O3∙5 H2O (105 mg) and Celite (65 mg) the filtrate was stirred slowly in the air for 16 h in 
the presence of daylight. Filtration through a short path of Celite, evaporation of the solvent, and 
flash chromatography (9:1 hexane/CH2Cl2) of the residue on silica gel provided the free ligand 107.  
Yield 35 mg (28%); m.p. = 204-207 °C; [α]D21 = +112.4 (c = 0.6 in CH2Cl2).  
 
1H NMR (400 MHz, CDCl3): δ 8.07 (s, 2H), 8.01 (d, 3J = 8.3 Hz, 2H), 7.62 (dd, 3J = 8.3, 6.4 Hz, 1H), 
7.41 (dd, 3J = 8.4, 6.4 Hz, 1H), 7.20 (d, 3J = 8.5 Hz, 2H), 4.36 (d, 2J = 15.6 Hz, 2H), 3.06 (d, 2J = 15.6 
Hz, 2H), 0.22 (s, 18H). 
13C NMR (100 MHz, CDCl3): δ 209.6, 164.7, 147.5, 138.9, 132.8, 132.1, 130.6, 129.1, 128.8, 128.3, 
128.0, 126.7, 119.0, 118.9 (q, 1J(C,F) = 321.5 Hz), 30.1, 0.2.  
19F NMR (282 MHz, CDCl3): δ -72.75.  
IR (film): ν = 2953.5, 2906.2, 1685.0, 1426.1, 1241.0, 1214.0, 1138.8, 847.1 cm-1.  
HRMS (ESI+): m/z 821.08966 [M + Na]+ (calcd. for C35H32O7F6S2Si2Na: 821.09244). 
 
6.5.13. Free ligand 108 
 
(R)-5,16-Diphenyl-1,3-bis(trimethylsilyl)-4,17-dihydro-2H-cyclopenta[6,7]cycloocta[2,1-a:3,4-
a']dinaphthalen-2-one [108] 
(R)-107 (35 mg, 0.044 mmol, 1 eq), Pd(OAc)2 (2 mg, 0.009 mmol, 0.2 eq), PPh3 (4.6 mg, 0.018 
mmol, 0.4 eq), K3PO4 (37 mg, 0.18 mmol, 3 eq), KBr (12 mg, 0.10 mmol, 2.2 eq) and phenylboronic 
acid (16 mg, 0.13 mmol, 3 eq) were dissolved in dioxane (1 mL). The reaction was stirred at 85 °C 
overnight. The mixture was diluted with CH2Cl2 (5 mL) and washed with 1 M NaOH (5 mL), H2O (5 
mL) and brine (5 mL), then dried over Na2SO4. Ligand (R)-108 – a yellow solid – was purified by 
flash column chromatography (29:1 hexane/ CH2Cl2).  
Yield 25 mg (86%); m.p. = 264-266 °C; [α]D20 = +150.5 (c = 0.5 in CH2Cl2).  
 
1H NMR (400 MHz, CDCl3): δ 7.92 (d, 3J = 8.2 Hz, 2H), 7.79 (s, 2H), 7.51 (ddd, 3J = 8.1, 6.7 Hz, 4J = 
1.2 Hz, 2H), 7.45-7.38 (m, 6H), 7.38-7.29 (m, 6H), 7.24 (d, 3J = 8.4 Hz, 2H), 4.00 (d, 2J = 15.4 Hz, 2H), 
3.30 (d, 2J = 15.4 Hz, 2H), -0.20 (s, 18H). 
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13C NMR (100 MHz, CDCl3): δ 210.8, 169.5, 142.1, 141.7, 137.7, 134.1, 132.3, 131.5, 129.9, 129.6, 
128.6, 128.1, 127.5, 126.9, 126.5, 126.4, 33.8, 0.0.  
IR (film): ν = 3058.6, 2958.8, 2896.1, 1679.7, 1542.3, 1245.3, 850.5, 748.2, 701.0 cm-1.  
HRMS (ESI+): m/z 655.28304 [M + H]+ (calcd. for C45H43O1Si2: 655.28470). 
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6.6. Synthesis of (cyclopentadienone)iron tricarbonyl complexes using an 
intermolecular cyclative carbonylation/complexation 
6.6.1. Cyclooctyne [122]  
 
 
To a solution of cyclooctene (33.2 mL, 0.25 mol, 1 eq) in CH2Cl2 (100 mL) was added dropwise at -
40 °C a solution of Br2 (0.25 mol) in CH2Cl2 (12 mL) until the yellow colour persisted. The reaction 
mixture was quenched with 10% Na2S2O3 solution (50 mL) and extracted (2 x 100 mL) with CH2Cl2. 
The organic layer was dried over Na2SO4 and concentrated in vacuo to give trans-1,2-
dibromocyclootane in quantitative yield, which was used in the following step without further 
purification. 
 
1H NMR (400 MHz, CDCl3): δ 4.59–4.57 (m, 2H, CHBr), 2.46–2.37 (m, 2H), 2.15–2.05 (m, 2H), 1.88–
1.81 (m, 2H), 1.70–1.56 (m, 4H), 1.54–1.46 (m, 2H).  
13C NMR (100 MHz, CDCl3): 61.6, 33.3, 26.0, 25.5. 
 
Trans-1,2-dibromocyclootane (65.78 g, 244 mmol) was dissolved in THF (100 mL) and the resulting 
solution was added to a suspension of KOtBu (41.07 g, 370 mmol) in THF (40 mL) at 0 °C. The 
reaction mixture was quenched with a saturated NH4Cl-solution (100 mL), and THF was 
evaporated. The resulting crude was extracted with CH2Cl2 (2 x 100 mL). The organic layer was 
dried over Na2SO4 and concentrated in vacuo. The residue was purified by distillation (bp: 73-80 
°C / 10 mbar) to obtained the 1-bromocyclooctene 121 as a colorless liquid. 
Yield 36.8 g (80%). 
 
1H NMR (400 MHz, CDCl3): δ 6.03 (t, 3J = 8.5 Hz, 1H), 2.58–2.64 (m, 2H), 2.08–2.19 (m, 2H), 1.51–
1.62 (m, 8H). 
13C NMR (100 MHz, CDCl3): 131.7, 35.2, 29.9, 28.6, 27.5, 26.4, 25.5. 
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1-Bromocyclooctene 121 (113.4 g, 0.60 mol) was added at once to a solution of lithium 
diisopropylamide, cooled at -25 °C. This solution was obtained by adding at -25 °C butyllithium 
(0.30 mol) in hexane (190 ml) to a mixture of dry diisopropylamine (32.3 g, 0.32 mol) and dry THF 
(125 mL). The temperature of the reaction mixture was allowed to rise gradually over a period of 
45 min to 15 °C and was kept at this level for another 90 min. It was then poured into a cold 
solution of 3N hydrochloric acid. The solution was extract with pentane and the combined extracts 
were washed several times with water in order to remove the THF. The organic layer was dried 
over Na2SO4 and concentrated in vacuo. Careful distillation of the residue gave cyclooctyne (b.p. 
50-55 °C / 20 torr). 
Yield 25.9 g (80%).  
 
1H NMR (400 MHz, CD2Cl2): δ 2.13 (m,4H), 1.85 (m, 4H), 1.61 (m, 4H).  
13C NMR (75 MHz, CD2Cl2): δ 94.90, 35.13, 30.32, 21.90. 
IR (Nujol, selected band): ν = 2216 cm-1 (C≡C stretch). Raman (Neat): 2217 cm-1 (C≡C stretch). 
 
6.6.2. [Bis(hexamethylene)cyclopentadienone]iron tricarbonyl complex 123 
 
Cyclooctyne 123 (230 μL, 1.85 mmol) and Fe(CO)5 (1.2 mL, 9.25 mmol, 5 equiv) were dissolved in 
dry toluene (10 mL), under argon, and heated to 90 °C overnight in a sealed glass tube. After 
cooling down to room temperature, the reaction mixture was filtered through a pad of celite 
(rinsing with CH2Cl2). The filtrate was concentrated in vacuo, and the residue was purified by flash 
column chromatography (7:3 hexane/EtOAc) to obtain complex 123 as a yellow solid.  
Yield 198 mg (56%); m.p. = 156 °C. 
 
1H NMR (400 MHz CDCl3): δ 2.76-2.78 (m, 2H), 2.59-2.64 (m, 2H), 2.40-2.49 (m, 2H), 1.74-1.92 (m, 
8H), 1.44-1.59 (m, 10H).  
13C NMR (100 MHz CDCl3): δ 209.35, 171.42, 102.42, 85.54, 31.29, 28.81, 26.24, 25.77, 23.70, 
23.43.  
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FT-IR: ν = 2924.1, 2856.6, 2050.3, 1978.9, 1950.0, 1620.2, 1585.5, 1456.3, 1354.0, 1278.8, 1203.6, 
1118.7, 1097.5, 1031.9, 987.5, 817.8, 736.8, 648.1, 621.1 cm-1. 
HRMS (ESI+): m/z 385.1098 [M + H]+; 407.0919 [M + Na]+ (calcd. for C21H25O4Fe: 385,1102; 
C20H24O4FeNa: 407.0922). 
 
Table 18. X-Ray Crystal data and structure refinement of complex 123  
 
Identification code  svf42  
Empirical formula  C20H24FeO4  
Moiety formula  C20H24FeO4  
Formula weight  384.24  
Temperature  100(2) K  
Wavelength  1.54178 Å  
Crystal system  Monoclinic  
Space group  P21/n  
Unit cell dimensions a = 9.7015(3) Å a= 90° 
 b = 16.0131(5) Å b= 102.5480(10)° 
 c = 11.9162(4) Å g = 90° 
Volume 1806.98(10) Å
3
  
Z 4  
Density (calculated) 1.412 Mg/m
3
  
Absorption coefficient 6.869 mm
-1
  
F(000) 808  
Crystal size 0.100 x 0.100 x 0.050 mm
3
  
Theta range for data collection 4.699 to 72.289°.  
Index ranges -10<=h<=11, -19<=k<=19, -14<=l<=14  
Reflections collected 18911  
Independent reflections 3539 [R(int) = 0.0385]  
Completeness to θ = 67.679° 99.5 %   
Absorption correction Multiscan  
Max. and min. transmission 0.7536 and 0.5330  
Refinement method Full-matrix least-squares on F
2
  
Data / restraints / parameters 3539 / 0 / 244  
Goodness-of-fit on F2 0.739  
Final R indices [I>2σ(I)] R1 = 0.0315, wR2 = 0.0803  
R indices (all data) R1 = 0.0347, wR2 = 0.0836  
Extinction coefficient n/a  
Largest diff. peak and hole 0.308 and -0.389 e.Å
-3
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Table 19. Selected bond lengths [Å] and angles [°] for complex 123 
_____________________________________________________  
Fe(1)-C(3) 1.799(2) 
Fe(1)-C(1) 1.8004(19) 
Fe(1)-C(2) 1.801(2) 
Fe(1)-C(7) 2.0718(17) 
Fe(1)-C(6) 2.0789(17) 
Fe(1)-C(8) 2.1140(17) 
Fe(1)-C(5) 2.1246(18) 
Fe(1)-C(4) 2.3968(18) 
O(1)-C(1) 1.138(2) 
O(2)-C(2) 1.142(3) 
O(3)-C(3) 1.140(2) 
O(4)-C(4) 1.241(2) 
C(4)-C(8) 1.471(2) 
C(4)-C(5) 1.478(2) 
C(5)-C(6) 1.439(2) 
C(6)-C(7) 1.429(3) 
C(7)-C(8) 1.439(2) 
 
C(8)-C(4)-C(5) 103.53(15) 
C(6)-C(5)-C(4) 108.36(15) 
C(7)-C(6)-C(5) 107.95(15) 
C(6)-C(7)-C(8) 107.96(15) 
C(7)-C(8)-C(4) 108.58(15) 
 
Selected torsion angles [°] 
 
C(4) C(5) C(6) C(7) -11.83(19) 
C(5) C(6) C(7) C(8) 0.03(19) 
C(6) C(7) C(8) C(4) 11.84(18) 
C(8) C(4) C(5) C(6) 18.37(18) 
C(5) C(4) C(8) C(7) -18.38(18) 
 
C(7) C(6) C(15) C(16) 90.3(2) 
C(6) C(5) C(20) C(19) 82.4(2)  
C(8) C(7) C(14) C(13) 87.9(2) 
C(7) C(8) C(9) C(10) -79.7(2) 
Planarity of 5-memered ring: 
 
 
 
 
 
 
Experimental Part 
147 
 
Distance from C(4) to lspl (C(5) C(6) C(7) C(8)) :   0.287(2) 
 see Listing  
Least-Squares Planes - P*X+Q*Y+R*Z=S   ::  First Line Orthogonal(XO,YO,ZO), Second Line Fractional(X,Y,Z)  
====================================       Ring/Plan/Resd/Lspl N Indicates that the Ring/Plane/Residue Involves 
N Atoms  
                                          Sigref - R.M.S-Error of the Contributing Atoms  
 The Deviation D of an Atom with          Sigpln - Sqrt(Sum(j=1:N)(D(j)**2/(N-3))  
                                          Chisq  - Chi-Squared = Sum(j=1:N)(D(j)**2)/Sigref**2  
 Fractional Coordinates X,Y,Z may be      Pl.Hyp. - Result of the Chi.Sq. Test for Planarity (See Stout & Jensen, p424)  
 Calculated via Substitution in  
                                          **** - Atoms Deviating by More Than 1.5 Angstrom and Hydrogen Atoms are NOT Listed  
 D = P*X + Q*Y + R*Z - S (2nd Line)       Note - Weights : UNIT  
                                          **** - Maximum Metal Containing Ring Size:     6  
                                               - Maximum Number of Bonds to Ring Metal:  6  
                                               - Deviations from planes are in Ångström Units  
                                               - The Plane determining Atoms have been Marked #  
                                               - DISTANCES TO PLANES ROUNDED TO 3 DECIMALS 
------------------------------------------------------------------------------------------------------------------------------------  
Nr  1        P             Q             R             S     Sigref  0.002     Sigpln  0.127     Chisq   10186.9    Pl.Hyp.    P<5   
------------------------------------------------------------------------------------------------------------------------------------  
Lspl     0.1670(9)     0.9829(2)     0.0781(9)      5.653(4) #C(4)    0.112(2) #C(5)   -0.092(2) #C(6)    0.037(2) 
#C(7)    0.036(2)  
A  5      1.620(8)     15.739(3)     0.476(10)      5.653(4) #C(8)   -0.092(2)  O(4)    0.292(1)  C(9)   -0.086(2)  C(10)   1.318(2)  
                                                             C(14)   0.267(2)  C(15)   0.219(2)  C(19)   1.371(2)  C(20)  -0.060(2)  
------------------------------------------------------------------------------------------------------------------------------------  
Nr  2        P             Q             R             S     Sigref  0.002     Sigpln  0.001     Chisq       0.2    Pl.Hyp.          
------------------------------------------------------------------------------------------------------------------------------------  
Lspl    0.2121(10)     0.9643(3)    0.1586(11)      6.016(5) #C(5)    0.000(2) #C(6)    0.000(2) #C(7)    0.000(2) 
#C(8)    0.000(2)  
A  4      2.058(9)     15.441(5)     1.296(13)      6.016(5)  O(4)    0.582(1)  C(4)    0.287(2)  C(9)    0.052(2)  C(10)   1.461(2)  
                                                             C(14)   0.121(2)  C(15)   0.071(2)  C(20)   0.076(2)                    
 
Figure 31. ORTEP diagram (CCDC 1511079) of the molecular structure of the 
[bis(hexamethylene)cyclopentadienone]iron complex 123 
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6.6.3. Cyclododecyne [128] 
  
 
To a solution of cyclododecanone (1.0 g, 5.48 mmol) in 2 mL of THF was added lithium 
diisopropylamide (6.03 mL, 6.03 mmol, 1.1 eq) in 6 mL of THF at -78 °C. The resulting solution was 
stirred at -78 °C for 2 h at which time a solution of N-phenyltriflimide (2.09 g, 5.86 mmol, 1.07 eq) 
in 10 mL of THF was added and the reaction was allowed to warm to 0 °C. The reaction was 
maintained at this temperature until completion, as observed by TLC. The workup consisted of 
filtering the reaction solution through a plug of silica gel using ether as eluent. The solvent was 
removed under reduced pressure and the residue was purified by flash column chromatography 
(eluting with hexanes) furnishing an 85% yield of the corresponding vinyl triflate (1.47 g). 
 
1H NMR (400 MHz, CDCl3): δ 5.37 (t, J = 8.3 Hz, 1H), 2.41 (t, J = 6.3 Hz, 2H), 2,25 (m, 2H), 1.55–1.25 
(m, 16H).  
13C NMR (100 MHz, CDCl3): δ 184.6, 123.8, 118.4 (q, J = 319 Hz), 33.2, 26.2, 25.7, 25.4, 25.3, 25.2, 
24.5, 24.4, 24.2, 22.9. 
IR (CHCl3): ν = 1692, 1411, 1221, 1142 cm−1. 
HRMS (ESI+): m/z 314.1160 [M + H]+ (calcd. for C13H21F3O3S: 314.1163).  
1H NMR data of the contaminated E-isomer (8%) δ: 5.48 (t, J = 8.3 Hz, 1H), 2.45 (t, J = 6.8 Hz, 2H), 
2.15 (dt, J = 8.3, 6.8 Hz, 2H), 1.70–1.25 (m, 16H). 
 
 
To a solution of the vinyl triflate 127 (0.8 g, 2.54 mmol) in 1 mL of THF at -78 °C was added a 
solution of lithium diisopropylamide (5.08 mL, 5.08 mmol, 2 eq) in 1 mL of THF over 5 min. The 
reaction mixture was stirred at -78 °C for 2 h then poured into pentane/H2O. The aqueous phase 
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was extracted with pentane (3 x 10 mL) and the combined organic layers were washed with brine, 
dried over NaSO4, filtered and concentrated in vacuo. Purification of the resulting oil by flash 
chromatography on silica gel (eluting with hexane) furnished cyclododecyne. 
Yield 396 mg (95%). 
 
1H NMR (400 MHz, CDCl3): δ 2,20–2.17 (m, 4H), 1.58–1.51 (m, 8H), 1.47–1.40 (m, 8H). 
13C NMR (100 MHz, CDCl3): δ 81.6, 25.7, 25.5, 24.9, 24.6, 18.5. 
IR (CHCl3): ν = 1461, 1447, 1322 cm−1. 
HRMS (ESI+): m/z 164.1531 [M + H]+ (calcd. for C12H20: 164.1565).  
 
6.6.4. [Bis(decamethylene)cyclopentadienone]iron tricarbonyl complex [129] 
 
Cyclododecyne 128 (167μL, 0.91 mmol) and Fe(CO)5 (613 μL, 4.6 mmol, 5 eq) were dissolved in 
dry toluene (5 mL), under argon and heated to 110 °C overnight in a sealed glass tube. After cooling 
down to room temperature, the reaction mixture was filtered through a pad of celite (rinsing with 
CH2Cl2). The filtrate was concentrated in vacuo, and the residue was purified by flash column 
chromatography (6:4 hexane/EtOAc) to obtain complex 129 as a yellow solid.   
Yield 12 mg (5%). 
 
1H NMR (400 MHz, CDCl3): δ 2.37-2.35 (br, 4H), 2.10-2.08 (br, 2H), 1.94-1.97 (br, 2H), 1.78 (br, 2H), 
1.56–1.30 (m, 27H), 1.21–1.19 (br, 3H). 
13C NMR could not be registered  
MS (ESI+): m/z 497.11 [M + H]+; 519.11 [M + Na]+ (calcd. for C28H41O4Fe: 497.24; C28H40O4FeNa: 
519,22). 
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6.7. Towards a planar chirality 
6.7.1. 2,3-diphenyl-4,5-dipropylcyclopenta-2,4-dien-1-one [152] 
 
Diphenylcyclopropenone (400 mg, 1.94 mmol), 4-octyne (190 μL, 1.3 mmol) and [RhCl(CO)2]2 (5 
mg, 1 mol%) were weighed out into a Schlenk with stirring bar under argon. To this was added 
toluene (600 μL). The reaction was capped with a septum and heated at 80 °C for 7.5 h. The crude 
reaction mixture was then cooled to room temperature and purified by flash column 
chromatography pentane/ether (30:1) to yield compound 152 as an orange-red oil. 
Yield 140 mg (34%). 
 
1H NMR (CDCl3, 400 MHz): 7.40-7.31 (m, 3H), 7.23 - 7.10 (m, 7H), 2.33 (t, J = 8.0 Hz, 2H), 2.23 (t, J 
= 8.4 Hz, 2H), 1.52 (m, 2H), 1.15 (m, 2H), 0.97 (t, J =7.6 Hz, 3H), 0.78 (t, J = 7.2 Hz. 3H). 
13C NMR (CDCl3, 100 MHz) δ: 202.6, 156.4, 154.1, 134.6, 131.0, 129.7, 128.6, 128.2, 128.1, 127.8, 
126.9, 126.5, 124.7, 28.5, 25.9, 22.9, 21.6, 14.3, 14.1. 
FTIR (thin film): ν = 3396, 3056, 2960, 2931, 2870, 1949, 1881, 1805, 1707, 1600, 1573, 1498, 1463, 
1443, 1357, 1339, 1307, 1090, 1071, 1027, 970, 914, 756, 691 cm-1. 
HRMS (ESI+): m/z 339.1725 [M + Na]+ (calcd. for C23H24NaO: 339.1731). 
Elemental analysis (%): C 87.34, H 7.49 (calcd. for C23H24O: C 87.30, H 7.64). 
 
6.7.2. Complex 155 
 
(2,3-diphenyl-4,5-dipropylcyclopenta-2,4-dien-1-one)iron tricarbonyl complex [155] 
Compound 152 (70 mg, 0.22 mmol) and Fe(CO)5 (207 μL, 1.54 mmol, 7 eq) were dissolved in dry 
toluene (2 mL) in a glass tube autoclave, under argon and heated to 90 °C overnight. After cooling 
down to room temperature, the reaction mixture was filtered through a pad of celite (rinsing with 
CH2Cl2). The filtrate was concentrated in vacuo, and the residue was purified by flash column 
chromatography (9:1 cyclohexane/Et2O) to obtain complex 155 as an orange oil. 
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Yield 86 mg (80%).  
 
1H NMR (400 MHz, CDCl3): δ 7.70-7.67 (dd, 3J = 7.8, 4J = 1.8, 2H), 7.36-7.34 (m, 3H), 7.27-7.24 (dd, 
3J = 7.8, 4J = 1.8, 2H), 7.18-7.14 (m, 3H), 2.57-2.47 (m, 1H), 2.36-2.33 (m, 1H), 2.23-2.16 (m, 2H), 
1.88-1.80 (m, 1H), 1.69-1.59 (m, 1H), 1.35-1.27 (m, 1H), 1.09 (t, 3J = 7.3 Hz, 1H), 0.72 (t, 3J = 7.3 Hz, 
1H). 
13C NMR (CDCl3, 100 MHz): δ 208.9, 171.7, 131.8, 131.2, 130.5, 129.2, 128.7, 128.5, 127.8, 127.4, 
103.4,102.4, 85.4, 80.9, 27.4, 26.7, 24.6, 22.8, 15.0,14.3. 
FTIR (thin film): ν = 2960.73, 2931.8, 2872.01, 2058.05, 2000.18, 1980.89, 1710.86, 1637.56, 
1600.92, 1577.77, 1498.69, 1463.97, 1446.61, 1411.89, 1379.1, 1336.67, 1313.52, 1276.88, 
1261.45, 1188.15, 1157.29, 1122.57, 1087.85, 1074.35, 1051.2, 1028.06, 1001.06, 983.7, 970.19, 
852.54, 802.39, 767.67, 744.52, 729.09, 694.37, 669.3, 613.36 cm-1. 
HRMS (ESI+): m/z 479.0908 [M + Na]+ (calcd. for C23H24O4FeNa: 479.0922). 
 
6.7.3. 2,3,5-triphenyl-4-(1-hydroxy-1ethyl)-cyclopenta-2,4-dien-1-one [154] 
 
Diphenylcyclopropenone (186 mg, 903 μmol) and 4-phenyl-but-3-yn-2-ol (88 mg, 602 μmol) were 
weighed out into a Schlenk with stir bar under nitrogen. To this was added dry toluene (2.0 mL) 
and [RhCl(CO)2]2 (2.4 mg, 6.0 μmol). The tube was then capped with a septum and then heated at 
110 °C overnight under nitrogen. The crude reaction mixture was then cooled to room 
temperature and purified by flash column chromatography (6:1 pentane/EtOAc). Product-
containing fractions were collected and concentrated under reduced pressure to give a red solid. 
Yield 135 mg (64%); m. p. 59-61 °C. 
 
1H NMR (CDCl3, 400 MHz): δ 7.46-7.34 (m, 10H), 7.20-7.13 (m, 5H), 4.93 (dq, Jquart = 6.6 Hz, Jdouble = 
6.5 Hz, 1H), 1.60 (d, J = 6.4 Hz, 1H), 1.26 (d, J = 6.7 Hz, 3H). 
13C NMR (CDCl3, 100 MHz): δ 200.6, 157.4, 154.6, 134.7, 130.7, 130.4, 130.1 (2C), 129.8 (2C), 128.8 
(2C), 128.7 (2C), 128.6, 128.3 (2C), 128.1, 127.9 (2C), 127.4, 126.4, 125.5, 65.3, 22.7. 
FTIR (thin film): ν = 3523, 3054, 2929, 2360, 2341, 1710, 1596, 1491, 1443, 1347, 1263, 1158, 1090, 
1072, 1029, 1015, 910, 796, 740, 697 cm-1. 
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HRMS (ESI+): m/z 352.1460 [M + Na]+ (calcd. for C25H20O2: 352.1463). 
 
6.7.4. Complex 156 
 
(2,3,5-triphenyl-4-(1-hydroxy-1ethyl)-cyclopenta-2,4-dien-1-one)iron tricarbonyl complex [156] 
Compound 154 (80 mg, 0.23 mmol) and Fe(CO)5 (153 μL, 1.13 mmol, 5 eq) were dissolved in dry 
toluene (2 mL) in a glass tube autoclave, under argon and heated to 90 °C overnight. After cooling 
down to room temperature, the reaction mixture was filtered through a pad of celite (rinsing with 
CH2Cl2). The filtrate was concentrated in vacuo, and the residue was purified by flash column 
chromatography (6:1 hexane/EtOAc) to obtain complex 156 as an orange oil. 
Yield 86 mg (80%).  
 
1H NMR (400 MHz, CDCl3): δ 7.74-7.42 (br, 10 H), 7.28-7.10 (br, 5H), 4.53 (br, 1H), 1.53-1.12 (br, 
3H), 0.79 (br, 1H). 
13C NMR could not be registered  
HRMS (ESI+): m/z 479.0908 [M + Na]+ (calcd. for C23H24O4FeNa: 479.0922). 
 
6.7.5. Racemic resolution of 4-phenyl-but-3-yn-2-ol 
 
To a hazy yellow solution of 0.3 g of racemic alcohol 153 in 20 mL of dry hexane and activated 4Å 
molecular sieves, at room temperature and under Argon, 0.69 g of vinyl acetate were added giving 
a clear solution. To this solution 0.15 g (0.5 mass equiv) of the Amano Lipase AK were added and 
the resulting brown suspension was stirred vigorously. The solution was stirred at 25 °C and the 
course of the reaction was followed by 1H NMR. After 7 h, 1H NMR indicated 52% conversion. The 
solution was filtered through a medium-fritted funnel, saving the recovered enzyme and volatiles 
were removed by reduced pressure giving a crude yellow oil. The crude product was 
chromatographed, eluting 20:1 hexane:EtOAc to afford the acetate and the alcohol. 
(R)-acetate, 158: 29.5 g (50%) as a light yellow oil, [α]D = + 173 (c 0.42, MeOH), 98% ee.  
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The column was then eluted with 1:1 hexane:EtOAc to elute the alcohol: 
(S)-4-phenyl-but-3-yn-2-ol, 156: 24.7 g (49.5%) as a light yellow oil. [α]D = - 31 (c 0.77, MeOH), 96% 
ee. 
1H NMR (400 MHz, CDCl3): 7.42 (m, 2H), 7.27 (m, 3H), 4.75 (q, J = 6.6 Hz, 1H), 2.81 (br s, 1H), 1.54 
(d, J = 6.6 Hz, 3H).  
13C NMR (100 MHz, CDCl3): 131.6, 128.3, 128.2, 125.5, 90.9, 83.9, 58.7, 24.3.  
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6.8. General procedure for hydrogenation  
6.8.1. General procedure for hydrogenation reactions with Me3NO as activator 
Hydrogenations were run in a 450 mL Parr autoclave equipped with a removable aluminum block 
that can accommodate up to fifteen magnetically stirred 7 mL glass vials. The pre-catalyst [0.01 
mmol (2 mol%) or 0.005 mmol (1 mol%)] was weighed in glass vials, which were accommodated 
in the aluminum block after adding magnetic stir bars in each of them. The block was placed in a 
Schlenk tube, where it was subjected to three vacuum/nitrogen cycles. iPrOH (0.25 mL) was added 
to each vial, and stirring was started. Me3NO [2 eq respect to the catalyst, 0.02 mmol (4 mol%) or 
0.01 mmol (2 mol%)] was added to each vial as an H2O solution (0.1 mL). After stirring at room 
temperature under nitrogen for 10 min, the substrate (0.5 mmol) was added to the mixture. Each 
vial was capped with a Teflon septum pierced by a needle, the block was transferred into the 
autoclave, and stirring was started. After purging four times with hydrogen at the selected 
pressure, heating was started. The reactions were stirred under hydrogen pressure overnight and 
then filtered through a pad of celite and analyzed for determining the conversion. Conversions 
were determined by 1H-NMR, 19F-NMR or by GC for conversion and ee determination. 
 
6.8.2. General procedure for photolytically induced hydrogenation 
Hydrogenation experiments were carried out in a custom-made glass autoclave equipped with a 
thick-walled glass reaction vessel (total capacity 20 mL, maximum pressure 25 bar), a single inlet 
valve, a manometer, and safety relieve valve. UV irradiation experiments were carried out in a 
Rayonet RPR-100 (Southern New England UV Company, USA). The UV lamps used have the 
specification F8T5BLB, 8 W, 352 nm (Sanyo Denki, Japan). 
Acetophenone (5.50 μL, 47.1 μmol, 1 equiv) and dodecane (8.0 μL, 44.0 μmol) were dissolved in 
toluene (1.0 mL) in a glass autoclave (20 mL capacity) under a stream of argon. A 0.0236 mM 
toluene stock solution of the iron pre-catalyst (0.1 mL, 2.36 μmol, 0.05 equiv) was added. The 
autoclave was sealed and filled with and then carefully discharged from argon (14 to 1 bar) and it 
was purged for three times with hydrogen (14 bar). After the last fill/vent cycle, the autoclave was 
loaded with hydrogen (14 bar) and discharged to the desired reaction pressure (10 bar). The vessel 
was placed in a Rayonet RPR-100 (Southern New England UV Company) and irradiated (λmax = 
350 nm). The reaction mixture was stirred under hydrogen pressure and 40 °C as indicated by the 
total reaction time. Conversions were determined by GC using dodecane as internal standard. 
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6.8.3. General procedure for the transfer hydrogenation 
A 10 mL Schlenk was charged with a stir bar and the iron complex (0.01 mmol, 0.02 eq) in iPrOH 1 
mL), followed by addition of a stock solution of Me3NO (1.5 mg, 0.02 mmol, 0.04 eq) in H2O (0.4 
mL). After stirring for 5 min, acetophenone (117 µL, 120.2 mg, 1.0 mmol, 1 eq) was added, and 
the obtained mixture was heated at 70 °C and stirred for 16 h. Conversions were determined by 
GC using dodecane as internal standard. 
 
6.8.4. Conditions for conversion and ee determination by GC for products in Table 9  
Products’ absolute configurations (Table 9, paragraph 4.3.4)  were assigned by comparison of the 
sign of optical rotation with literature data (see the references cited for each compound).  
(S)-1-Phenylethanol (GC): capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β- 
cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 
bar; oven temperature: 95 °C for 20 min: tsubstrate = 6.0 min; tproduct(R) = 13.2 min; tproduct(S) = 15.1 
min.[193]  
(S)-1-(4-(Trifluoromethyl)phenyl)ethanol (GC): capillary column: MEGADEX DACTBSβ, diacetyl-
tert-butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet 
pressure: 1 bar; oven temperature: 110 °C for 20 min: tsubstrate = 6.4 min; tproduct(R) = 14.3 min; 
tproduct(S) = 15.4 min.[194]  
(S)-1-(4-Methoxyphenyl)ethanol (GC): capillary column: MEGADEX DACTBSβ, diacetyl-tert- 
butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet 
pressure: 1 bar; oven temperature: 110 °C for 10 min; 30 °C/min gradient; 120 °C for 10 min; 30 
°C/min gradient; 130 °C: tsubstrate = 20.1 min; tproduct(R) = 21.1 min; tproduct(S) = 22.6 min.[195]  
(S)-1-(4-Chlorophenyl)ethanol (GC): capillary column: MEGADEX DACTBSβ, diacetyl-tert-
butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet 
pressure: 1 bar; oven temperature: 110 °C for 10 min; 30 °C/min gradient; 120 °C for 10 min; 30 
°C/min gradient; 130 °C: tsubstrate = 12.8 min; tproduct(R) = 23.4 min; tproduct(S) = 24.3 min.[195] 
(S)-1-(Naphthalen-2-yl)ethanol (GC): capillary column: MEGADEX DACTBSβ, diacetyl-tert-
butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet 
pressure: 1 bar; oven temperature: 150 °C for 20 min: tsubstrate = 10.6 min; tproduct(R) = 16.9 min; 
tproduct(S) = 17.9 min.[195] 
(S)-1-Phenylpropan-1-ol (GC): capillary column: MEGADEX DACTBS, diacetyl-tert-butylsilyl--
cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 
bar; oven temperature: 95 °C for 20 min: tsubstrate = 9.4 min; tproduct(R) = 16.6 min; tproduct(S) = 18.5 
min.[196] 
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(S)-1-Cyclohexylethanol (GC): capillary column: MEGADEX DACTBS, diacetyl-tert-butylsilyl--
cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 
bar; oven temperature: 120 °C for 20 min: tsubstrate = 4.9 min; tproduct(S) = 6.2 min; tproduct(R) = 7.6 
min.[197] 
(S)-1,2,3,4-Tetrahydronaphthalen-1-ol (GC): capillary column: MEGADEX DACTBS, diacetyl-tert-
butylsilyl--cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet 
pressure: 1 bar; oven temperature: 120 °C for 20 min: tsubstrate = 9.5 min; tproduct(R) = 11.0 min; 
tproduct(S) = 12.2 min.[198] 
(R)-2,3-Dihydro-1H-inden-1-ol (GC): capillary column: MEGADEX DACTBS, diacetyl-tert-
butylsilyl--cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet 
pressure: 1 bar; oven temperature: 110 °C for 20 min: tsubstrate = 12.9 min; tproduct(S) = 11.8 min; 
tproduct(R) = 14.2 min.[199] 
rac-4-Methylpentan-2-ol (GC): capillary column: MEGADEX DACTBS, diacetyl-tert-butylsilyl--
cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 
bar; oven temperature: 120 °C for 20 min): tsubstrate = 10.6 min; ten.1 = 11.6 min; ten.2 = 13.5 min. 
(S)-1-(Naphthalen-1-yl)ethanol (GC and HPLC): GC conditions for conversion determination: 
capillary column: MEGADEX DACTBS, diacetyl-tert-butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 
0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 bar; oven temperature: 150 °C for 15 
min): tsubstrate = 8.0 min; tproduct(R+S) = 10.4 min. HPLC conditions of ee determination: column: Daicel 
Chiralcel OD-H; eluent: 9:1 n-hexane/iPrOH; flow: 1 mL/min; λ = 210 nm; tsubstrate = 7.1 min; tproduct(S) 
= 9.3 min; tproduct(R) = 13.3 min.[195] 
(S)-1-(Pyridin-3-yl)ethanol (GC and HPLC): GC conditions for conversion determination: capillary 
column: MEGADEX DACTBS, diacetyl-tert-butylsilyl--cyclodextrin, 0.25 μm; diameter = 0.25 
mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 bar; oven temperature: 130 °C for 15 min: 
tsubstrate = 3.4 min; tproduct(R+S) = 12.0 min. HPLC conditions of ee determination: column: Daicel 
Chiralcel OB-H; eluent: 9:1 n-hexane/iPrOH; flow: 0.8 mL/min; λ = 210 nm; tproduct(S) = 10.6 min; 
tproduct(R) = 17.4 min; tsubstrate = 20.1 min.[170] 
(S)-3,3-Dimethylbutan-2-ol (GC): capillary column: CP-Chirasil-Dex CB, 0.25 μm; diameter = 0.25 
mm; length = 25 m; carrier: hydrogen; inlet pressure: 1.89 bar; oven temperature: 60 °C for 11 
min: tsubstrate = 3.3 min; tproduct(S) = 10.1 min; tproduct(R) = 10.6 min.[200] 
(R)-1,2,3,4-Tetrahydronaphthalen-2-ol (GC): the product was derivatized as acetate before 
injection. Capillary column: MEGADEX DACTBS, diacetyl-tert-butylsilyl--cyclodextrin, 0.25 μm; 
diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 bar; oven temperature: 
110 °C for 40 min: tproduct(R) = 29.3 min; tproduct(S) = 30.3 min; tsubstrate = 35.1 min.[201] 
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6.8.5. NMR conversion and conditions for conversion by GC for products in Table 12 
NMR conversions (Table 12, paragraph 4.4.1) were calculated from the signal integrals (all the 
substrates and reduction products are known compounds, and the spectra are superimposable to 
those reported in the literature). The NMR spectra were measured taking d1 = 20 s. 
1-Phenylethanol: Capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β-cyclodextrin, 
0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 bar; oven 
temperature: 95 °C for 20 min: tsubstrate = 6.0 min; tproduct(R) = 13.2 min; tproduct(S) = 15.1 min. After the 
hydrogenation, the volatiles were evaporated and the residue was purified by flash column 
chromatography (eluent: 9:1 hexane/AcOEt). The product was isolated as a colorless oil. Yield: 239 
mg (98%). Its physical and spectroscopic data are superimposable with those reported in the 
literature. 1H-NMR (300 MHz, CDCl3): δ 7.43-7.34 (m, 4H), 7.33-7.28 (m, 1H), 4.92 (q, J = 6.5 Hz, 
1H), 1.91 (s, 1H), 1.53 (d, J = 6.5 Hz, 3H).[202] 
1-(3-Nitrophenyl)ethanol: 1H-NMR (300 MHz, CDCl3): δ 8.22 (s, 1H), 8.09 (d, J = 6.8 Hz, 1H), 7.70 
(d, J = 6.8 Hz, 1H), 7.49 (t, J = 6.0 Hz, 1H), 5.01 (q, J = 6.0 Hz, 1H), 2.73 (br s, 1H), 1.52 (d, J = 6.0 Hz, 
3H).[202] 
1-(4-Methoxyphenyl)ethanol: After the hydrogenation, the volatiles were evaporated and the 
residue was purified by flash column chromatography (eluent: 9:1 hexane/AcOEt). The product 
was isolated as a colorless oil. Yield: 298 mg (98%). Its physical and spectroscopic data are 
superimposable with those reported in the literature. 1H-NMR (300 MHz, CDCl3): δ 7.32 (d, J = 8.7 
Hz, 2H), 6.91 (d, J = 8.7 Hz, 2H), 4.88 (q, J = 6.4 Hz, 1H), 3.83 (s, 3H), 1.82 (br s, 1H), 1.50 (d, J = 6.4 
Hz, 3H).[202] 
4-Bromophenyl)ethanol: After the hydrogenation, the volatiles were evaporated and the residue 
was purified by flash column chromatography (eluent: 9:1 hexane/AcOEt). The product was 
isolated as a white solid. Yield: 390 mg (97%). Its physical and spectroscopic data are 
superimposable with those reported in the literature. 1H-NMR (300 MHz, CDCl3): δ 7.49 (d, J = 8.4 
Hz, 2H), 7.27 (d, J = 8.4 Hz, 2H), 4.89 (q, J = 6.5 Hz, 1H), 1.85 (s, 1H), 1.49 (d, J = 6.5 Hz, 3H).[203] 
1-(2-Methoxyphenyl)ethanol: 1H-NMR (300 MHz, CDCl3): δ 7.33 (d, J = 7.6 Hz, 1H), 7.24 (dt, J = 
7.6, 1.6 Hz, 1H), 6.95 (t, J = 7.6 Hz, 1H), 6.87 (d, J = 7.6 Hz, 1H), 5.09 (q, J = 6.4 Hz, 1H), 3.84 (s, 3H), 
2.74 (br s, 1H), 1.49 (d, J = 6.4 Hz, 3H).[203] 
1-(2-Chlorophenyl)ethanol: 1H-NMR (300 MHz, CDCl3): δ 7.56 (d, J = 7.6 Hz, 1H), 7.29 (m, 2H), 7.18 
(d, J = 7.6 Hz, 1H), 5.26 (d, J = 6.4 Hz, 1H), 2.45 (br s, 1H), 1.45 (d, J = 6.4 Hz, 3H).[203] 
1-(Pyridin-2-yl)ethanol: 1H-NMR (300 MHz, CDCl3): δ 8.52 (d, J = 7.7 Hz, 1H), 7.69 (t, J = 7.9 Hz, 1H), 
7.30 (d, J = 7.9 Hz, 1H), 7.19 (t, J = 7.9 Hz, 1H), 4.90 (d, J = 6.5 Hz, 1H), 4.46 (br s, 1H), 1.50 (d, J = 
6.5 Hz, 3H).[202] 
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1,2,3,4-Tetrahydronaphthalen-1-ol: Hydrogenated product (conv. = 80%): 1H-NMR (300 MHz, 
CDCl3): δ 7.44 (m, 1H), 7.24-7.19 (m, 2H), 7.13-7.10 (m, 1H), 4.76 (s, 1H), 2.87-2.70 (m, 2H), 2.01-
1.76 (m, 5H). 
Residual starting material (20%): 1H-NMR (300 MHz, CDCl3): δ 8.03 (d, J = 8.0 Hz, 1H), 7.46 (t, J = 
7.6 Hz, 1H), 7.30 (t, J = 7.6 Hz, 1H), 7.25 (d, J = 7.6 Hz, 1H), 2.96 (t, J = 6.0 Hz, 2H), 2.65 (t, J = 6.4 
Hz, 2H), 2.17-2.10 (m, 2H). [203] 
Octan-3-ol: 1H-NMR (300 MHz, CDCl3): δ 3.53 (br s, 1H), 1.25-1.56 (m, 11H), 0.86-0.97 (m, 6H).[204] 
1-Cyclopropylethanol: 1H-NMR (300 MHz, CDCl3): δ 3.05 (dq, J = 8.3, 6.2 Hz, 1H), 1.85 (s, 1H), 1.25 
(d, J = 6.2 Hz, 3H), 0.91-0.84 (m, 1H), 0.48-0.46 (m, 2H), 0.26-0.23 (m, 1H), 0.17-0.15 (m, 1H).[205] 
4-Phenylbut-3-en-2-ol: 1H-NMR (300 MHz, CDCl3): δ 7.18-7.39 (5H, m), 6.53-6.58 (1H, m), 6.22-
6.29 (1H, m), 4.46-4.50 (1H, m), 1.36 (d, J = 6.0 Hz, 3H).[206] 
4-Phenylbutan-2-ol: 1H-NMR (300 MHz, CDCl3): δ 7.18-7.39 (m, 5H), 3.78-3.85 (m, 1H), 2.63-2.75 
(m, 2H), 3.78-3.85 (m, 1H), 1.78 (br s, 1H), 1.75-1.77 (m, 2H), 1.22 (d, J = 6.0 Hz, 3H).[207] 
3,5,5-Trimethylcyclohex-2-enol: Hydrogenated product (conv. = 15%): 1H-NMR (300 MHz, CDCl3): 
δ 5.89 (s, 1H), 2.20 (2H, s), 2.17 (s, 2H), 1.94 (s, 3H), 1.04 (s, 6H). 
Residual starting material (85%): 1H-NMR (300 MHz, CDCl3): δ 5.43 (m, 1H), 4.25 (m, 1H), 1.87-1.74 
(m, 10H), 1.68 (s, 3H), 1.96-2.10 (m, 1H).[206] 
2-Methylcyclopentan-1-ol (mixture of trans and cis isomer): Trans isomer: 1H-NMR (300 MHz, 
CDCl3): δ 3.73 (q, J = 6.0 Hz, 1 H), 1.31-1.89 (m, 8H), 1.20 (d, J = 7.0 Hz, 3H). 
Cis isomer: 1H-NMR (300 MHz, CDCl3): δ 4.06 (m, 1 H), 1.31-1.89 (m, 5H), 1.16 (m, 1 H), 0.96 (d, J 
= 7.0 Hz, 3H). No attempts were made to separate the two isomers.[208] 
Benzyl alcohol: Capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β-cyclodextrin, 0.25 
μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 bar; oven 
temperature: 95 °C for 20 min: tsubstrate = 3.54 min; tproduct = 11 min.  
After the hydrogenation, the volatiles were evaporated and the residue was purified by flash 
column chromatography (eluent: 9:1 hexane/AcOEt). The product was isolated as a colorless 
liquid. Yield: 203 mg (94%). Its physical and spectroscopic data are superimposable with those 
reported in the literature. 1H-NMR (300 MHz, CDCl3): δ 7.30-7.42 (m, 5H), 4.73 (s, 2H), 1.66 (s, 
1H).[202] 
Cyclohexylmethanol: Capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β-
cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 
bar; oven temperature: 95 °C for 20 min: tsubstrate = 2.98 min; tproduct = 18.9 min. 
 After the hydrogenation, the reaction mixture was diluted with water and extracted with Et2O (3 
x 10 mL). The combined organic extracts were dried over Na2SO4 and then the solvent was 
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removed by rotary evaporator (temperature, pressure and time of evaporation had to be carefully 
controllled, as the product is quite volatile). The residue was purified by flash column 
chromatography (eluent: CD2Cl2), giving a a colorless liquid. Yield: 196 mg (86%). Its physical and 
spectroscopic data are superimposable with those reported in the literature. 1H-NMR (300 MHz, 
CDCl3): δ 3.47 (d. J = 6.4 Hz, 2H), 1.83 -1.66, (m, 5H), 1.56-1.39 (m, 2H), 1.35-1.12 (m, 3H), 0.97 (m, 
2H).[209] 
Dodecan-1-ol: Capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β-cyclodextrin, 0.25 
μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 bar; oven 
temperature: 95 °C for 17 min, then 30 °C/min ramp to 200 °C: tsubstrate = 19.5 min; tproduct = 20.1 
min. 1H-NMR (300 MHz, CDCl3): δ 3.39 (t, J = 6.6 Hz, 2H), 1.61-1.68 (m, 2H), 1.57-1.59 (m, 2H), 
1.24-1.34 (m, 16H), 0.88 (t, J = 6.81 Hz, 3H).[210] 
3-Phenylprop-2-en-1-ol: Capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β-
cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 
bar; oven temperature: 95 °C for 20 min: tsubstrate = 19.6 min; tproduct(a) = 19.2 min; tproduct(b) = 20.1 
min.  
1H NMR (300 MHz, CDCl3): δ 4.36 (d, J = 5.7, 2H), 6.37-6.43 (m, 1H), 6.65 (d, J = 15.9 Hz, 1H), 7.22-
7.43 (m, 5H).[211] 
3-Phenyl-1-propanol: Capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β-
cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; inlet pressure: 1 
bar; oven temperature: 95 °C for 20 min: tsubstrate = 19.6 min; tproduct(b) = 19.2 min; tproduct(a) = 20.1 
min.  
1H NMR (300 MHz, CDCl3): δ 7.22-7.31 (m, 5H), 3.71 (t, J = 6.4 Hz, 2H), 2.74 (t, J = 7.2 Hz, 2H), 1.93 
(m, 2H).[212] 
Benzyl alcohol and 2,2,2-trifluoroethanol: For benzyl alcohol, see above. 2,2,2-Trifluoroethanol 
(conv. = 99%): 1H-NMR (300 MHz, CDCl3): δ 3.92 (q, J = 8.4 Hz, 2H), 3.40 (br s, 1H). 19F NMR (300 
MHz, CDCl3): δ -76.93 (s, 3F). 
Residual of starting material (1%): 1H-NMR (300 MHz, CDCl3): δ 7.40 (s, 5H), 5.36 (s, 2H). 19F NMR 
(282 MHz, CDCl3): δ -75.96 (s, 3F).[213] 
 
6.8.6. Determination of the hydrogenation kinetics of acetophenone 
Abbreviations used: Rsub.,t = fraction of unreacted substrate (Rsub.,0 = 1); ccat. = catalyst 
concentration; c0,Sub = initial substrate concentration. 
Experimental parameters: T = 243.15 K; c0,Sub = 0.501 M; ccat. = 5 mM; solvent:5:2 iPrOH/H2O; 
Phydrogen = 30 bar. 
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General procedure. The kinetic experiments were carried out using a computer-controlled Parr 
multireactor. Each reaction was set up as follows: the pre-catalyst 46 or 123 (0.03508 mmol, 0.01 
equiv) was weighted in a glass vessel and, after purging with argon for 2 minutes, it was dissolved 
in dry iPrOH (5 mL), and then a solution of Me3NO (5.3 mg, 0.07016 mmol, 0.02 equiv) in H2O (2 
mL) was added. The resulting solution was stirred for 10 minutes, and then the vessel was placed 
into the autoclave, evacuated and filled with hydrogen (P = 30 bar). Mechanical stirring (300 rpm) 
was immediately started together with heating (70 °C), and the reaction was run overnight 
measuring the hydrogen uptake, from which conversion values were calculated. The final 
conversion was confirmed by GC analysis of the crude reaction mixture. 
Note: time = 0 was marked when the reactor was filled with hydrogen. Pseudo-first order rate 
constants kapp and corresponding half-lives t1/2 were determined from the slope of a linear least 
squares fit to the graph of ln(Rsub.,t) = -kt. Second order constants k were calculated dividing kapp 
by ccat (assumed to be constant). 
 
Figure 32. Kinetics of the hydrogenation of acetophenone promoted by pre-catalyst 123 activated with 
Me3NO.  
 
Table 20. Kinetic parameters of the hydrogenation of acetophenone promoted by pre-catalyst 123 
activated with Me3NO. 
 
 
Regression  interval = 12-24 min
Linear Slope Intercept
regression -0,0360 0,0000
Standard error = 0,0010 #N/D
R
2
 = 0,9899 0,0695
F index = 1174,7910 12,0000
5,6825 0,0580
k app (min
-1
) = 0,036
t 1/2 (min) = ln(2) / k = 19,27
k  (L mol
-1
 min
-1
) = 7,19
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Figure 33. Kinetics of the hydrogenation of acetophenone promoted by pre-catalyst 46 activated with 
Me3NO. 
 
Table 21. Kinetic parameters of the hydrogenation of acetophenone promoted by pre-catalyst 46 
activated with Me3NO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression  interval = 6 - 16 min
Linear Slope Intercept
regression -0,0396 0,0000
Standard error = 0,0012 #N/D
R
2
 = 0,9916 0,0439
F index = 1174,5795 10,0000
2,2630 0,0193
k app (min
-1
) = 0,040
t 1/2 (min) = ln(2) / k = 17,49
k  (L mol
-1
 min
-1
) = 7,93
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7.1.2. Complex 66 
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7.1.3. Complex 67 
 
 
 
 
 
1
9
5
.2
2
8
.3
4
8
.8
1
6
.0
0
0
.4
7
0
.5
5
0
.4
7
0
.5
9
1
.1
0
0
.9
2
1
.0
8
1
.1
3
1
2
.7
4
3
.9
9
5
.9
5
-0
.2
2
0
.2
9
1
.7
9
1
.8
2
3
.5
8
3
.6
4
3
.6
9
3
.7
0
3
.7
4
3
.7
5
3
.9
9
4
.0
0
4
.0
4
4
.0
6
6
.9
0
6
.9
3
7
.0
9
7
.1
9
7
.2
0
7
.2
2
7
.2
4
7
.2
7
7
.3
5
7
.4
3
7
.4
7
7
.4
9
7
.5
2
7
.5
4
7
.5
7
7
.6
0
7
.7
9
7
.8
1
7
.8
2
7
.8
4
7
.8
5
7
.8
6
7
.8
8
7
.8
9
7
.9
8
8
.0
0
8
.0
3
8
.0
6
8
.0
9
31P NMR 161.9 MHz (CD2Cl2) 
Appendix 
174 
 
7.1.4. Complex (R)-85 
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7.1.5. Complex (R)-86 
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7.1.6. Complex (R)-97 
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7.1.7. Complex (R)-98 
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7.1.8. Complex (R)-99 
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7.1.9. Complex (R)-100 
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7.1.10. Complex (R)-101 
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7.1.11. Complex (R)-102 
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7.1.12. Complex (R)-103 
 
 
19F NMR 282 MHz (CDCl3) 
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7.1.13. Free ligand 106 
 
 
 
7.1.14. Free ligand 107 
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7.1.15. Free ligand 108 
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7.1.16. Complex 123 
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7.1.17. Complex 155 
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